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ZUSAMMENFASSUNG 
 
Reelin ist ein grosses extrazelluläres Matrixprotein, welches essenziell für die korrekte neuronale 
Positionierung während der embryonalen/neuronalen Entwicklung ist. Dieselbe lipoprotein-
vermittelte Signalkaskade reguliert die NMDA Rezeptor vermittelte Neurotransmission und 
moduliert synaptische Funktionen und Plastizität im adulten Gehirn. Dies geht einher mit der 
Tatsache, dass eine altersbedingte Reduktion der Reelin Expression zur kognitiven 
Beeinträchtigungen während des normalen Alterns beiträgt. Neueste experimentelle Erkenntnisse 
weisen auf die Beteiligung von dysfunktionalem Reelin in pathologischen Formen des Alterns 
hin, wie sporadische Alzheimer Demenz (AD), welche histopathologisch durch senile Plaques 
und Neurofibrillen charakterisiert ist. Da das Alter als Hauptrisikofaktor für die AD gilt, wurden 
die potentiellen Veränderungen in der Reelin Expression während normalem und 
pathologischem Altern untersucht. Diese Daten zeigten einen äußerst konsistenten 
altersbedingten Verlust von Reelin-exprimierenden Neuronen, begleitet von einer Anreicherung 
in extrazellulären Reelin-positiven amyloid-ähnlichen Ablagerungen im Hippokampus 
verschiedener alternder Spezies. Eine pränatale Immunstimulation durch Injektion der virus-
ähnlichen Substanz Polyriboinosin-Polyribocytidil-Säure (PolyI:C) in Wildtyp Mäusen 
resultierte interessanterweise in früheren, sowie erhöhten und beständigeren Mengen dieser 
Ablagerungen. Dennoch bleibt der molekulare Mechanismus, durch welchen dieses konservierte 
extrazelluläre Glykoprotein zur Krankheitsentstehung von AD beiträgt, weitgehend unbekannt. 
 
Das allgemeine Ziel dieser Arbeit war, die morphologischen, ultrastrukturellen und 
biochemischen Eigenschaften der Reelin Aggregate aufzuklären, um deren Herkunft und 
Bedeutung im Hinblick auf neurodegenerative Prozess im alternden Gehirn zu ermitteln. Auf 
diese Weise sollte eine potentielle molekulare Verbindung zwischen einer Reelin-Fehlfunktion 
und AD-assoziierter Neuropathologie untersucht werden. Dafür wurde zu Beginn ein 
immunohistochemisches Protokoll entwickelt, welches eine stringente und verlängerte 
Vorbehandlung mit der Endopeptitase Pepsin beinhaltete, um die Reelin-positiven Strukturen im 
Hippokampus alternder Wildtyp Mäuse optimal zu detektieren und zu charakterisieren. Diese 
Methode verbesserte die Reelin-Immunreaktivität (IR) merklich, was deutlich auf einen 
aggregierten und Protease-resistenten Zustand dieser Ablagerungen hinweist. Darüber hinaus 
ermöglichte diese Behandlung erstmals den spezifischen Nachweis verschiedener muriner 
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proteolytischer Amyloid-Precursor Protein (APP) Fragmente in alten Wildtyp Mäusen. Diese 
Untersuchungen zeigten, dass Reelin sehr selektiv mit fibrillären Amyloid-beta (Aβ) Spezies 
assoziiert, aber nicht vollständig co-lokalisiert ist. Auf der anderen Seite zeigten oligomere Aβ-
Ablagerungen eine hohe Co-Lokalisationsrate mit Reelin, welches vorangegangene 
Untersuchungen mit transgenen AD-Mausmodellen bestätigt und erweitert. Diese 
immunhistochemischen Daten wurden mit ultrastrukturellen Untersuchungen ergänzt, welche die 
Präsenz von Reelin im extrazellulären Raum und im Somata von Interneuronen sowohl in jungen 
als auch alten Wildtyp Mäusen bestätigte. Zusätzlich wurde in alten Mäusen sowohl Reelin- als 
auch Aβ-IR in extrazellulären, granulären Ablagerungen detektiert und bekräftigte unsere 
vorangegangenen immunhistochemischen Resultate. Weitere Untersuchungen ergaben eine enge 
Assoziation der einzelnen Sphären mit Astrozyten beziehungsweise Mikroglia, was auf einen 
phagozytischen Prozess hindeutet. Interessanterweise waren diese Strukturen ebenfalls eng mit 
Dendriten verbunden, was auf eine intrazelluläre Herkunft der Ablagerungen hindeutet. Dies 
wurde ferner durch die immunhistochemischen Beobachtungen bekräftigt, welche Reelin in 
Axonen als auch axonalen Schwellungen aufzeigen. Dieses Phänomen beeinträchtigt 
möglicherweise die axonale Integrität und repräsentiert eine denkbare Herkunft der individuellen 
globulären Strukturen. Ultrastrukturelle Untersuchungen der PolyI:C-exponierten Mäuse zeigten 
signifikante Unterschiede in Bezug auf die Plaquemorphologie. Im Vergleich zur Kontrollgruppe 
(NaCl) zeigten die immunstimulierten Tiere (PolyI:C) grössere granuläre Ablagerungen, eine 
erhöhte Präsenz von Mitochondrien in diesen Strukturen, als auch degenerative Merkmale. 
 
Um die Präsenz von Reelin und seinen proteolytischen Fragmenten in den granulären Strukturen 
nachzuweisen und zu bestätigen, wurde ein biochemischer und proteomischer Ansatz initiiert. 
Dafür wurde Laser-Mikrodissektion mit Massenspektrometrie kombiniert, um die Komposition 
und Herkunft der granulären Ablagerungen zu untersuchen. Obwohl dieser Ansatz noch weiterer 
technischer Verbesserungen bedingt, um die Plaque Komponenten mit hoher Genauigkeit zu 
charakterisieren, konnte die Anreicherung von Reelin als auch des N-terminalen Fragmentes 
mittels Western Blot bestätigt werden.  
 
Weitere Untersuchungen über den Einfluss von Reelin auf die APP Prozessierung und Aβ-
Produktion wurden in transgenen AD-Mäusen mit genetisch reduzierten Reelin Levels 
durchgeführt. Diese Ergebnisse lieferten den ersten Beweis verstärkter amyloidogener 
Prozessierung als auch beschleunigter Plaque Formation in den Doppel-Mutanten im Vergleich 
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zu den Kontrollmäusen und ergänzten jüngste in vitro Daten, welche eine Regulierung in der 
APP Prozessierung nach der Bindung von Reelin an dieses Membranprotein belegen. Darüber 
hinaus zeigten die Reelin-defizienten AD-Mäuse eine nachhaltig verstärkte Aβ-Plaque-
Pathologie mit zunehmendem Alter. Dieses Phänomen war von erheblicher Mikro- and 
Astrogliose begleitet und einer beachtlichen Anreicherung phosphoTau-positiver Neuronen und 
Neurofibrillen um die Aβ-Ablagerungen im Hippokampus. Diese Studie liefert den ersten in vivo 
Support, dass eine Fehlfunktion in der Reelin-vermittelten Signalübertragung einen kritischen 
Einfluss auf die amyloidogene APP Prozessierung als auch Tau Hyperphosphorylierung hat.  
 
Zusammenfassend liefert diese Arbeit wichtige neue Einblicke in die Funktion der Reelin-
vermittelten Signalübertragung im erwachsenen und alternden Gehirn. Diese Beobachtungen 
heben Fehlfunktionen von Reelin als einen massgeblichen Initialfaktor hervor, der 
möglicherweise imstande ist, eine AD-ähnliche Neuropathologie auszulösen. Daraus folgt, dass 
eine fehlgeleitete Reelin Signalübertragung eine entscheidende treibende Kraft in der 
Verlagerung von Alterungsprozessen zu einer pathologischen, neurodegenerativen Krankheit 
darstellt. Dies beinhaltet die intrazelluläre abnormale Aggregation von Reelin, welche die Aβ- 
und Tau-Pathologie begünstigt und zu Neurodegeneration führen kann. Unsere Daten zeigen  
zudem, dass diese neuropathologischen Veränderungen durch eine pränatale, periphere 
Immunstimulation (PolyI:C) oder einer genetischer Reduktion von Reelin  stark beschleunigt 
werden können.  
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SUMMARY 
 
Reelin is a large extracellular matrix protein essential for mediating proper neuronal positioning 
during development. Employing the same lipoprotein-mediated signaling cascade, Reelin 
regulates NMDA receptor homeostasis and modulates synaptic function and plasticity in adult 
synapses. In line, aging-related reduction in Reelin expression has been shown to contribute to 
cognitive impairments during normal aging. Recent experimental evidence suggests an 
involvement of dysfunctional Reelin in pathological forms of aging, such as late-onset 
Alzheimer’s disease (AD), which is characterized histopathologically by senile plaques and 
neurofibrillary tangles. Since aging is the major risk factor of AD, the putative changes in Reelin 
expression during normal and pathological forms of aging have recently been investigated. This 
data revealed a highly consistent age-related loss of Reelin-expressing neurons and concomitant 
accumulation in extracellular Reelin-positive amyloid-like deposits in the hippocampal 
formation of several aged species. Interestingly, a prenatal immune challenge in normal wild 
type mice using the synthetic viral mimic polyriboinosinic-polyribocytodilic acid (PolyI:C) 
resulted in earlier, higher and much more persistent levels of these Reelin-positive deposits in the 
hippocampal formation. However, the molecular mechanism by which this conserved 
glycoprotein contributes to the pathogenesis of AD remains still largely unknown.  
 
Here, the general aim was to elucidate the morphological, ultrastructural, and biochemical 
properties of the Reelin aggregates in order to identify their origin and significance with respect 
to neurodegenerative processes characteristic of the aged brain. With that we aimed to provide a 
putative molecular link between Reelin dysfunction and AD-related neuropathology. To achieve 
these aims, we first developed an immunohistochemical protocol involving stringent and 
prolonged pretreatment with the endopeptidase pepsin to optimally detect and characterize 
Reelin-positive clustered structures in the hippocampal formation of aged wild type mice. This 
procedure markedly enhanced Reelin-immunoreactivity (IR) pointing to an aggregated and 
protease-resistant state of these deposits. Moreover, this treatment allowed for the first time the 
specific detection of several murine proteolytic amyloid precursor protein (APP) fragments in 
aged wild type mice. These investigations revealed that Reelin was selectively associated but not 
completely co-localized with fibrillary Aβ species. Oligomeric Aβ deposits on the other hand 
showed a very high degree of co-localization with Reelin, confirming and extending previous 
 X 
findings involving transgenic AD mouse models. These data were complemented by 
ultrastructural investigations. We confirmed the presence of Reelin in extracellular space and 
somata of interneurons in young and aged wild type mice. In aged mice, Reelin- and amyloid-β-
IR was detected in extracellular, spherical deposits, confirming our immunohistochemical data. 
Additional investigations revealed a close association of the individual granules with astrocytes 
and microglia, respectively, likely indicative of a phagocytic process. Interestingly, these 
granules were closely associated with dendritic processes confirming a putative intracellular 
origin. This was further confirmed by immunohistochemical observations, detecting Reelin in 
axons as well as Reelin aggregates in axonal swellings, likely affecting the axonal integrity and 
representing a possible origin of the individual granules. Ultrastructural investigations of PolyI:C 
exposed mice revealed significant differences with respect to plaque morphology following 
prenatal immune challenge compared to saline exposed mice, as indicated by a larger granule 
size, the increased presence of mitochondria in the granules, as well as degenerative features.  
 
In order to confirm the presence of Reelin and its proteolytic fragments within these granular 
aggregates, we initiated a biochemical and proteomic investigation. We combined laser 
microdissection with mass spectrometry in order to investigate the granular composition and 
provide information on their origin. Although this current approach needs further technical 
improvement in order to characterize with high fidelity the plaque components, we confirmed 
the enrichment of full-length Reelin and its N-terminal fragment in these deposits by western 
blotting. 
 
Further investigations on the involvement of Reelin in AD pathology included biochemical 
analyses on APP processing and amyloid-β peptide production in transgenic AD mice with 
genetically reduced Reelin levels. Our data provided first evidence of enhanced amyloidogenic 
processing and accelerated plaque formation in double-mutant as compared to control mice, 
complementing recent in vitro data showing modulation in APP trafficking and processing 
following Reelin binding to this membrane protein. Furthermore, we observed that the Aβ-
plaque pathology was strongly aggravated in the Reelin deficient AD mice during aging, 
accompanied by significant micro- and astrogliosis and a striking accumulation of phospho-Tau 
positive neurons and neurofibrillary tangle-like structures around amyloid plaques in the 
hippocampal formation. This study provides the first in vivo support that dysfunctional Reelin-
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mediated signaling is a critical upstream modulator of amyloidogenic APP processing and Tau 
hyperphosphorylation. 
 
Taken together, we provide important novel insights into the function of Reelin-mediated 
signaling in the adult and aging brain. These observations highlight Reelin as an important 
upstream factor able to trigger AD-like pathology in the pathogenesis of sporadic AD. We 
propose dysfunctional Reelin signaling as an important driving force able to induce a shift from 
normal to pathological aging, including an intracellular and abnormal aggregation of Reelin, 
possibly leading to neurodegeneration.  This gets accelerated by a prenatal peripheral immune 
challenge (PolyI:C), and increased Aβ- and Tau pathology due to genetic reduction of Reelin.  
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 1
I. GENERAL INTRODUCTION 
 
1. REELIN  
Reelin, a large glycoprotein, is a major secretory protein with important roles during 
neurodevelopment in regulating neuronal migration and correct lamination of the cortex 
(Cooper, 2008; D'Arcangelo et al., 1999; Forster et al., 2006; Frotscher et al., 2009; Rice and 
Curran, 2001). In the adult brain, Reelin plays a crucial modulatory role in the induction of 
synaptic plasticity and successful formation of long-term memory (Herz and Chen, 2006).  
 
1.1 THE REELIN PROTEIN AND ITS PROCESSING 
Reelin, with a relative molecular mass of 450 kDa, consists of a highly glycosylated N-terminal 
region, containing a signal peptide and a sequence with 25 % F-spondin homology. This is 
followed by a central region containing eight unique repeats, each composed of two sub-repeats 
A and B with an EGF-like motif in between. The protein ends in a short highly charged C-
terminal region. The protein is subjected to proteolytic cleavage in the extracellular and/or post-
endoplasmic environment at the N- and C-terminus (Kohno et al., 2009; Lambert de Rouvroit et 
al., 1999) producing a total of 5 different fragments (Fig. 1). The physiological functions of the 
cleaved Reelin fragments are not fully understood. Current evidence suggests that the N-terminal 
region of Reelin is required for protein homodimerization and full signaling activity (Kohno et 
al., 2009; Kubo et al., 2002); a process shown to be essential for postnatal dendritic maturation 
of cortical pyramidal neurons (Chameau et al., 2009). The central region represents the minimal 
receptor-binding and signaling unit sufficient for normal cortical development (Jossin et al., 
2004, 2007) and an amyloid precursor protein (APP) interaction domain (Hoe et al., 2009b). The 
highly conserved C-terminal fragment appears to be required for protein secretion, and/or proper 
protein folding, as well as intracellular signaling activity (de Bergeyck et al., 1997; Nakano et 
al., 2007). It has been shown by cell adhesion assays that processed Reelin can form large 
homomeric protein complexes (Kubo et al., 2002; Utsunomiya-Tate et al., 2000). Dependent on 
processing, Reelin can form dimers or even oligomeric complexes, indicating an effect of the 
proteolytic processing of Reelin on its tertiary structure, which is required for its proper and 
stable assembly. Despite the pharmacological data that classified the Reelin proteases into the 
family of zinc-dependent disintegrin and metalloproteinases with or without
Reelin 
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FIGURE 1: Reelin protein and its proteolytic processing 
Reelin, with a relative molecular mass of 450 kDa, consists of a highly glycosylated N-terminal region, containing a 
signal peptide and a sequence with 25 % F-spondin homology. This is followed by a central region containing eight 
unique repeats, each composed of two sub-repeats A and B with an EGF-like motif in their center. The protein ends 
in a short highly charged C-terminal region. The protein is subjected to proteolytic cleavage, by so far unidentified 
proteinases, producing a total of 5 different fragments named after the position and number of repeats. The N-
terminal cleavage site is located between the Reelin repeats 2B and 3A, whereas the cleavage site at the C-terminal 
region is located between the Reelin repeats 6B and 7A. The complete proteolytic cleavage results in the generation 
of 3 major fragments: the N-terminal (NR2; N –term to repeat 2 ~180 kDa), a central fragment (R36; repeats 3 to 6, 
190 kDa) and the C-terminal fragment (R78C; repeat 7 and 8, 80 kDa). Further intermediate fragments as the 
370 kDa fragment (NR6; N-term to repeat 6) and 270 kDa fragment (R38C; repeat 3 to 8) result from partial 
processing (adapted from (Knuesel et al., 2009; Rice and Curran, 2001)). 
 
thrombospondin motifs (ADAM and ADAMTS (Kohno et al., 2009; Lambert de Rouvroit et al., 
1999) the nature of the involved metalloproteinase is still not identified nor is it known whether 
it is involved in both the N- and C-terminal cleavage. Tissue plasminogen activator (tPA), a 
serine protease, has been suggested to degrade Reelin in the plasma (Lugli et al., 2003). Our own 
research gives evidence that this protease is possibly involved in Reelin processing, cleaving at 
the C-terminal end (D. Krstic, unpublished data). Furthermore, ADAMTS-4 was found to be 
another protease likely being involved in cleaving Reelin at the C- and N-terminal ends 
General Introduction 
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(D.Krstic, unpublished data). In addition, although processing of Reelin certainly modulates its 
signaling in the developing (and potentially also in the adult) brain, neither the biological 
significance nor the factors that modulate this process are known.  
 
1.2 ROLE OF REELIN IN THE DEVELOPING BRAIN  
The role of Reelin in the developing brain has been studied in great detail (for recent reviews, 
see (Förster et al., 2010; Knuesel, 2010)). During neuronal development, Reelin is secreted by 
Cajal-Retzius (CR) cells located in the marginal zone. Interestingly, there is recent evidence that 
Reelin can also be synthesized and secreted by oligodendroglial cells in the central nervous 
system (CNS) (Siebert and Osterhout, 2011). The highly conserved protein is essential for 
neuronal migration and brain development (Alcantara et al., 1998; Cooper, 2008; D'Arcangelo 
et al., 1995; Hirotsune et al., 1995). This is achieved through the activation of the apolipoprotein 
E receptor 2 (ApoER2) and very-low-density lipoprotein receptor (VLDLR, (D'Arcangelo et al., 
1995; Hiesberger et al., 1999; Howell et al., 1999; Trommsdorff et al., 1999); for review (Reddy 
et al., 2011)), which constitute the major Reelin receptors (Fig. 2). Reelin binding to these 
lipoprotein receptors induces their clustering and results in tyrosine phosphorylation of the 
adaptor protein Disabled-1 (Dab1) that interacts with conserved NPxY motifs in the cytoplasmic 
domains of VLDLR, ApoER2 and APP family members (Hoe et al., 2006; Homayouni et al., 
1999; Howell et al., 1999; Strasser et al., 2004; Trommsdorff et al., 1998, 1999). The 
phosphorylation of Dab1 results in the recruitment and activation of Src family tyrosine kinases 
(SFKs) and additional non-receptor tyrosine kinases (Bock et al., 2003), which in turn trigger 
downstream cytosolic kinase cascades involving phosphatidylinositol-3-kinase (PI3K), 
Akt/PKB, mTor and the inhibition of Glycogen synthase kinase 3β (GSK3β) as well as cyclin-
dependent kinase 5 (CDK5) (Beffert et al., 2002, 2004). In line with this modulatory role, 
Reelin-deficient animals show hyperphosphorylation of the microtubule-associated protein Tau, 
which represents a major target of both latter kinases. Michael Frotscher and his group provided 
evidence that signaling molecules of the Reelin pathway involving Dab1, SFKs and PI3K are 
also involved in n-cofilin phosphorylation and actin cytoskeleton regulation (Chai et al., 2009). 
Following phosphorylation of serine3, n-cofilin is unable to depolymerize F-actin and this in turn 
leads to a stabilization of the actin cytoskeleton. These results suggest a novel role of Reelin in 
controlling directional neuronal migration processes during development. Further support of 
Reelin in regulation of the cytoskeleton has been given by the group of Hans Bock (Leemhuis et 
al., 2010), showing increased growth cone motility and filipodia formation after Reelin-induced 
Reelin 
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activation of Cdc42 (known for its role in neuronal morphogenesis, directed migration and cell 
cycle progression), promoting neuronal development.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2: Reelin-mediated signaling during development 
Binding of multimeric Reelin to VLDLR and ApoER2 induces their clustering and phosphorylation of the 
cytoplasmic adapter protein disabled 1 (Dab1) by the Src family tyrosine (SFKs) kinases Fyn and Src. Dab1 is 
initially phosphorylated on two (Tyr185, Tyr198) sites which seem to be required to permit transphosphorylation of 
adjacent Dab1 molecules at all four sites (Tyr185, Tyr198, Tyr220, Tyr232, (Park and Curran, 2008)). This leads to 
the recruitment and activation of additional activated non-receptor tyrosine kinases allowing the activation of 
cytosolic kinase cascades, involving Phosphatidylinositol-3-kinase (PI3K), Akt/PKB, and the inhibition of Glycogen 
synthase kinase 3β (GSK3β) as well as CDK5, two main kinases that phosphorylate the microtubule-stabilizing 
protein Tau (Beffert et al., 2002, 2004). Phospho-Dab1 recruits also Crk/CrkL-C3G complexes which in turn 
stimulate Rap1 (Park and Curran, 2008). The central Reelin domain also directly interacts with the E1 extracellular 
domain of APP; an interaction that appears to be necessary for proper neurite outgrowth both in vitro and in vivo 
(Hoe et al., 2009b). Regulation of the actin cytoskeleton through the Reelin signaling cascade also involves 
activation of LIM1 kinase which results in increased n-cofilin phosphorylation in the leading processes of migrating 
neurons approaching the marginal zone (Chai et al., 2009). Recruitment of ubiquitin ligases to phosphorylated Dab1 
results in ubiquitination of the protein, which mediates the phosphorylation-dependent endocytosis of the entire 
Reelin signaling complex (Bock et al., 2004; Suetsugu et al., 2004).  
 
 
In agreement with the fundamental role of Reelin during neuronal development, impaired Reelin 
signaling has a devastating effect on the gross morphology of the hippocampus, cerebellum and 
neocortex, as evident by the abnormal cortical layering (“outside-in” instead of “inside-out”) and 
neuronal positioning in Reelin homozygous knockout mice (reeler, Fig. 3A, (Goffinet, 1984; 
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Trommsdorff et al., 1999)), although the cortical neurons are generated normally. The reeler 
mutant mouse was first described in 1951 (Falconer, 1951), holding an autosomal recessive 
mutation leading to the development of severe ataxia, tremor and a reeling gait. Reelin was 
discovered nearly 50 years later as the responsible gene for this phenotype (D'Arcangelo et al., 
1995). Also the hippocampus displays abnormal neuron disorganization (Fig. 3B) compared to 
wild type mice, evident by no compact granule cell layer in the dentate gyrus (Lambert de 
Rouvroit and Goffinet, 1998; Weiss et al., 2003) and the split in two layers of the pyramidal 
neurons (so-called double layered structure).  
 
 
FIGURE 3: Role of Reelin in the cell lamination of 
cortex and hippocampus 
Differences in cell layering in wild type and reeler 
mice. (A) During embryonic development the preplate 
is formed, consisting of Cajal-Retzius (CR) neurons in 
the marginal zone and subplate (sp) neurons. A first 
cohort of cortical plate neurons (gray) migrates along 
radial glia into the intermediate zone (iz) past the 
subplate level and stops beneath the Reelin producing 
(stipple) CR cells (black) in the marginal zone, a zone 
relatively cell-free in wild type mice. Following cells 
migrate past the older subplate neurons and insert 
themselves directly beneath the CR cells, resulting in 
the typical and normal layered pattern, where the 
cortical plate represents the prospective cortical layers 
II-VI and the marginal zone the future cortical layer I. 
In reeler mice, the cortical layering defect is apparent 
at the onset of the cortical plate formation as the first 
cohort of cortical plate neurons already fails to migrate 
past the subplate and accumulates instead in a 
disorganized fashion in the superplate (spp, cell-dense 
region), resulting in dispersed and inversed cellular 
layers, forming a so called “inverted cortex”. (B) Brain 
slices of wild type and reeler mice showing differences 
in the histotypical appearance of cortical and 
hippocampal layering. Beside the abnormal inverted 
layering of the cortex in reeler mice, they also exhibit 
a failure in establishing a distinct granule cell layer in 
the dentate gyrus, showing intermingled granule cells 
and hilar mossy cells as compared to wild type mice. 
vz - ventricular zone; CR – Cajal-Retzius neurons; SP 
– subplate; mz – marginal zone; spp – superplate (A 
obtained from (Rice and Curran, 2001). 
 
 
Despite normal brain morphology, heterozygous reeler mice, expressing only 50 % of Reelin 
mRNA levels of wild type mice, show significant impairments in synaptic plasticity as well as 
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learning disabilities compared to wild type littermates (Weeber et al., 2002). A reeler phenotype 
has also been described in mice with a loss of both Reelin receptors (Trommsdorff et al., 1999), 
whereas single-mutants do not show the characteristic cortical disorganization. This indicates 
that ApoER2 and VLDLR can compensate for each other to a certain extent. However, novel 
evidence for divergent roles of the Reelin receptors has already emerged (Hack et al., 2007; Hoe 
et al., 2006). These different functions might stem from either structural differences in the 
intracellular domains or selective localizations within distinct sub-domains in the plasma 
membrane. Support for the latter hypothesis has been provided by the recent study by Duit and 
colleagues (Duit et al., 2010). Investigating the functional difference between the two Reelin 
receptors using a fibroblast cell culture system, they found that the endocytosis of Reelin is 
linked to specific sorting to raft versus non-raft domains of the plasma membrane. Duit and 
colleagues reported that VLDLR is present in non-raft domains and Reelin binding to this 
receptor results in fast endocytosis of the complex. Reelin is then targeted to the lysosome and 
the receptor recycled back to the cell membrane. Binding of Reelin to ApoER2, which is 
predominantly localized to raft domains of the plasma membrane, however, does not result in 
significant reduction of extracellular Reelin since this receptor-mediated endocytosis is rather 
slow. Activation of this pathway results in lysosomal sorting of both the ApoER2 and Reelin. 
Together with the Reelin-mediated ubiquitination and proteosomal degradation of Dab1 
following receptor-mediated endocytosis, these differential processes provide not only an 
essential feedback mechanism and termination signal in the regulation of neuronal positioning 
(Arnaud et al., 2003; Bock et al., 2004; Kerjan and Gleeson, 2007; Morimura et al., 2005), they 
likely also contribute to a highly selective and receptor-specific fine-tuning of the Reelin signal 
that is required for normal synaptic plasticity and learning in the adult brain. 
 
1.3 REELIN-MEDIATED SIGNALING IN THE ADULT BRAIN 
The studies focusing on developmental functions of Reelin clearly outnumber the investigations 
addressing the role of Reelin in the mature brain and we are just beginning to understand the 
implications of reduced Reelin expression during aging.  Interestingly, the expression pattern of 
Reelin changes after the end of the neuronal migration phase (Frotscher, 1998). In the adult 
brain, the Reelin-expressing CR cells are largely replaced by Reelin-expressing GABAergic 
interneurons that are dispersed throughout the forebrain (Fig. 4). Reelin is also expressed by 
glutamatergic pyramidal neurons in layer II of the entorhinal cortex, olfactory mitral cells and 
cerebellar granule cells (Abraham and Meyer, 2003; Abraham et al., 2004; Alcantara et al., 
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1998; Baloyannis, 2005; Chin et al., 2007; Knuesel et al., 2009; Lacor et al., 2000; Miettinen et 
al., 2005; Pappas et al., 2003; Pesold et al., 1998a; Ramos-Moreno et al., 2006). ApoER2 and 
VLDLR and the adapter protein Dab1 also remain expressed in the adult brain. The distinct 
expression pattern of Reelin and its signaling members in brain regions implicated in mediating 
learning and memory (Alcantara et al., 1998; Beffert et al., 2005; Cooper, 2008; Forster et al., 
2002; Frotscher et al., 2003; Pesold et al., 1998a) suggest that Reelin-mediated signaling in the 
adult brain is crucial for normal cognitive function.  
 
FIGURE 4: Reelin expression in the adult 
rodent brain 
Immunoperoxidase staining showing the 
expression pattern of Reelin in the dorsal (A, B) 
and ventral (C, D) hippocampus and entorhinal 
cortex (E, F) in coronal brain sections obtained 
from adult (ad, 3 months, A, C and E) and 
mature (ma, 12 months, B, D and F) wild type 
mice. Reelin-IR is evident in the neuronal soma 
of GABAergic interneurons and in the neuropil 
throughout the hippocampus and cortex. The 
neuropil staining is especially dominant in the 
stratum lacunosum moleculare (slm) in ad 
subjects. B, D) In ma mice Reelin-IR is also 
present in plaque-like accumulations (arrows), 
restricted to the dorsal CA stratum oriens (so) 
and radiatum (sr) and outer dentate gyrus (DG) 
molecular layer (ml). In the ventral 
hippocampus they are strongly enriched in the 
slm and DG ml (arrows). E, F) High 
magnification images of the lateral entorhinal 
cortex (EC) of representative ad and ma mice. 
Reelin-IR was predominantly found in layers II 
and I. Age related plaques are found 
exclusively in layer I. Scale bars: B, C = 500 
μm, E = 50 μm. (adapted from (Knuesel et al., 
2009)). 
 
Interestingly, a new role for Reelin in the healthy and injured adult brain was discovered recently 
(Courtes et al., 2011), showing that Reelin signaling participates in spontaneous cell 
mobilization and post-lesional cell migration. This demonstrates how the developmental function 
of Reelin is reused in the adult brain to control regenerative processes. 
 
1.3.1 THE ROLE OF REELIN IN SYNAPTIC PLASTICITY 
First evidence that Reelin plays a role in synaptic plasticity came up in 2002 (Weeber et al., 
2002). The team of Joachim Herz demonstrated in vitro that application of recombinant Reelin 
can dramatically elevate the magnitude of long-term potentiation (LTP), a form of synaptic 
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plasticity induced by high frequency stimulations that results in a persisting increase in synaptic 
efficacy (Bliss and Lomo, 1973). Using ApoER2- and VLDLR-deficient mice, they verified that 
high frequency stimulation results in reduced LTP induction in VLDLR-knockout mice and a 
pronounced decay in late-phase LTP in ApoER2-null mice (Weeber et al., 2002). These findings 
are in line with the described hypomorphic phenotype of the single-mutants with developmental 
defects affecting mainly hippocampus and neocortex (ApoER2) or cerebellum (VLDLR), as well 
as the reeler phenotype in double-mutants (Trommsdorff et al., 1999). Overall, the results 
provided the first experimental evidence for a critical role of Reelin in modulating synaptic 
function and enabling the formation of long-term memory. Other studies have confirmed the 
significant contribution of the Reelin signaling pathway to synaptic plasticity (Beffert et al., 
2005; Chen et al., 2005; Herz and Chen, 2006; Qiu et al., 2006a, 2006b) by demonstrating that 
binding of Reelin to ApoER2 and VLDLR at postsynaptic sites controls glutamatergic 
neurotransmission through differential modulation of the activity of NMDA and AMPA 
receptors (Fig. 5). Similar to the signaling in the developing brain, the effect was dependent on 
Reelin-induced activity of SFKs that are involved in tyrosine phosphorylation of the NR2 
subunits of the NMDA receptors (Beffert et al., 2005; Chen et al., 2005). This in turn results in a 
potent enhancement of glutamate-stimulated Ca2+ influx that is required for LTP induction and 
maintenance (Malenka, 2003). The Herz lab also established a molecular mechanism by which 
Reelin, in conjunction with alternatively spliced forms of ApoER2, regulates synaptic function 
and plasticity in the adult brain. They discovered that adaptor proteins binding to the exon 19-
encoded intracellular domain of ApoER2 (Gotthardt et al., 2000; Stockinger et al., 2000) are 
necessary for transmitting the Reelin signal that is required to enhance LTP. Together, these 
results provided the first evidence for a physiological role of Reelin signaling in the control of 
NMDA receptor function and synaptic strength, suggesting that Reelin can physiologically 
modulate LTP through regulation of NMDA receptor activity.  
All these findings implicate the influence of Reelin on postsynaptic functions; however no 
studies have been conducted to investigate the proteins effect on presynaptic functions. Very 
recently, first evidence for a role of Reelin at the presynaptic site was given by Hellwig and 
colleagues (Hellwig et al., 2011). Their findings point to an altered vesicle fusion and 
neurotransmitter release in adult reeler mice, suggesting an involvement of Reelin in 
hippocampal presynaptic functions; however, the signaling pathway might not involve VLDLR 
and ApoER2. 
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FIGURE 5: Reelin modulates synaptic plasticity and learning and memory.  
Dab1 binding site and exon 19-encoded domain of ApoER2 are necessary for the Reelin-mediated increase in 
synaptic plasticity that allow the coupling of the Reelin receptor and the activated Dab1–Src/Fyn complex to the 
NR2A and NR2B subunit of the NMDA receptor for its subsequent tyrosine phosphorylation and Ca2+ entry in the 
postsynaptic density, PSD (Beffert et al., 2005). Prolonged presence of Reelin at synaptic sites also modulates 
AMPA receptor-mediated responses, associated with an increased receptor number in the PSD (Qiu et al., 2006b) 
and reduction in the number of silent synapses that facilitated the developmental switch from NR2B to NR2A (Qiu 
and Weeber, 2007). Reelin-induced augmentation of Ca2+ entry through NMDA receptors increases phosphorylation 
and nuclear translocation of the transcription factor cAMP-response element binding protein (CREB), indicating that 
Reelin may physiologically modulate learning and memory by modulating NMDA receptor functions (Chen et al., 
2005). These data fit with the observations that in the absence of Reelin or the Reelin receptors, neurons exhibit 
stunted dendritic growth, a reduction in dendritic branches and significantly fewer spines (Borrell et al., 1999; 
Borrell et al., 2007; Del Rio et al., 1997; Niu et al., 2004, 2008; Qiu and Weeber, 2007; Trommsdorff et al., 1999).  
 
 
1.3.2 REELIN AND ITS IMPACT ON DENDRITE AND SPINE FORMATION, MODULATION AND 
MAINTENANCE 
One critical aspect of synaptic adaptations associated with LTP involves the changes in dendritic 
spine morphology. Similarly to the situation during development where Reelin-dependent 
signaling is required for the outgrowth of dendrites and the formation of dendritic spines 
(Chameau et al., 2009; Jossin and Goffinet, 2007; Matsuki et al., 2008; Niu et al., 2004,  2008), 
the Reelin signaling cascade is used in adulthood to regulate plasticity-induced morphological 
changes of dendritic spines. First evidence to support a role for Reelin in this process has been 
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provided by the work of Stanfield and Cowan (Stanfield and Cowan, 1979a, 1979b). They 
reported altered dendritic morphology and orientation in the cortex and hippocampus of adult 
reeler mice. In line, heterozygous reeler mice exhibited reduced spine density, as well as defects 
in the molecular composition of the synapses in the hippocampus and cortex that was 
accompanied by impaired performance in certain learning and memory tasks (Liu et al., 2001; 
Pappas et al., 2001; Qiu et al., 2006a; Tueting et al., 1999; Ventruti et al., 2011). In the absence 
of Reelin or its receptors, Dab1-expressing neurons also exhibited stunted dendritic growth and 
reduction in dendritic branches (Niu et al., 2004). It has been further shown that application of 
recombinant Reelin can reverse this deficit in neuronal cultures lacking one or both Reelin genes 
(Niu et al., 2004, 2008; Qiu et al., 2006a). The rescue was again dependent on the activation of 
the downstream tyrosine kinase-dependent signaling pathway, as shown for the regulation of 
neuronal migration and adult synaptic plasticity. In addition, data showed that stimulation of 
cultured hippocampal neurons with Reelin leads to enhanced dendritogenesis (Matsuki et al., 
2008). This effect was blocked by reduced expression of Crk family proteins, suggesting that 
Dab1-binding proteins are important downstream components of the Reelin signaling pathway in 
regulating hippocampal dendritogenesis. Altogether, these studies demonstrate that constitutive 
levels of Reelin and its receptors are required for correct formation and maintenance of dendritic 
structures that are crucial for normal information processing in adult synapses. 
 
Recently, the group of Eduardo Soriano addressed for the first time the impact of Reelin 
overexpression on synaptic plasticity and associated morphological changes (Pujadas et al., 
2010). They reported that adult generated neurons in the dentate gyrus of transgenic mice exhibit 
an increased complexity in their developing dendrites that was accompanied by a significant 
enlargement of dendritic spines and an increase in the number of synaptic contacts. Furthermore, 
the overexpression evoked a dramatic increase in LTP induction and maintenance as compared 
to controls. They also discovered that overexpression of Reelin leads to dispersion, impaired 
migration and abnormal positioning of adult-generated neurons, indicating that adequate levels 
of Reelin above and below a certain threshold are required for successful neuronal migration, 
dendritic development and morphological adaptations that are associated with processes 
underlying synaptic plasticity and learning and memory (Pujadas et al., 2010). Taken together, 
these results suggest that Reelin and its lipoprotein receptors participate in the control of 
developmental processes that are fundamental for proper synaptic and neuronal functioning in 
the adult brain. 
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1.3.3 REELIN EXPRESSION IN HUMANS 
In the developing human brain, CR cells in the marginal zone also constitute the main source of 
Reelin as described in rodents and non-human primates (Meyer and Goffinet, 1998; Ogawa et 
al., 1995).  However, besides the well-characterized human developmental disorder, 
Lissencephaly, which is caused by dominant mutations in the Reelin gene in humans (Hong et 
al., 2000), relatively little information is available on the expression and localization of Reelin in 
the healthy adult and aged human brain. Reelin-positive CR cells can still be detected in the neo- 
and entorhinal cortex of adult and aged humans (Belichenko et al., 1995; Martin et al., 1999; 
Mikkonen et al., 1997; Riedel et al., 2003), but they appear to decline during pathological aging 
(Baloyannis, 2005). In 2005, Roberts and colleagues reported the first ultrastructural localization 
of Reelin in postmortem human brain samples (Roberts et al., 2005). Reelin-IR was readily 
detected in the neocortex; being present both in interneurons and glia cells. In the neuropil, 
Reelin-IR was found in small axons, axon terminals, dendrites and postsynaptic spines. These 
results are consistent with immunohistochemical studies involving postmortem brain tissue 
obtained from rodents (Knuesel et al., 2009; Ramos-Moreno et al., 2006), ferrets (Martinez-
Cerdeno et al., 2003), primates (Abraham and Meyer, 2003; Martinez-Cerdeno et al., 2002) as 
well as humans (Abraham and Meyer, 2003; Deguchi et al., 2003; Guidotti et al., 2000; 
Impagnatiello et al., 1998). The data fit with the important role of Reelin in normal synaptic 
function, including synaptic plasticity and dendritic remodeling in the adult brain in several 
species. However, it is currently unknown whether Reelin expression changes across aging in 
humans. Recent genome-wide SNP association studies revealed that polymorphisms in the 
Reelin gene (especially in and near the promoter region) are associated with Alzheimer’s disease 
(AD) neuropathology (Kramer et al., 2010; Seripa et al., 2008), suggesting that putative 
alterations in Reelin expression levels correlate with aging-associated mental decline and 
contribute to a pathological mechanism involving AD-associated neuropathology.  
 
 
2. REELIN AND ALZHEIMER’S DISEASE  
In line with the previous hypothesis and the critical role of Reelin in synaptic transmission and 
learning and memory, several recent findings suggest that alterations in Reelin expression and 
abnormal Reelin signaling may contribute to neuronal dysfunction associated with AD. In 
addition, several studies have investigated the molecular mechanism by which Reelin, its 
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receptors and downstream signaling proteins may contribute to the etiology of this progressive 
neurodegenerative disease.  
 
2.1 ALZHEIMER’S DISEASE  
AD is the most common form of age-related dementia; approximately 10 % of people over 65 of 
age are affected, with rates doubling every five years from that age on (Source: AlzForum, 2010; 
(Querfurth and LaFerla, 2010)), turning AD into a major health problem. AD is an incurable 
disease, clinically characterized by progressive decline in memory and cognition, disorientated 
behavior, altered personality, difficulties with language and impaired movements, leading to 
death within 3-9 years after diagnosis (Hirtz et al., 2007). The entorhinal cortex, the basal 
forebrain and the hippocampus are primarily affected by the disease (Braak and Braak, 1991); 
specialized brain regions playing a critical role in encoding, storage and retrieval of episodic 
memory (reviewed in (Eichenbaum, 2004)).  
AD can be divided into two forms: the rare early-onset familial AD (EOAD) and the common 
late-onset AD (LOAD). The familial form accounts for only a small proportion of all known AD 
cases and usually affects people younger than 65 years (Schellenberg, 1995). Dominant genetic 
effects induced by mutations located in genetic loci encoding proteins involved in the 
amyloidogenic APP processing (app, presenilin-1 (PSEN1) and presenilin-2 (PSEN-2)) are 
responsible for the early-onset form of the disease (Bertram et al., 2010; Bird, 2008). All these 
mutations enfavor amyloidogenic APP cleavage and, therefore, amyloid-β (Aβ) production  
(Goate et al., 1991; Levy-Lahad et al., 1995; Rogaev et al., 1995a; Sherrington et al., 1995). 
One current hypothesis known as the "amyloid hypothesis" postulates that the imbalance 
between production and clearance of Aβ, the transformation of Aβ to its toxic forms, and the 
direct toxic effect of aggregated Aβ, result in the formation of aggregated Aβ deposits leading to 
AD neuropathology (Hardy and Selkoe, 2002); accompanied by a series of downstream events 
(synapse loss, plaque deposition, inflammation, vascular damage, tangles).   
The sporadic late-onset form of AD occurs after the age of 65, and accounts for the majority of 
all AD cases (Bertram et al., 2010; Bertram and Tanzi, 2009). Even though the prevalence is 
much higher, the cause of the late-onset form remains largely unknown. Although, genome-wide 
association studies (GWAS) performed in humans in the last years revealed several candidate 
genes that potently increase the risk to develop LOAD (for review Bertram et al., 2010; 
Hollingworth et al., 2011; Naj et al., 2011), beside the so far strongly confirmed genetic risk 
factor apolipoprotein E (ApoE) ε4 (Bertram et al., 2010; Bertram and Tanzi, 2008; Corder et al., 
General Introduction 
 13
1993; Schmechel et al., 1993; Strittmatter et al., 1993). However, the details of the process 
through which ApoE contributes to the induction and progression of AD pathology remains still 
largely unclear (Kim et al., 2009). Further, regarding the amyloid cascade hypothesis, sporadic 
AD has been hypothesized to develop after a failure of Aβ clearance, a gradual rise of Aβ42 in 
the brain and deposition in the form of plaques at a certain point. Hence, the sporadic form 
appears to follow the same pathway as the familiar form of AD, although they differ in their 
initiation/onset.  
 
2.1.1 NEUROPATHOLOGICAL HALLMARKS  
The histopathological hallmarks of AD comprise neurofibrillary tangles (NFTs), consisting of 
hyperphosphorylated Tau (Grundke-Iqbal et al., 1986) and the formation of senile plaques, 
primarily composed of Aβ peptides, a hydrophilic peptide of 39–43 amino acids (Glenner and 
Wong, 1984; Haass and Selkoe, 2007). In parallel, the disease is also defined by neuronal and 
synaptic loss, brain atrophy, and inflammation. 
 
APP AND AMYLOID-β 
Aβ peptides are the amyloidogenic cleavage product of APP, a transmembrane protein playing a 
major role in the nervous system and is involved in synapse formation or stabilization as well as 
synaptic plasticity (Gralle and Ferreira, 2007; Hoe et al., 2009a; Wang et al., 2009). The 
amyloid-β peptides result from the sequential cleavage by β- and γ-secretases (Estus et al., 1992; 
Haass et al., 1992), also termed as amyloidogenic processing (Fig. 6). β-secretase, also termed 
as BACE1, catalyses the initial step in the amyloidogenic processing, generating two fragments: 
an N-terminal soluble fragment (sAPPβ) and a C-terminal membrane bound fragment (C99). 
C99 is further processed by γ-secretase, a large protein complex consisting of nicastrin, anterior 
pharynx-defective phenotype-1 (APH-1), PS enhancer 2 (PEN-2) and PSENs, within its 
transmembrane domain (Steiner et al., 2008), generating an APP intracellular domain (AICD) 
and Aβ species, mainly Aβ40 and Aβ42, being the most prone to aggregate (Jarrett et al., 1993). 
Due to an imbalance between formation and clearance of these peptides, Aβ starts to accumulate 
in the brain, forming oligomers, fibrils or even insoluble fibers assembling into senile plaques in 
AD. This abnormal amyloidogenic Aβ processing and formation of amyloid-β plaques have been 
suggested to lead to synaptic dysfunction, synapse loss, and ultimately to neuronal death. The 
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alternative non-amyloidogenic processing of APP occurs by the subsequent cleavage through α- 
and γ-secretase, preventing the formation of Aβ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6: The two alternative processing pathways of Amyloid precursor protein (APP).  
Senile plaques are primarily composed of amyloid-β (Aβ) peptides, which result from sequential cleavage of APP 
by β- and γ-secretases (Estus et al., 1992; Haass et al., 1992), also termed amyloidogenic processing. This results in 
an extracellular N-terminal fragment (sAPPβ), and intracellular AICD domain and several amyloid peptides. The 
main amyloid peptides released by this cleavage are Aβ40 and Aβ42 being the most prone to aggregate (Jarrett et al., 
1993). Non-amyloidogenic processing by cleavage through α- and γ-secretase in turn results in the production and 
release of a large N-terminal extracellular fragment (sAPPα) and smaller, membrane-bound C-terminal fragments 
(P3 and AICD) with putative neuroprotective and transcriptional functions. Recently, an additional disease-
modifying, N-terminal fragment of APP that acts as ligand of the death receptor 6 (DR6, a member of the tumor 
necrosis factor receptor superfamily) has been discovered. This fragment is produced upon growth factor withdrawal 
by β-secretase cleavage plus an additional, as yet unidentified, protease (Knuesel, 2010). 
 
 
α-secretase cleaves in between the Aβ domain, yielding a large soluble N-terminal extracellular 
fragment (sAPPα) and a smaller, membrane-bound C-terminal fragment (C83). The latter one is 
further processed by γ-secretase, generating a non-amyloidogenic 3 kDa peptide (P3) and as well 
AICD with putative neuroprotective and transcriptional functions (Furukawa et al., 1996; Gao 
and Pimplikar, 2001; von Rotz et al., 2004) (Fig. 6). AICD has also been suggested to play an 
important role for APP in early neurodevelopment (Konietzko, 2011). Lately, the team of 
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Tessier-Lavigne discovered an additional disease-modifying, N-terminal fragment of APP that 
acts as a ligand of the death receptor 6 (DR6, a member of the tumor necrosis factor receptor 
superfamily). This fragment is produced upon growth factor withdrawal by β-secretase plus an 
additional, as yet unidentified, protease and has been shown to induce Caspase-6-mediated 
axonal degeneration (Nikolaev et al., 2009) (Fig. 6) a process involved in axonal pruning during 
development.  
 
TAU 
Neurofibrillary tangles, the second neuropathological hallmark of the disease, comprise neuronal 
filamentous inclusions of aggregated hyperphosphorylated Tau (pTau) (Grundke-Iqbal et al., 
1986). Under physiological conditions, Tau is an abundant soluble axonal protein, promoting 
assembly and stability of microtubules and is responsible for axonal vesicle transport and neurite 
outgrowth (Binder et al., 1985; for review Morris et al., 2011). In physiological equilibrium, Tau 
undergoes site-specific phosphorylation events regulated by several phosphatases and kinases 
(mainly GSK3β and CDK5). In AD, Tau phosphorylation is elevated, leading to insoluble pTau. 
In turn, Tau detaches from the microtubules, due to highly decreased affinity, and gets 
delocalized from axonal in somatodentritic compartments, leading to instability of the 
microtubule network (Ballatore et al., 2007; Brunden et al., 2009; Ittner et al., 2010; Lee et al., 
2001; for review Morris et al., 2011). Factors which trigger this imbalance in the progression of 
this pathology are so far unknown. Experimental evidence indicates that Aβ is one of these 
factors driving Tau aggregation (Gotz et al., 2001; Hardy and Selkoe, 2002; Lewis et al., 2001), 
or the other way around - that Tau enables the pathogenic effects of Aβ (Ittner et al., 2010; 
Roberson et al., 2011; Roberson et al., 2007). In addition, the activity of the Tau specific kinases 
resulting in increased Tau phosphorylation can be also modulated by cytokine-mediated 
signaling, e.g. through the p35/MAPK pathway activated by IL-1β, highly overexpressed in AD 
brains (Li et al., 2003; Sheng et al., 2001; Sheng et al., 2000). Further, IL-6 levels are also 
correlating with increased Tau phosphorylation (Jones et al., 2009; Luterman et al., 2000; 
Quintanilla et al., 2004). These results suggest that abnormal neurodegeneration associated with 
AD might be due to inappropriate activation or reactivation of a developmental pathway in the 
aged brain. 
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3. THE MOLECULAR LINK BETWEEN REELIN DYSFUNCTION AND 
AD-RELATED NEUROPATHOLOGY 
Current experimental evidence supports that altered Reelin expression and abnormal Reelin 
signaling are contributing to the etiology of AD: 
 
1) Besides binding to the intracellular domain of ApoER2, it was already shown that 
intracellular Dab1 binds also to the cytoplasmic NPxY motif of APP (Homayouni et al., 
1999; Trommsdorff et al., 1998), affecting directly the trafficking and processing of 
ApoER2 and APP. This was tested in vitro by the group of Rebeck and Hoe (Hoe et al., 
2006) demonstrating that Reelin significantly increased the intracellular interaction of 
Dab1 with both ApoER2 and APP, promoting their surface localization and favoring non-
amyloidogenic APP processing. Both groups also provided first evidence of a direct 
interaction between Reelin and the extracellular domain of APP (Hoe et al., 2009b), 
appearing to be necessary for proper neurite outgrowth. In addition, other results showed 
in turn that the extracellular N-terminal fragment of APP induces axon pruning and 
neuron death following growth factor withdrawal (Nikolaev et al., 2009).  
2) One Reelin-mediated signaling pathway involves the suppression of the major 
downstream kinases GSK3β and CDK5, the key mediators in Tau phosphorylation 
(Gonzalez-Billault et al., 2005; Hiesberger et al., 1999). Thus, Reelin-mediated signaling 
reduces Tau phosphorylation by downregulating these kinases, as also confirmed by 
elevated levels of pTau in reeler and apoer2/vldlr double knockout mice (Beffert et al., 
2004; Hiesberger et al., 1999; Ohkubo et al., 2003). Therefore, abnormal Reelin-
mediated signaling could promote NFT formation and potentially neuronal cell death.  
3) AD patients show decreased Reelin levels in the entorhinal cortex compared to non-
demented individuals (Chin et al., 2007).  
4) Another critical role of Reelin and its associated signaling cascade in AD-associated 
neuropathology is given by identifying AD-related polymorphism (SNPs) in the Reelin 
locus (Kramer et al., 2010; Seripa et al., 2008).  
5) The human ApoE comprises 3 different isoforms, which differentially compete with 
Reelin for binding and activation of VLDLR and ApoER2 receptors (Chen et al., 2010; 
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D'Arcangelo et al., 1999). In the case of ApoE ε4, this leads to impaired Reelin-mediated 
synaptic plasticity and phosphorylation of NMDA (Chen et al., 2010).  
 
Furthermore, novel insights into the pathophysiology of Aβ suggested a potent negative impact 
of Aβ oligomers on synaptic functions that may underlie impairments in long-term synaptic 
plasticity (Lacor et al., 2004; Lambert et al., 1998; Selkoe, 2002). Incubation of hippocampal 
neurons with Aβ oligomers lead to intracellular trapping or functional impairment of AMPA and 
NMDA receptors (Hsieh et al., 2006; Kamenetz et al., 2003; Snyder et al., 2005), thereby 
decreasing LTP (Lacor et al., 2004; Lambert et al., 1998; Shankar et al., 2007; Shankar et al., 
2008; Townsend et al., 2006; Walsh et al., 2002). As already mentioned, several studies showed 
an increase in LTP following Reelin application to hippocampal slices (Weeber et al., 2002), 
demonstrating that Reelin has an opposite effect on synaptic function compared to Aβ oligomers. 
A study conducted in Joachim Herz’ lab demonstrated that Reelin could indeed antagonize the 
suppressive effects of Aβ oligomers on synaptic NMDA receptor-mediated neurotransmission 
(Durakoglugil et al., 2009). They demonstrated that Reelin signaling in excitatory synapses 
could restore oligomeric Aβ-induced impairments in synaptic plasticity to normal levels. 
Activation of SFKs by Reelin through ApoER2 and VLDLR binding was necessary for 
neutralizing the Aβ-mediated suppression, supporting again the crucial role of Reelin-mediated 
signaling for normal synaptic function.  
The group of Saez-Valero has addressed the putative link between abnormal Reelin levels and 
AD pathogenesis. They analyzed the expression and glycosylation pattern of Reelin in the 
cerebrospinal fluid (CSF) and cortical tissue extracts obtained from AD patients and non-
demented controls (Botella-Lopez et al., 2006, 2010; Saez-Valero et al., 2003). They reported 
abnormal glycosylation of Reelin as well as a preferential up-regulation of the N-terminal 
180 kDa Reelin fragment in the CSF and frontal cortex of AD patients. Full-length and other 
proteolytic fragments of Reelin remained unaltered in control and AD subjects (Botella-Lopez et 
al., 2006), suggesting alterations in Reelin processing and signaling in AD. Another study 
showed that the N-terminal fragment of Reelin can be generated within the endosomes after 
internalization of the full-length form (Hibi and Hattori, 2009), pointing to the possibility that, in 
AD patients, the endosomal recycling and re-secretion of this fragment into the extracellular 
space could also be significantly affected.  
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Studies performed in our lab provide an alternative explanation for the selective increase in the 
N-terminal Reelin fragment. We have previously observed that Reelin accumulates in oligomeric 
amyloid-like plaques in the hippocampal formation (Fig. 4) of several aged species (Knuesel et 
al., 2009), indicating that the N-terminal fragments may preferentially oligomerize and aggregate 
in the extracellular matrix during aging. Further experimental support for Reelin being involved 
in AD pathology is given by Wirths and colleagues, showing the presence of Reelin in amyloid 
plaques involving transgenic AD mouse models (Wirths et al., 2001). To address the putative 
functional implications, we have investigated whether early accumulations of extracellular 
protein deposits in the projection areas of subcortical neurons can act retrogradely to induce 
degeneration of cholinergic neurons in the basal forebrain (Madhusudan et al., 2009), known to 
be affected early in AD pathogenesis and significantly contributing to the progressive 
hippocampus-dependent memory impairments (Gold, 2003). Considering the highly consistent 
finding of aging-related Reelin plaque deposition in target areas of cholinergic neurons, such as 
the hippocampus, entorhinal and piriform cortices, we reasoned that these plaques could impair 
the integrity of axonal terminals, potentially resulting in or contributing to the degeneration of 
basal forebrain projection neurons. We found that the age-related neuropathological changes in 
the target areas of these neurons were indeed accompanied by abnormal axonal varicosities and 
altered expression profiles of calcium-binding proteins in plaque dense areas. Moreover, we 
reported a significant reduction in the number of parvalbumin-positive GABAergic as well as 
choline acetyltransferase-positive cholinergic projection neurons in several basal forebrain areas. 
No Reelin deposits were found in these regions, suggesting that the loss of projection neurons 
was not due to adverse effects of local protein deposition and plaque formation. Altogether, our 
findings suggest that the elevated Reelin plaque load in the projection areas of afferent 
subcortical GABAergic and cholinergic neurons affects the axonal integrity and survival of these 
neurons, potentially also contributing to the cognitive impairments observed in aged wild type 
mice.  
 
Although all these data strongly imply an involvement of the Reelin signaling cascade in the 
neuropathology of AD, the molecular mechanisms through which this glycoprotein participates 
in the pathogenesis of AD is still unknown. 
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4. THE ROLE OF INFLAMMATION IN ALZHEIMER’S DISEASE 
Since the first suggestion that inflammation might play a role in the pathogenesis of AD was 
made about 20 years ago, neuroinflammation is increasingly accepted to be associated with the 
onset and/or progression of the disease (Lucin and Wyss-Coray, 2009). Even recent GWAS 
revealed that immune system members show a strong association with sporadic AD (Lambert et 
al., 2009). Chronic activation of inflammatory pathways can be detrimental and promote 
degeneration, as suggested by the accumulation of activated microglia and astrocytes in the 
vicinity of senile Aβ plaques and neuronal lesions (for review, (Lucin and Wyss-Coray, 2009). It 
has become apparent that the inflammatory mediators, including cytokines, chemokines, 
prostaglandins, free oxygen radicals and complement activation components, are not only 
produced in the circulating leukocytes and peripheral immune organs, but are also generated 
locally in the brain; most of them by the activated glial cells, but many of them also by neurons 
(Lucin and Wyss-Coray, 2009). Beside the activation of these inflammatory modulators, 
numerous human postmortem studies have also shown that the initial pathological stages in the 
hippocampus and entorhinal cortex in AD include a pronounced up-regulation of cell cycle and 
cell adhesions proteins (Parachikova et al., 2007), hypothesized to reflect an initial regenerative 
response of neurons to the presence of diffuse Aβ plaques and oligomeric or protofibrillic forms 
of Aβ peptides (Hoozemans et al., 2006; Salminen et al., 2009). Later stages are characterized by 
the widespread deposition of Aβ plaques and NFTs, with their focal complement activation and 
accumulation of activated glial cells. Under these chronic insulting conditions, the efficiency of 
the innate immune system appears to fluctuate and it has been suggested that an unwanted 
potentiation of pro-inflammatory responses could turn the beneficial innate immunity into a 
negative driving force in AD pathogenesis by inducing autotoxicity (McGeer and McGeer, 2002; 
Salminen et al., 2009; Wyss-Coray, 2006). On the other hand, another study revealed that the 
formation and maintenance of Aβ plaques in transgenic AD mouse models was independent 
from the presence of microglia (Grathwohl et al., 2009), challenging our view of the role of 
inflammatory mediators derived from activated microglia cells. Clearly, more information is 
needed to understand the role of activated glia cells and to support an adverse, and potentially 
early-misregulated innate immunity defense in AD pathogenesis. Consequently, treating AD 
using an anti-inflammtory strategy is complicated due to the contradictory role of microglia.   
Clinical evidence for a critical role of inflammation in the disease is given by several 
epidemiological studies. Individuals suffering from a chronic inflammatory disease such as 
rheumatoid arthritis showed a considerable reduced risk of developing AD after a regularly long-
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term nonsteroidal anti-inflammatory agents (NSAIDs) administration/medication (McGeer et al., 
1996; Stewart et al., 1997), supporting the hypothesis of an inflammatory background in AD. 
Interestingly, a novel hypothesis includes the statement that normal aging itself is attended by a 
chronic upregulation of certain inflammatory responses such as cytokine production and 
microglia activation. This phenomenon is also termed “inflammaging” and refers to an over-
active innate immunity in some elderly people (Giunta et al., 2008). Importantly, this 
phenomenon can be found in both healthy and pathological aging. Although all these findings 
support an active involvement of the immune system in the etiology of sporadic AD, 
experimental evidence is still lacking.  
 
 
5. PRENATAL BRAIN INFLAMMATION AND ITS IMPACT ON REELIN-
MEDIATED SIGNALING  
In addition to regulating inflammatory responses induced by neurodegenerative processes, 
cytokines released from both astrocytes and microglia have also critical effects on 
synaptogenesis and contribute to the targeting of synapses for elimination, thereby representing 
important modulators of neuronal activity, differentiation, and survival during 
neurodevelopment, as well as synaptic strength and plasticity in adulthood (for review, 
Deverman and Patterson, 2009). These cytokine-mediated developmental processes are highly 
susceptible to disruption by immune dysregulation. Overexposure to cytokines, for example, 
during early brain development in mice has been shown to strongly affect cell migration, 
neuronal differentiation, and synaptogenesis, leading to multiple morphological and 
neurochemical defects which result in disturbances of homeostatic neuronal network activity and 
subsequent behaviour and cognitive functions in the adult offspring (Deverman and Patterson, 
2009). In line with these data obtained from animal studies, elevation of inflammatory cytokines 
in the maternal serum has been associated with an increased risk factor for neuropsychiatric 
disorders in the offspring (Patterson, 2009; Penner and Brown, 2007). Our own recent findings 
provide first support for a comparable relationship for neurodegenerative diseases like AD. We 
have previously demonstrated that systemic administration of the synthetic cytokine releaser and 
viral mimic polyriboinosinic-polyribocytidilic acid (PolyI:C) in mice provides convincing 
support to the link between maternal infection during pregnancy and behavioral and 
neurochemical abnormalities in the adult offspring (Meyer et al., 2005; Shi et al., 2003; 
Zuckerman et al., 2003). We have shown that the middle and late gestation periods correspond to 
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two windows of enhanced vulnerability to inflammatory cytokines, leading to an acute response 
in the fetal brain and delayed brain neuropathology, including defective Reelin expression, 
apoptosis in early adolescence (Meyer et al., 2006), as well as pronounced changes in the 
GABAergic, glutamatergic, and dopaminergic system in limbic structures in the adult brain 
(Fig. 7, (Meyer et al., 2008a; Meyer et al., 2008b; Nyffeler et al., 2006).  
 
 
 
FIGURE 7: Animal models of neuropsychiatric and neurodegenerative diseases  
The time of maternal immune challenge critically determines the patterns of fetal immunological, juvenile 
neurochemical, as well as adult behavioural abnormalities displayed by the offspring. An acute systemic challenge 
of the viral mimic polyriboinosinic-polyribocytodilic acid (PolyI:C), a synthetic analog of double-stranded RNA and 
cytokine releaser, during mid-gestation (gestational day, GD9) results in a behavioural profile that mimics certain 
aspects of psychotic symptoms in the adult offspring, potentially linked to the pronounced impact of this treatment 
on the dopaminergic system. Late-gestational (GD17) immune challenge results in a behavioural phenotype 
characterized primarily by cognitive impairments, accompanied by a strong imbalance in the glutamatergic 
neurotransmitter system. The fetal brain can directly contribute to the specific changes in inflammatory cytokine 
protein levels at a late-gestational but not mid-gestational immune challenge, suggesting a close correlation between 
acute immunological modulators and histopathological changes in the adult offspring. Although both mid- and late 
gestational PolyI:C treatments are equivalently effective in reducing the number of Reelin-positive neurons, the time 
of the maternal immune challenge is expected to determine whether the reduction in Reelin-mediated signaling 
primarily affects proper neuronal migration or impairs synaptogenesis. This might further contribute to the distinct 
symptom clusters characteristic of the adult offspring born to mid- or late-gestational immune challenged dams.  
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Moreover, our studies demonstrated for the first time that this prenatal viral–like infection in 
wild type mice significantly accelerates the reduction in Reelin-expressing interneurons and its 
accumulation in extracellular amyloid-like plaques, a phenomenon consistently seen in aged 
subjects across species and correlating with the cognitive performance (Knuesel et al., 2009).  
 
Taken together, these findings suggest that prenatal exposure to infection is not only an 
important factor in the segregation of symptom clusters in neuropsychiatric disorders but does 
also represent a critical driving force of aging-related neurodegenerative processes. Moreover, 
the acceleration of senescence after early brain inflammation confirms the critical role of non-
genetic components as major risk factors of LOAD. 
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II. AIM OF THE THESIS 
 
Previous studies performed in our lab suggest that Reelin aggregates into abnormal oligomeric or 
protofibrillary deposits during aging, potentially creating a precursor condition for Aβ plaque 
formation in animal models of sporadic AD. The overall aim of this thesis was to elucidate the 
significance of this neuropathology and to identify the role of abnormal Reelin-mediated 
signaling in the etiology of the more common late-onset form of the disease. Therefore, we 
focused on the following four specific aims: 
 
 
STUDY I Do Reelin and APP associate in the hippocampus of aged wild type mice? 
We previously reported an age-related decline in Reelin-expressing interneurons, accompanied 
by an accumulation in amyloid-like plaques in the hippocampal formation of aged mice (Knuesel 
et al., 2009). Further, Reelin was found to closely associate with fibrillary Aβ-plaques in 
transgenic AD mice. The question here was whether there is also a close correlation between 
APP and Reelin in the amyloid-like plaques, potentially mimicking neuropathological changes in 
the prodromal phase of AD. Therefore, we aimed to explore the immunohistochemical properties 
of Reelin-positive plaques by adapting an optimized immunohistochemical protocol involving 
pepsin pre-digestion to investigate their potential to sequester murine proteolytic APP species in 
wild type mice across aging. Moreover, we aimed to clarify whether these aggregates are extra- 
or intracellular and investigate their potential association with glia cells and the cerebral 
vasculature. 
 
 
STUDY II Are there ultrastructural differences in the Reelin-positive granule 
morphology after a prenatal immune challenge? 
Recent studies from our group revealed that a prenatal immune challenge using the viral mimic 
PolyI:C results in significant acceleration of aging-associated neuropathological alterations in 
wild type mice, including precocious accumulation of the Reelin-positive clusters. These 
findings suggested that a prenatal immune challenge represents a critical driving force of aging-
related neurodegenerative processes and confirms a role of dysregulated components of the 
innate immune system as major risk factor of sporadic AD. Here, we were interested to elucidate
Aim of the Thesis 
24 
 whether Reelin-positive deposits in the hippocampal formation differ in size, density and 
ultrastructural properties between immune challenged compared to saline treated 
subjects.Moreover, employing a longitudinal immuno-electron microscopy study, we aimed to 
characterize the temporal and spatial properties, as well as their potential intracellular origin that 
may be indicative of degenerative processes. Another aspect of this study was the clarification of 
whether these observed granular clusters share similarities to the polyglycogen bodies (PGs) 
described by several research groups. 
 
 
STUDY III Is Reelin present in the granular structures and can they be analyzed by a 
mass spectrometric approach?  
In order to confirm our immunohistochemical and ultrastructural data, we also wanted to 
characterize the protein composition of the clustered granular plaques characteristic of aged wild 
type mice using a biochemical approach. The first question to be solved was the confirmation of 
Reelin, potentially its proteolytic fragments and also proteolytic fragments of APP being actually 
present in these age-related deposits. This was accomplished by using laser microdissection 
(LMD) to isolate these accumulations from the hippocampal formation of wild type mice and 
processed further for western blot analysis. Secondly, would a precise proteomic analysis be 
achievable with this small amount of sample? To address this issue, we chose a proteomic 
approach combining the LMD with mass spectrometry. We hypothesized that a systematic 
analysis of the protein composition associated and enriched in the extracellular deposits could 
shed light on potential signaling pathways that govern their formation, potentially even allowing 
a prediction on critical determinants involved in plaque initiation and maintenance. 
 
 
STUDY IV Influence of reduced Reelin expression on APP processing and Tau 
pathology  
Besides the fundamental roles of Reelin in the developing and adult brain, it has been suggested 
that alterations in Reelin mediated signaling contribute to neuronal dysfunction associated with 
AD (Beffert et al., 2002, 2004; Hiesberger et al., 1999; Hoe et al., 2006, 2009b). Based on in 
vitro data from the group of Rebeck (Hoe et al., 2006) as well as on our previous findings on 
age-associated aggregation of Reelin (Knuesel et al., 2009; Madhusudan et al., 2009) we 
hypothesized that reduced Reelin-mediated signaling represents a critical upstream factor in 
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initiating both amyloidogenic APP processing and pTau/NFTs formation. We aimed to decipher 
the putative association of Reelin and its functional signaling in amyloid plaque formation as 
well as its influence on Tau pathology in vivo. We crossed heterozygous Reelin knock-out mice 
(reeler) into a transgenic AD background and tested the hypothesis that the AD-like 
neuropathology accelerates and aggravates during aging in the transgenic offspring expressing 
only 50 % of the reeler gene in comparison to the control. To address this issue I employed 
immunohistochemical and biochemical methods. 
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1.1 ABSTRACT 
 
Reelin is a large extracellular glycoprotein required for proper neuronal positioning during 
development. In the adult brain, Reelin plays a crucial modulatory role in the induction of 
synaptic plasticity and successful formation of long-term memory. Recently, alterations in 
Reelin-mediated signaling have been suggested to contribute to neuronal dysfunction associated 
with Alzheimer’s disease (AD). We previously reported that aging in several species is 
characterized by a decline in Reelin-expressing interneurons and concomitant accumulation in 
amyloid-like plaques in the hippocampal formation, significantly correlating with cognitive 
impairments. In transgenic AD mice, we detected Reelin in oligomeric amyloid-β aggregates and 
in tight association with fibrillary plaques. Here, we used immunohistochemistry at the light and 
electron microscopy level to characterize further the morphology, temporal and spatial 
progression, as well as the potential of Reelin-positive plaques to sequester murine amyloid-β 
peptides in wild type mice across aging. We developed a new immunohistochemical protocol 
involving a stringent protease pretreatment which markedly enhanced Reelin-IR and allowed 
specific detection of variable shapes of murine anti-amyloid beta precursor protein (AβPP)-IR in 
plaques in the hippocampus, likely representing N-terminal fragments and amyloid-β species. 
Ultrastructural investigations confirmed the presence of Reelin in extracellular space, somata of 
interneurons in young and aged wild type mice. In aged mice, Reelin- and amyloid-β-IR was 
detected in extracellular, spherical deposits; likely representing small intermediates or fragments 
of amyloid fibrils. Our results suggest that Reelin itself aggregates into abnormal oligomeric or 
protofibrillary deposits during aging, potentially creating a precursor condition for fibrillary 
amyloid-β plaque formation. 
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1.2 INTRODUCTION 
 
Many age-associated degenerative diseases are associated with abnormal proteinaceous 
aggregates, often in the form of amyloid deposits. In Alzheimer’s disease (AD), amyloid-β (Aβ) 
peptides, the β- and γ-secretase-mediated cleavage product of amyloid beta-precursor protein 
(AβPP), are the major plaque components (Glenner and Wong, 1984). Besides cerebrovascular 
amyloid deposits, non-vascular Aβ-plaques are highly abundant in neocortex and hippocampal 
formation of AD patients, typically referred to as “senile plaques” with different morphologies 
and protein contents, assumed to reflect different temporal and spatial aggregation states (Fiala, 
2007; Thal et al., 2006). The linkage of rare familial AD mutations which all affect the 
proteolysis of AβPP, leading to increased production of aggregation-prone Aβ peptides, supports 
a central role of Aβ in AD pathophysiology (Hardy and Selkoe, 2002). However, it is currently 
unknown which type of Aβ aggregate plays a primary causative part and whether the underlying 
mechanisms are identical in familial and sporadic AD. Growing experimental evidence suggest 
that soluble Aβ species in the form of pre-fibrillary oligomers may be important in initiating 
neuronal malfunction and cell death (Glabe, 2008). Moreover, it has been reported that soluble 
Aβ correlates better with dementia than insoluble fibrillary deposits (McLean et al., 1999). 
Experimental support has been provided by numerous cell culture models of Aβ aggregate 
neurotoxicity (Dahlgren et al., 2002; Hartley et al., 1999; Lambert et al., 1998; Zhang et al., 
2002) as well as administration of non-fibrillary Aβ oligomers to hippocampal slice cultures and 
live animals (Cleary et al., 2005; Klyubin et al., 2005; Knobloch et al., 2007a; Knobloch et al., 
2007b; Walsh et al., 2002) that produced deficits in long-term potentiation and cognition.  
Amyloid-β plaques also commonly occur in absence of disease, injury or dementia in elderly 
humans, aged primates and many non-primate species (Fiala et al., 2007; Giannakopoulos et al., 
1997; Peters, 2002; Price et al., 1991). Despite numerous investigations reporting AD-like 
neuropathology in aged rodents (Armstrong et al., 1988; Jucker and Ingram, 1997; Jucker et al., 
1994a; Lamar et al., 1976; Mandybur et al., 1989; Vaughan and Peters, 1981) the development 
of transgenic AD mouse models focusing on genetic factors resulted in decreasing interest in this 
topic. However, the recent implications of soluble Aβ species in AD pathophysiology prompted 
us to investigate aging-related neuropathological changes in wild type rodents and non-human 
primates to re-evaluate abnormalities in protein expression and aggregation, expected to provide 
important information regarding early markers of sporadic AD-like neuropathology (Knuesel et 
Study I: Co-localization of Reelin and APP fragments in WT mice 
30 
al., 2009). We reported that normal aging is accompanied by the occurrence of amyloid-like 
plaques in hippocampus, entorhinal and piriform cortex. These extracellular, glial-associated 
deposits are positive for Reelin, a conserved glycoprotein with fundamental roles during 
neurodevelopment (Rice and Curran, 2001). The full-length form of Reelin is a 3,461 amino 
acid protein with a relative molecular mass of about 400 kDa. The N-terminus is glycosylated 
and shares 25 % identity with that of F-spondin. The central sequence consists of eight “Reelin 
repeats” containing an intermediate EGF-like motif (D'Arcangelo et al., 1995). This is followed 
by a highly charged C-terminus which appears to be essential for both secretion and signal 
transduction (D'Arcangelo et al., 1997; de Bergeyck et al., 1997; Nakano et al., 2007). In the 
extracellular matrix, Reelin is processed proteolytically at two sites to produce a total of six 
different fragments (Lambert de Rouvroit et al., 1999). In the adult brain, Reelin is produced by 
GABAergic interneurons and expressed in layer II glutamatergic pyramidal cells in the 
entorhinal cortex (Herz and Chen, 2006; Knuesel et al., 2009) locally modulating 
neurotransmission in the hippocampus (Herz and Chen, 2006). This is achieved via the same 
signaling cascade as used in the developing brain, involving binding of Reelin to its receptors, 
the ApoE receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR), and the 
activation of an intracellular signaling cascade involving Dab1, Src and Fyn tyrosine kinases that 
modulate NMDA receptor-dependent synaptic plasticity and learning (Beffert et al., 2006a, 
2005; Chen et al., 2005). In line, we recently reported that the age-related decline in Reelin 
expression was accompanied by significant impairments in episodic-like memory in aged mice 
(Knuesel et al., 2009). Moreover, recent findings describing direct binding of Reelin to the N-
terminus of AβPP (Hoe et al., 2009b), an involvement of Reelin in AβPP processing in-vitro 
(Hoe et al., 2006), in Tau phosphorylation (Beffert et al., 2004; Hiesberger et al., 1999; Ohkubo 
et al., 2003) as well as binding-competition with ApoE to ApoER2 and VLDL receptors 
(D'Arcangelo et al., 1999) point to a critical function of this signaling cascade in AD 
pathogenesis. Here, we explored the biochemical and ultrastructural properties of Reelin-positive 
plaques by adapting a novel immunohistochemical protocol involving pepsin pre-digestion and 
preembedding immuno-electron microscopy (IEM) to investigate their potential to sequester 
murine proteolytic AβPP species.  
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1.3 METHODS AND MATERIALS  
 
EXPERIMENTAL ANIMALS 
All procedures were approved by the local authorities of the Cantonal Veterinary Office in 
Zurich. Female wild type mice were obtained from our in-house C57BL/6J(FUE) breeding 
colony (RCC Ltd, Fuellinsdorf, Switzerland). Transgenic AD mouse models included the 
following lines: 1) Mice overexpressing human AβPP695 containing the Swedish 
(K670N+M671L) and Arctic (E693G) mutations in a C57Bl/6 background under the control of 
the prion protein promoter (PrP); named ArcAβ mice (Knobloch et al., 2007b). These mice show 
intracellular Aβ deposition that coincides with behavioral deficits around 6 months of age before 
the onset of β-amyloid plaque formation and cerebral amyloid angiopathy, which starts around 9 
months (Knobloch et al., 2007b). 2) Mice with a complete inactivation of the mouse amyloid 
precursor protein gene (AβPP -/-) were obtained from The Jackson Laboratory, Bar Harbor, 
Maine, USA (Strain: B6.129S7-Apptm1Dbo/J; Stock Nr. 004133). The deletion encompasses a 
3.8 kb sequence encoding the promoter and the first exon, which encodes the ATG translation 
initiation codon and the signal peptide of the murine amyloid precursor protein (Zheng et al., 
1995). Neither AβPP mRNA nor protein can be detected in the mutant animals. The 
homozygous AβPP -/- mice are viable and show no physical or behavioural abnormalities at birth, 
but have a lower body mass, decreased locomotor activity, and compromised neuronal and 
muscular functions at 14 weeks of age (Zheng et al., 1995). Finally, for antibody specificity 
controls, 4 female reeler orleans (Relnrl-orl) mice aged 15 months were obtained from Jessica 
Maas, Forschungszentrum Jülich GmbH, Jülich, Germany. The Relnrl-orl mice, which in contrast 
to the original reeler (RelnJ) mice survive into adulthood and old ages, harbor a L1 transposable 
element near the 3’ end of the gene that causes the skipping of a 220-bp exon (Bar et al., 1995; 
Hirotsune et al., 1995). This deletion results in a frame shift that alters the predicted amino acid 
sequence of the C-terminus of Reelin; allowing the production but not the secretion of the C-
terminally truncated protein (de Bergeyck et al., 1997; Takahara et al., 1996). All animals were 
housed in same sex groups of 3 - 4 in an optimized hygiene area (OHB, University of Zurich 
Irchel, Switzerland) under 12-h light-dark cycle and ad libitum food and water. For the 
immunohistochemical examinations we employed wild type mice of 1, 2, 3, 9, 12 and 15 months 
of age (n = 3-5 per age), as well as 15 month-old transgenic ArcAβ and AβPP-/- mice (n = 3 per 
transgenic line). For the ultrastructural investigations, we included in total of 3 young (2 mo) and 
3 aged (9 and 12 mo) C57Bl/6 wild type mice. Finally, for the western blotting we included brain 
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hippocampal lysates obtained from 15 month-old C57Bl/6 mice (n = 3). All experiments were 
repeated 2 (western blotting) or 3 times (EM, IHC). 
 
TISSUE PREPARATION  
Paraformaldehyde-fixation: Animals were anesthetized (Nembutal™; 4 ml/kg body weight; i.p.) 
and perfused with 4 % paraformaldehyde and 15 % saturated picric acid in PBS buffer and the 
brain tissue processed as described (Knuesel et al., 2009). Serial coronal sections (40 μm) 
starting at Bregma level -0.82 to -3.40, or serial transverse sections starting from lateral level 2.4 
to 0.48 (Paxinos and Franklin, 2001) were cut on a sliding microtome, collected and stored at 
-20°C in cryoprotectant solution until further processing. Immunohistochemical stainings were 
performed on either free-floating or air-dried mounted sections. Paraffin-embedding: The 
preparation of brain sections from 15 mo old ArcAβ mice (5 μm thick) was performed by 
Marlene Knobloch, Division of Psychiatry Research, University of Zurich, as described 
(Knobloch et al., 2007b). Microwave pretreatment (10 min in 85°C citrate buffer), followed by a 
5 min submersions in 95 % formic acid, 10 min incubation in 3 % H2O2 in MeOH, and blocking 
in  4 % BSA, 5 % goat serum and 5 % horse serum at RT for 1 h was done before the 
immunostaining. Cryotissue: Mice were decapitated, the dissected brains rapidly frozen on 
powdered dry ice and cut coronally (12 μm) on a cryostat, mounted on gelatinized glass slides 
and fixed in 70 % ice-cold acetone for 1 min.  
 
PEPSIN PRETREATMENT 
Prior to conventional immunohistochemical incubations, paraformaldehyde- and acetone-fixed 
brain sections were treated with pepsin (DAKO, Carpinteria, CA). Frozen aliquots containing 
3 mg/ml of pepsin solution in 0.2 N HCl were thawed immediately before use and added to 
0.2 N HCl to a final pepsin concentration of 0.15 mg/ml. Free-floating perfusion-fixed or 
mounted acetone-fixed brain sections were then incubated with the pepsin solution at 37°C. 
After 10, 30 (cryotissue) or 60 min (paraformaldehyde-fixation) incubation, sections were briefly 
washed with phosphate-buffered saline (PBS, pH 7.4) and processed for immunohistochemistry. 
 
IMMUNOHISTOCHEMICAL PROCEDURES 
Reelin immunoperoxidase stainings without pepsin pretreatment were performed on wild type 
brain sections as described previously (Nyffeler et al., 2007). Paraffin-embedded and pepsin-
treated brain sections were incubated overnight at 4°C in the primary antibody solutions diluted 
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in PBS containing 2 % normal goat serum and 0.2 % Triton X-100. The antibodies and dilutions 
used in this study are summarized in Table 1. After three washes in PBS, tissue sections were 
incubated for 30 min at room temperature (RT) in corresponding secondary antibodies coupled 
to Alexa488 (diluted 1:1000; Molecular Probes, Eugene, OR), Cy3 (diluted 1:500) and Cy5 
(diluted 1:200; Jackson ImmunoResearch Laboratories) and processed as described (Nyffeler et 
al., 2007). Thioflavin-S counterstaining involved a 10 min incubation in filtered 1 % aqueous 
Thioflavin-S (Sigma-Aldrich, Buchs, Switzerland) solution at RT, followed by 2 washes for 5 
min in 80 % EtOH, 5 min wash in 95 % EtOH, and 3 times 5 min washes in distilled water. 
Brain sections were then air-dried in the dark and mounted with aqueous permanent mounting 
medium (DAKO).  
 
TABLE 1: Primary antibodies used in this study 
Antigen Immunogen   Manufacturer, Species, type, cat.no Dilution  
Reelin, clone G10 Rodent Reelin, amino acid residues 
164-496 
 Chemicon (Millipore, Billerica, MA) 
 mouse monoclonal, #MAB5364 
1:1000 (IHC) 
1:1000 (IEM) 
Amyloid-β1-40/42 Synthetic Aβ1-40 conjugated to BSA. The
immunogenic peptides shows a high  
degree of homology with human/mouse 
Aβ1-40 and Aβ1-42 
 Chemicon (Millipore, Billerica, MA) 
 rabbit polyclonal, #AB5076 
1:5000 (IHC) 
1:1000 (IEM) 
1:1000 (WB) 
Amyloid-β, clone 6E10 Human Aβ protein, amino acid  
residues 1-17 
 Chemicon (Millipore, Billerica, MA) 
 mouse monoclonal, #MAB1560 
1:500 (WB) 
Amyloid-β protein 
precursor  
(AβPP A4, clone 22C11) 
Bacterial recombinant AβPP  
(pre-AβPP695) fusion protein, human  
amino acid residues 66-81 (N-terminus)
 Chemicon (Millipore, Billerica, MA) 
 mouse monoclonal, #MAB348 
1:1000 (IHC) 
1:1000 (WB) 
Amyloid-β protein 
precursor 
(C-terminus) 
Nine amino acid peptide from the  
C-terminus of human AβPP 
(YKFFEQMQN) 
 Chemicon (Millipore, Billerica, MA) 
 rabbit polyclonal, #AB5352 
1:500 (IHC) 
11000 (WB) 
α1-syntrophin Synthetic peptide (CRQPSSPGPQPRN 
LSEA), Rat amino acid residues 191-
206 (Haenggi et al., 2005) 
 Affinity purified polyclonal rabbit 
 serum 
1:500 (IHC) 
IHC: Immunohistochemistry; IEM: Immuno-electron Microscopy; WB: Western Blotting 
 
ANTIBODY CHARACTERIZATION 
The anti-Reelin, clone G10 antibody recognizes the full-length (~400 kDa) protein and two N-
terminal products (~300 and ~180 kDa) on Western blot of wild type but not Reelin knockout 
(reeler) mouse tissue (Lambert de Rouvroit et al., 1999). On brain tissue sections obtained from 
mouse, rat, monkey and postmortem human samples, the G10 antibody shows highly selective 
somatic IR in GABAergic interneurons throughout the forebrain, as well as granule cells in the 
Study I: Co-localization of Reelin and APP fragments in WT mice 
34 
cerebellum, mitral cells in the olfactory bulb, pyramidal neurons in entorhinal and piriform 
cortex; which is absent on brain tissue collected from reeler mice (Chin et al., 2007; Knuesel et 
al., 2009; Miettinen et al., 2005; Pappas et al., 2001, 2003; Ramos-Moreno et al., 2006). All the 
studies revealed that the G10 antibody additionally shows a distinct neuropil staining, 
particularly prominent in the CA1 stratum lacunosum-moleculare and outer molecular layer of 
the DG, likely reflecting the secreted protein located in the extracellular matrix. The 
immunohistochemical staining described here is highly comparable to the published studies 
mentioned above. In addition, we confirmed the specificity of the G10 antibody on perfused 
brain tissue obtained from aged Relnrl-orl mice which revealed only intraneuronal but no 
extracellular IR (data not shown). 
The rabbit polyclonal antibody beta-amyloid Aβ1-40/42 was raised against a synthetic BSA-
conjugated peptide corresponding to the beta-amyloid 1-40 and recognizes the β- and γ-
secretase-mediated proteolytic cleavage product of AβPP, Aβ1-40/42, the major component of 
human senile amyloid-β plaques (Glenner and Wong, 1984). According to the manufacturer’s 
technical information, the immunogenic peptide shows a high degree of homology between 
human and mouse, and correspondingly, the antibody recognizes the human and mouse AβPP, β-
stubs (β-secretase-cleaved C-terminal fragments), and the fully cleaved Aβ peptides, in line with 
the immunohistochemical and western blot data described here and our previous study (Knuesel 
et al., 2009).  
The mouse monoclonal antibody β-amyloid clone 6E10 was raised against amino acid residues 
1-17 of the beta-amyloid protein and reacts with human but not mouse full-length AβPP on 
paraffin-embedded and perfusion-fixed brain tissue, as well on brain lysates of transgenic 
(overexpressing mutant human AβPP), but not wild type mice (Knobloch et al., 2007b; Mayeux 
et al., 1999; Van Dooren et al., 2006). The mouse monoclonal 22C11 anti- AβPP (N-terminus) 
was raised against a bacterial recombinant amyloid precursor protein (AβPP A4) fusion protein 
(human AβPP695). The antibody recognizes amino acids 66-81 of the  N-terminus of the full-
length AβPP molecule (Hilbich et al., 1993; Knobloch et al., 2007b) and detects all three 
isoforms of AβPP in rodent and human tissue: the mature form of ~130 kDa, the secretory N-
terminal fragments s AβPP of ~120 kDa, the immature AβPP of ~110 kDa (Knobloch et al., 
2007b) as well as the newly described N-terminal fragment of ~35 kDa (Dooley et al., 1992; 
Nikolaev et al., 2009).  
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The rabbit anti-AβPP polyclonal antibody was raised against a nine amino acid peptide from the 
C-terminus of AβPP. According to the manufacturer’s technical information, the immunogenic 
peptide shows a high degree of homology between human and monkey, and correspondingly, the 
antibody shows reactivity in both species. This antibody has also been used in numerous murine 
studies, and was shown to recognize full-length AβPP, C-terminal fragments resulting from 
cleavage by secretases by both immunoblotting and immunocyto- and histochemistry (Chang et 
al., 2004; Muresan and Muresan, 2004). 
The affinity-purified rabbit polyclonal α1-syntrophin antibody was raised against a peptide 
sequence derived from the first pleckstrin-like domain of the rat syntrophin α1 gene (Haenggi et 
al., 2005) α1-syntrophin is a member of the dystrophin-associated protein complex and localized 
to cellular membranes in skeletal muscles, kidney, liver, and brain, including the postsynaptic 
density of glutamatergic synapses as well as astrocytic endfeet (Haenggi and Fritschy, 2006). 
Specificity of the antibody has been demonstrated using tissue from α1-syntrophin knockout 
mice, as well as in preadsorption experiments incubating primary antibodies with peptide 
antigen, which resulted in a dose-dependent loss of specific IR (Haenggi et al., 2005). 
 
PREEMBEDDING IMMUNO-ELECTRON MICROSCOPY 
Mice were anesthetized as described above and perfused with a fixative containing 4 % 
paraformaldehyde, 0.2 % picric acid and 0.1 % glutaraldehyde in 0.1 M phosphate buffer, 
pH 7.4. The tissue was postfixed for 5 h at 4°C, washed and stored in phosphate buffer 
overnight. Coronal sections (70 μm) were cut with a Vibratome, the hippocampus dissected and 
cryoprotected in 30 % sucrose overnight. The sections were then processed for anti-Reelin and 
-Aβ immunohistochemistry using DAB immunoperoxidase reactions (secondary goat-anti 
mouse/anti rabbit, conjugated to biotin, 1:250; Jackson ImmunoResearch Laboratories Inc., West 
Grove, PA) or secondary immunogold-conjugated antibodies (1:200; Alexa Fluor-488-
Fluoronanogold-Fab, Nanoprobes Yaphank NY, USA). The latter immunoprobe consists of a 1.4 
nm gold particle conjugated with goat-anti mouse Fab fragment and fluorescein. 
The DAB reaction product was silver-intensified and gold-toned according to (Sassoe-Pognetto 
et al., 1994). Briefly, sections were incubated in a solution containing 2.8 % 
hexamethylenetertramine (Merck, Darmstadt, Germany), 0.2 % silver nitrate (Merck) and 
0.02 % disodium tetraborate (Merck) for 10 min at 60°C. The sections were then rinsed in 
distilled water and treated for 2 min with gold chloride (0.05 % in distilled water, Merck). 
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Finally the sections were rinsed in distilled water and incubated for 2 min in sodium thiosulfate 
(2.5 % in distilled water, Merck). 
Optimal visualization of the 1.4 nm gold-particles (FNG-labeled tissue samples) at the electron 
microscopic level required gold enhancement. The specimens were incubated with a 
commercially available kit (GOLDENHANCETM-EM, Nanoprobes, Yaphank NY, USA) 
containing four vials with solutions called enhancer (solution A), activator (solution B), initiator 
(solution C) and buffer (solution D). Equal volumes of each solution were mixed to form the 
final reagent. The samples were then immersed in 300 μl of this solution and incubated for 7min 
at RT. After the enhancement for both procedures, samples were kept in Na-cacodylate buffer 
(0.1 M, pH 7.4) overnight. Finally, sections were postfixed in 0.5 % OsO4 (on ice), 
counterstained with 1 % uranyl acetate, dehydrated in acetone and embedded in Epon 812. 
Ultrathin sections (50 nm) were collected on adhesive-coated nickel grids (300 mesh) and 
examined using a Philips 208 transmission electron microscope equipped with a side mounted 
digital camera (4k x 3k; Gatan GmbH, Munich, Germany).  
 
REELIN-POSITIVE PLAQUE ESTIMATES AND QUANTIFICATION OF REELIN-Aβ CO-
LOCALIZATION 
The immunoperoxidase stainings were analyzed with bright-field microscopy and digital images 
acquired using a color digital camera (AxioCam, Zeiss, Jena, Germany) controlled by 
AxioVision 4.1 software (Zeiss). Quantification of Reelin-positive plaques in the dorsal 
hippocampus, cerebellum, and olfactory bulb were performed on transverse sections obtained 
from young (3 mo; n = 3) and old (15 mo; n = 5) wild type mice on 4-5 sections per subject. 
They were counted exhaustively, i.e. involving all and not only a representative sample of the 
immunoreactive plaques labeled within the outlined brain regions using the 40x objective (NA 
1.3). The total number of plaques was estimated according to the formula Ptot = ∑P × 1/ssf, 
where ∑P is the sum of plaques, and ssf = the section sampling fraction (1/6). Qualitative 
evaluations of immunofluorescence labelings were done with confocal microscopy (LSM-710, 
Zeiss) using either 40x (NA1.3) or 100x objectives (NA1.4). Double-immunofluorescence 
stainings were visualized using sequential acquisition of each channel. The pinhole aperture was 
set to 1.0 Airy unit for each channel. Stacks of consecutive optical sections (3-6; 512 x 512 
pixels, spaced 1 µm in z) were acquired at a magnification of 0.11-0.22 µm/pixel. For visual 
display, Z-sections of all channels were projected in the z-dimension (maximal intensity), and 
merged using the image analysis software Imaris (Bitplane, Zurich, Switzerland). Cropping of 
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images, adjustments of brightness and contrast were identical for each labeling using electron 
microscopy, bright field or epifluorescence microscopy and done using Adobe Photoshop 
(Adobe Systems, San Jose, CA). Reelin- and Aβ−immunoreactive signals in amyloid-like 
plaques were quantified on projected z-sections acquired in CA1 stratum radiatum and 
lacunosum-moleculare obtained from paraformaldehyde-fixed brain tissue. Red and green 
channels were first individually segmented and analyzed in regard to pixel brightness (area and 
integrated density), as well as pixel overlap between Reelin- and Aβ-IR within outlined plaques 
using a co-localization plug-in of ImageJ (NIH, http://rsbweb.nih.gov/ij/). A total of 6-10 
plaques collected from 3-7 perfusion-fixed sections per animal (n = 4; 15 month old wild type 
mice) and treatment (no pepsin, 60 min pepsin pre-incubation) were included in this quantitative 
analysis.  
 
STATISTICAL ANALYSIS 
The analysis was performed with the software StatView version 5.0 (Abacus Concepts, Inc., 
Berkeley, CA). Nonparametric Mann-Whitney U tests were used to statistically compare the 
estimated total number of Reelin-positive plaques in young (3 mo, n = 3) versus aged (15 mo, 
n = 5) wild type mice for each brain region separately. The same test was also used for the 
quantification of the difference in immunofluorescence staining intensity of Reelin IR and 
Reelin-Aβ co-localized signals (total area and integrated density of individually labeled plaques) 
with or without pepsin pretreatment (n = 4 animals per treatment group). Statistical significance 
was set at p < 0.05. 
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1.4 RESULTS 
 
AGING-RELATED ACCUMULATIONS OF REELIN-POSITIVE PLAQUES CORRELATE WITH THE 
EXPRESSION PATTERN OF REELIN    
Young and aged wild type mice (3 and 15 mo) were employed in an immunohistochemical 
evaluation without pepsin pretreatment to confirm the aging-associated changes in Reelin 
expression and to investigate the spatial profile of Reelin-positive plaque deposition in the 
murine brain. Anti-Reelin immunoperoxidase stainings confirmed our previous findings of a 
pronounced age-associated reduction in Reelin-immunoreactivity (IR) in GABAergic 
interneurons and neuropil of the hippocampus, particularly prominent in the CA1 stratum 
lacunosum-moleculare (slm) and outer molecular layer of the DG (Fig. 1A-B). Reelin-positive 
plaques were detected at comparable densities, layer-specific locations, as well as in close 
vicinity to Reelin-expressing neurons in aged individuals (Fig. 1C-D) as described previously 
(Knuesel et al., 2009) confirming the consistency and robustness of this age-related pathology. 
Moreover, we found a pronounced reduction in Reelin-IR in cerebellar granule cells, 
accompanied by plaque depositions around Purkinje cells (Fig. 1E), and prominent 
accumulations in the main and accessory olfactory bulb (Fig. 1F); all areas with high densities of 
Reelin-secreting cells in adulthood, indicating a close association between extracellular Reelin 
levels and plaque deposition. Counterstaining using Thioflavin-S to detect β-sheet containing 
proteinous aggregates revealed a high degree of co-localization between Reelin-IR and 
Thioflavin-S staining in extracellular plaques in 15 month old subjects (Fig. 1G), confirming the 
presence of amyloid-like depositions in aged wild type mice. Thioflavin-S staining was not 
detectable in 3 month old mice (data not shown), in line with the absence of Reelin-positive 
plaques at this age (Fig. 1A). Stereological estimates of the number of Reelin-positive plaques in 
these areas revealed significant differences in the total number of plaques in the cerebellum 
(3 mo: median = 72; 15 mo: median = 522; Mann–Whitney U = 15.5, p = 0.02) and 
hippocampus (3 mo: median = 48; 15mo: median = 684; U = 15.1, p = 0.03). In the olfactory 
bulb, the difference in distribution of the plaque density between the two groups closely 
approached significance (U = 13.5, p = 0.057; Fig. 1H).  
To examine the relationship between Reelin- and β-amyloid plaques in aged transgenic ArcAβ 
AD mice, we performed double-immunofluorescence staining using anti-Reelin and anti-
amyloid-β antibodies (rabbit anti-Aβ1-40/42, Table 1). Reelin-positive plaques were detected in 
the hippocampus and cortex (Fig. 2A), showing similar granular morphologies as described in
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FIGURE 1: Accumulation of Reelin in extracellular plaques in the aged brain. A-B) Immunoperoxidase staining 
using anti-Reelin antibodies on brain sections of young (3 mo) and old (15 mo) wild type mice (n = 3 per age). Note 
the reduction in IR in Reelin-expressing interneurons and neuropil, particularly prominent in CA1 stratum 
lacunosum-moleculare (slm) and outer molecular layer (ml) of the DG; concomitantly with the striking high density 
of Reelin in amyloid-like plaques (arrows) in aged compared to young mice. C-D) Higher magnification of Reelin-
positive plaques (arrows) located in the CA1 and DG. Most of these aggregates are detected around or in close 
proximity to Reelin-expressing neurons (arrowheads). E) A high density of Reelin-positive deposits was also 
evident in the cerebellum (CERE), precisely surrounding Purkinje cells (PC, arrow) and again closely associated 
with Reelin-producing cerebellar granule cells (arrowheads). F) Similar observations were done in the main (OB) 
and accessory olfactory bulb (AOB), with many amyloid-like plaques (arrow) centered around Reelin-expressing 
interneurons (arrowheads). G) Thioflavin-S counterstaining (green) confirms the amyloid-like nature of the Reelin-
positive plaques (red) in the hippocampus of 15 mo-old mice. Note the dense aggregated core that contains both 
Reelin-IR and Thioflavin-S stainings (yellow signal, box is enlarged in the upper right corner). Crossed lines 
indicate the levels of the xz- and yz-view of one individual granule positive for Reelin and Thioflavin-S. 
H) Stereological estimates of the total number of Reelin-positive plaques in the olfactory bulb, cerebellum and 
hippocampus of young and aged wild type mice. *p < 0.05; #p = 0.056, statistical significance based on Mann-
Whitney U test. Abbreviations: ml, molecular layer; gcl, granular cell layer. Scale bars: B = 500 μm, F = 50 μm, 
G = 10 μm.  
 
old wild type mice. Interestingly, Reelin-IR was closely associated but never completely co-
localized with fibrillary Aβ plaques (Fig. 2B-D, suggesting a tight association between Reelin- 
and amyloid-β plaques in transgenic AD mice with ~6-fold overexpression of human AβPPswe,arc 
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(Knobloch et al., 2007b). Human and rodent AβPP not only share >96 % amino acid sequence 
identity, the Aβ peptides also have highly similar biophysical properties with respect to their 
ability to form congophilic filaments and amyloid fibers (Fung et al., 2004; Hilbich et al., 
1991b). However, immunohistological investigations so far failed to confirm the presence of 
fibrillary amyloid plaques in aged rodents. 
 
PEPSIN PRETREATMENT ENHANCES REELIN-IMMUNOREACTIVITY AND ENABLES THE 
DETECTION OF DISTINCT MURINE AβPP-DERIVED IMMUNOREACTIVITY 
To test whether Reelin-positive plaques may also serve as a nucleation site for murine amyloid 
plaques in aged wild type rodents, we optimized our protocols to better visualize rodent AβPP, 
putative N-terminal fragments and Aβ peptides and their association with Reelin-positive 
plaques in aged subjects. Immunostaining using cryotissue allows the detection of Reelin both 
intraneuronally and extracellularly in plaques (Fig. 3A). However, background labeling 
especially in the cerebral vasculature suggests reduced antigenicity due to tissue fixation. We 
therefore decided to apply an antigen retrieval step, based on the protocol of Watanabe and 
colleagues (Watanabe et al., 1998). They applied short pepsin pretreatment to improve the 
epitope accessibility and immunohistochemical detection of postsynaptic proteins. Here, we 
extended the protease pretreatment up to 60 min at 37°C (Fig. 3), which allowed us to 
significantly enhanced immunodetection and visualization of Reelin-IR in neurites, particularly 
prominent in axonal projections (Fig. 3B’’) as compared to non-treated brain sections. 
Importantly, the prolonged pepsin pretreatment significantly reduced background staining as 
well as IR of soluble intraneuronal Reelin and allowed a visual enrichment of aggregated Reelin 
in both cryotissue (Fig. 3A) and perfusion-fixed brain (Fig. 3B) sections, pointing to an 
aggregated and protease-resistant state of the deposits. For the perfusion-fixed tissue, we 
obtained a 3-fold increase in total area (Mann-Whitney U, p = 0.01) and 8-fold increase in 
brightness (integrated density, Mann-Whitney U, p < 0.0001) covered by immunoreactive 
signals within the amyloid-like plaques following a 60-min pepsin treatment as compared to no 
pepsin. Control treatments using solvent solution (0.2 M HCl in PBS) alone, did not effect the 
intensity and density of Reelin-immunoreactive signals (Suppl. Fig. 1 online), indicating that the 
proteolytic activity of pepsin and not the acidic environment is responsible for the antigen-
retrieval effect. 
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FIGURE 2: Reelin-positive plaques associate with amyloid-β in AD mice. Representative confocal images of 
immunofluorescence stainings of brain tissue obtained from 15 mo old transgenic ArcAβ mice (n = 3) using mouse 
anti-Reelin and rabbit anti-Aβ1−40/42 antibodies. A-B) Granular Reelin-positive deposits (green) were detected at 
high densities and close association with amyloid-β plaques (red) throughout the hippocampus. B’ shows a higher 
magnification of the boxed area outlined in B. Note the lack of co-localization between the two markers. C-D) Tight 
linkage between Reelin- and fibrillary Aβ-immunoreactive signals was evident in numerous amyloid-β plaques, 
most prominently at the edge of the extracellular deposits. Scale bars: A-B = 30 μm, C-D = 15 μm, J, B’ = 5 μm.  
 
 
 
FIGURE 3: Pepsin pretreatment strongly enhances Reelin-immunoreactivity in extracellular deposits. Anti-
Reelin immunohistochemistry using aceton-fixed cryosections (A) and paraformaldehyde perfusion-fixed sections 
(B) of 15 mo old wild type mouse brain tissue (n = 4 animals per treatment) processed with or without pepsin 
pretreatment for 10, 30 or 60 min. Note the pronounced treatment effect in terms of reduction of the background 
staining and the visual enhancement of Reelin-IR in amyloid-like plaques and axonal projections (B”). Scale bar: 
B” = 15 μm. 
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Our pepsin-pretreatment protocol allowed for the first time the specific detection of rodent anti-
Aβ1-40/42−IR in granular Reelin plaques in aged wild type mice, which was not possible without 
pepsin pretreatment (Fig. 4). With the conventional protocol, anti-Aβ-IR was readily detectable 
in neuronal somata (Fig. 4A) and to some extent also in neurites throughout the brain, likely 
representing full-length AβPP. Following 60 min pepsin pretreatment, the intraneuronal IR was 
lost but extracellular aggregates were clearly detectable (Fig. 4B), indicating that intraneuronal, 
soluble AβPP is degraded while extracellular, aggregated Aβ is not, likely due to its protease-
resistant state. Since the Aβ-specific antibody also detects full-length AβPP and the soluble 
sAβPP α/β fragments, we included additional antibodies raised against the N- (N-AβPP) and the 
C-terminus of AβPP (C-AβPP) to characterize further the plaque components. Without pepsin 
pretreatment, both antibodies revealed again strong IR in neuronal somata and neurites in both 
young and old wild type mice, confirming the presence of full-length AβPP (data not shown). As 
described for the Aβ- and Reelin-IR, pepsin treatment resulted also in a strong reduction of 
intraneuronal fluorescence but at the same time it strongly enhanced extracellular IR using 
antibodies against the N-terminus (Fig. 4C). This was not seen using an antibody raised against 
the C-terminus of AβPP (Fig. 4D), suggesting the presence of either the 35 kDa N-terminal 
fragment (Nikolaev et al., 2009) and/or soluble s AβPP α/β ectodomains. Although the presence 
of low levels of full-length AβPP cannot be completely ruled out, the absence of immunoreactive 
signals within the extracellular deposits using C-terminus-specific AβPP antibodies suggest that 
proteolytic cleavage products rather than the full-length form of AβPP preferentially accumulate 
in these plaques. Importantly, the same pepsin treatment of brain sections obtained from young 
(1 month old) mice did not yield any extracellular immunoreactive signals (data not shown), 
pointing to the possibility that aggregated Reelin deposits might act as a seed for murine 
amyloid-β and N-terminal AβPP fragments. Support for this hypothesis is provided by our 
observations that variable shapes of the Aβ-IR in extracellular plaques located around Reelin-
positive deposits were detected in aged wild type mice after pepsin pretreatment. Their 
morphology included both typical granular but also fibrillar features (Fig. 4E), which closely 
resembled the amyloid-β plaques in transgenic ArcAβ mice. Reelin was again associated but not 
co-localized with Aβ−IR in fibrillary plaques (Fig. 4E’’). Control stainings using brain sections 
of age-matched AβPP knockout mice incubated with the same antibody dilutions confirmed the 
specificity of the immunoreactive signals (Fig. 4F), suggesting the presence of murine Aβ 
peptides and N-terminal AβPP fragments in granular and fibrillary amyloid-like plaques in aged
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FIGURE 4: Pepsin pretreatment enables the detection of murine Aβ and N-terminal AβPP fragments. Double-
immunofluorescence stainings of perfusion-fixed (A-D) and fresh frozen (E-F) wild type mice brain sections using 
anti-Reelin (green: A, B, D, E), anti-Aβ1-40/42 (red: A-C, E-F), anti-N-AβPP (green: C) and anti-C-AβPP (red: D) 
antibodies following a 60 min or 30 min pepsin pretreatment reveals murine Aβ- and N-terminal AβPP IR in Reelin-
positive plaques in the hippocampus of aged wild type mice (12 mo, n = 3). A) Without pepsin pretreatment, murine 
Aβ−IR is not detectable in plaque-like deposits. B) Note the co-localization of Reelin and Aβ (yellow signal) in a 
subfraction of individual granules on pepsin pre-treated sections. C) Pepsin pretreatment also revealed 
immunoreactive signals in the extracellular granules using an N-terminus-specific AβPP antibody, but not with the 
antibody raised against the C-terminus of AβPP (D). Control stainings using 1 month-old wild type mice did not 
yield any extracellular IRs (data not shown). E) Prolonged pepsin pretreatment on cryotissue even allowed the 
visualization of fibrillary Aβ (red) plaques in close vicinity to Reelin (green) plaques. In line with findings from 
transgenic brain sections, fibrillary Aβ plaques (E’-E’’’) showed no co-localization with Reelin-IR (E’’). 
F) Representative images of control labelings using identically processed sections from age-matched wild type and 
AβPP knockout mice (n = 3 per mouse line). No specific anti-Aβ IR (red) was evident in mutants as compared to 
control subjects. Scale bars:  A-E, F = 15 μm, E’= 10 μm, E’’’= 7 μm.  
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wild type mice. Quantification of the co-localization of Reelin- and Aβ-IR within granular 
plaques confirmed these observations and revealed significant differences following pepsin 
pretreatment as compared to the non-treated brain sections in the total area covered (w/o pepsin: 
median = 1.01 μm2; w pepsin: median = 160.3 μm2, Mann–Whitney U = 15.1, p = 0.02), as well 
as the integrated pixel brightness, combining both size and staining intensity of the co-localized 
immunoreactive signals  (w/o pepsin: median = 650.2; w pepsin: median = 3180.6, Mann–
Whitney U = 15.2, p = 0.03). 
 
ULTRASTRUCTURAL PROPERTIES OF REELIN-POSITIVE PLAQUES IN AGED WILD TYPE MICE 
To characterize the ultrastructural features of the Reelin-positive deposits and their potential 
association with rodent Aβ, brains of young and aged wild type mice were analyzed using IEM. 
We detected specific Reelin-IR in the soma of interneurons in CA1 stratum lacunosum-
moleculare (slm), particularly prominent in the smooth endoplasmatic reticulum (Fig. 5A, 
arrows, enlarged in A’). Importantly, it was not associated with the highly abundant intracellular 
lipofuscine deposits, characteristic of aged cells (Fig. 5A, asterisks, enlargement in A’’) as 
described in detail elsewhere (Peters et al., 1991; Harris and Spacek, Synapse Web 
http://synapses.clm.utexas.edu). Reelin-IR was also highly enriched in the extracellular space in 
aged individuals as compared to young mice (Fig. 5B-C), potentially representing preliminary 
stages of protein aggregates. In addition, we found prominent accumulations of Reelin-IR in 
astrocytic end-feet enclosing cerebral blood vessels (Fig. 5D-E), highly similar to the close 
association of Reelin plaques with the vasculature as shown by immunohistochemical stainings 
using the end-feet marker, α1-syntrophin (Fig. 5F). These findings point to putative clearance 
pathways of the extracellular deposits that might be less effective in aged compared to young 
individuals. 
Our ultrastructural investigations confirmed the presence of Reelin in amyloid-like plaques, 
again highly selectively abundant in the CA1 slm of aged wild type (Fig. 6). The stained 
globular structures very likely represent the individual granules of the Reelin deposits. They 
were typically surrounded by discontinuous membranes, indicative of extracellular localizations. 
Surprisingly, they exhibited a distinctive ultrastructure; with the center of the granule containing 
mostly fibrillary material and being free of any normal cell organelles (Fig. 6). Reelin-IR was 
detected in these membranes and fibrillary components. With immunoperoxidase reactions 
(DAB), the core of the granules was usually homogenously covered and the underlying 
structures difficult to identify (Fig. 6A-D).  
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FIGURE 5: Immuno-electron microscopy using anti-Reelin antibodies in CA1 stratum lacunosum-moleculare. 
Sections from young (2 mo; B) and aged (9 mo: C; 12 mo: A, D-E) wild type mice (n = 3 animals per age group) 
were processed using 3,3'-Diaminobenzidine (DAB) immunoperoxidase reactions (A-D) or Fluoronanogold-
conjugated antibodies (E). A) Representative image of the soma of a Reelin-expressing interneuron showing Reelin-
IR in the smooth endoplasmic reticulum (A, arrows, white box is enlarged in A’). Intraneuronal lipofuscine deposits, 
which are indicative of aged cells, were devoid of Reelin-IR (A, asterisks, enlarged in A’’). B-C) Reelin-IR in the 
extracellular space was much denser in aged (C) compared to young mice (B, arrows). D-F) Reelin-IR in granular 
deposits was also associated with astrocytic endfeet enclosing the cerebral blood vessels, as shown with DAB 
labeling (D) as well as Fluoronanogold-conjugated antibodies (E, asterisks). F) The strong accumulation of Reelin-
positive deposits in astrocytic endfeet is also observed in immunohistochemical stainings using the same anti-Reelin 
antibody (green), as confirmed in double-immunofluorescence labelings with the astrocytic endfeet marker, α1-
Syntrophin (red). Scale bars: A, E = 2 μm, B-D = 1 μm, F = 15 μm. 
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FIGURE 6: Ultrastructural characterization of Reelin plaques in CA1 stratum lacunosum-moleculare. 
Representative electron micrographs taken from DAB- (A-D), Fluoronanogold- (E) and non-stained (F) brain 
sections of aged wild type mice (12 mo, n = 3). Individual Reelin-positive granules revealed a distinct fibrillary 
structure with varying staining intensities, from partial-light (A, arrows, D) to full-dark stainings (A, arrowheads, B, 
C). A’) The enlarged area in A (box) show the selective and specific anti-Reelin IR in two of the light-stained 
granules. E) A similar picture was also evident using Fluoronanogold-conjugated antibodies, showing a dense array 
of Reelin-immunoreactive granules with fibrillar morphologies in the neuropil of CA1 slm, as shown at higher 
magnification in E’. F) Granular plaques filled with fibrillar material were also easily detectable without 
immunostaining. F’ shows the enlargement of the boxed area in F. Scale bars: A, F = 2 μm, A’-D, E’, F’ = 1 μm, E 
= 5 μm. 
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FIGURE 7: Ultrastructural characterization of murine amyloid-β−immunoreactivity in CA1 stratum-
lacunosum-moleculare. Representative electron micrographs taken from DAB-stained brain sections of aged wild 
type mice (12 mo, n = 3). A) Aβ-IR was detected in a subpopulation of granular plaques in the neuropil showing 
highly similar shapes and morphologies as described for the Reelin-positive deposits.  A’ shows the enlargement of 
the outlined granular plaque in A. Arrows point to the few but distinct immunoreactive signals in the center and 
edge of the plaque. Note the difference of the labeled compared to the unlabeled (C) deposits. B) Numerous Aβ-
immunoreactive granules were detected in astrocytic endfeet, closely opposed to the endothelial cells of brain 
capillaries. B’ shows an enlarged view of the outlined area in B. Scale bars: A, B = 1 μm, A’,B’ = 500 nm. 
 
 
The immunolabeled granules displayed a wide spectrum of staining patterns and intensities, 
potentially reflecting different stages of protein aggregations or technical limitations due to 
antibody penetration (Fig. 6A-D). Tissue sections stained with Fluoronanogold-coupled 
antibodies (Fig. 6E), displayed enrichments of gold-particles in the fibrillary area of the 
granules. This method allowed a much better identification of the ultrastructure of the individual 
granules as compared to the immunoperoxidase reaction. To characterize their morphology even 
better, we also analyzed tissue without anti-Reelin immunostaining (Fig. 6F). Pale fibrillary 
structures identical to the Reelin-positive granular plaques described above were detected in 
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these brain sections (Fig. 6F’), confirming that they are extracellular deposits of fibrillary 
proteinous material and devoid of organelles or cytoskeletal elements. Finally, immunostaining 
with the anti-Aβ1-40/42 antibody revealed specific labelings of a subfraction of pale granules with 
the same morphology and ultrastructure. The reaction product was most prominent at the edges 
but also seen over the entire surface of these plaques (Fig. 7A-B). In line with the localization of 
the Reelin deposits, we found a considerable fraction of Aβ-positive granules associated with 
astrocytic end-feet (Fig. 7B-B’), suggesting again a potential clearance mechanism of aggregated 
protein depositions. Compared to the Reelin-labeling, the intensity of the anti-Aβ-
immunoreactive signals was much lower, which is in agreement with our immunofluorescence 
stainings. On the other hand, the signal was clearly much stronger when compared with non-
labeled deposits seen without primary antibodies (Fig. 7C), pointing to the presence of murine 
amyloid-β species in extracellular plaques in aged wild type mice.  
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1.5 DISCUSSION 
 
The present study provides first ultrastructural and immunohistochemical evidence that age-
related neuropathological changes involve the accumulation of murine AβPP-derived proteolytic 
peptides, likely including the N-terminal fragments s AβPPα/β; and potentially also N-AβPP and 
amyloid-β species in a subset of Reelin-positive plaques in aged wild type mice. While we do 
not have direct biochemical evidence of the presence of Aβ1-40 or 42 species, the distinct 
fibrillar structure labeled by the anti-Aβ antibody using IEM points to a specific accumulation of 
these highly aggregation-prone peptides in the aged murine hippocampus.  
IR was only detectable after prolonged protease pretreatment, suggesting that the unmasking of 
epitopes is a prerequisite to detect rodent proteolytic AβPP species in amyloid deposits in aged 
rodents. The same treatment in young wild type and aged AβPP knockout mice did not reveal 
any comparable staining pattern, confirming the specificity of the IR. Moreover, our 
investigations using this adapted immunohistochemical protocol allowed the detection of 
fibrillary Aβ deposits as seen in transgenic AβPP mice, indicating that similar aging-related 
pathophysiological changes occur in wild type mice, pointing to the usefulness of non-transgenic 
animals in addressing certain aspects of early molecular mechanisms of Aβ plaque deposition 
that may potentially underlie the shift from normal to pathological forms of aging.   
Interest in neuropathological studies in aged wild type rodents aimed at identifying possible 
markers and models of AD rapidly declined after the successful production of transgenic AD 
mouse models that recapitulated amyloid-β plaque and neurofibrillary tangle formation, the two 
major neuropathological hallmarks of AD. The observations that amyloid-like deposits described 
in aged mice did not resemble senile human AD plaques and did not stain with monoclonal 
antibodies to Aβ (Jucker et al., 1994a) reinforced the view that wild type rodents were not useful 
to study amyloid-β plaque formation. However, AβPP in mouse, rats, monkeys and humans 
share >96% amino acid sequence identity (Shivers et al., 1988; Yamada et al., 1987) and only 17 
amino acid distinguish mouse AβPP from its human homolog. Three of amino acid substitutions 
are located within the N-terminal domain of the Aβ peptide, a region thought to be important for 
the specificity of interaction between Aβ peptides, whereas the highly conserved hydrophobic C-
terminal sequence governs the rate of Aβ aggregation (Hilbich et al., 1991b; Jarrett and 
Lansbury, 1993) espite these three amino acid substitutions, in-vitro studies using synthetic Aβ 
peptides revealed no difference in the ability of rodent and human peptides to form congophilic 
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filaments in aqueous buffers and they can also co-aggregate in solution to form mixed Aβ fibers 
(Fung et al., 2004; Hilbich et al., 1991a). Due to technical limitations including the availability 
of rodent-specific anti-Aβ antibodies, the precise amino acid composition and size of these 
peptides are currently unknown. However, due to the sequence homology and the ultrastructural 
properties described here (see below) it is likely that the antibody employed (anti-Aβ1-40/42) 
indeed recognizes the corresponding rodent peptides. Interestingly N-terminus-specific AβPP 
antibodies also revealed comparable enrichments in extracellular plaques, indicating that other 
proteolytic cleavage products accumulate in these aging-associated proteinous deposits. Based 
on their biochemical properties it is, however, unlikely that these N-terminal fragments form 
fibrils. Rather, they might associate with the aggregated Reelin oligomers. Putative N-terminal 
AβPP components include the recently described 35 kDa N-AβPP peptide (Nikolaev et al., 2009) 
and the α- and β-secretase produced soluble sAβPPα and sAβPPβ fragments. Based on the 
recent report of Hoe et al. (Hoe et al., 2009b) demonstrating direct binding of the central Reelin 
repeats (R3-6) to the N-AβPP domain it is tempting to speculate that Reelin co-aggregates and 
sequesters N-terminal AβPP fragments, potentially preventing the production and/or allowing 
the elimination of potentially neurotoxic fragments that have been shown to trigger death 
receptor 6-mediated caspase-6 activation and axonal degeneration following trophic factor 
withdrawal (Nikolaev et al., 2009). Finally, based on a lack of C-terminal-specific 
immunoreactive signals in these plaques, we consider it unlikely that the extracellular plaques 
also contain full-length AβPP. 
Altogether, our data, obtained with an adapted pepsin pretreatment protocol originally developed 
by Watanabe and colleagues (Watanabe et al., 1998) to improve of detection of synaptic 
proteins, suggest that the failure so far to detect amyloid pathology in rodents is likely due to 
masking of antibody epitopes. Support for an enhancement of staining specificity rather than 
increase in unspecific detection is provided by the visualization of Reelin-positive axons, which 
were not visible following standard immunohistochemistry protocols. In addition, control 
experiments in young wild type as well as aged AβPP knockout mice revealed no specific 
extracellular anti-Aβ or anti-N-AβPP stainings, demonstrating that the immunoreactive signals 
reported here are specific and not caused by fixation- or staining artifacts. Similarly, the 
treatment with solvent alone did not have any effect on the staining intensity as well as the 
detectability of murine N-AβPP/Aβ-IR, suggesting that pepsin is responsible for the antigen 
retrieval effect. Pepsin is a member of the aspartyl proteases with broad structural specificity. 
However, they are known to cleave specific dipeptide bonds as well as beta-methylene groups in 
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their substrates (MEROPS Peptide database). Pepsin in particular elicits a preference for those 
amino acid residues composed of Phe and Tyr amino acid residue (Ryle and Auffret, 1979) 
indicating that the mechanism of action of pepsin is to break methylene cross-links created by 
binding of formaldehyde to these amino acid residues occurring during the fixation process, 
resulting in an unmasking of the epitope and better accessibility of the antibody. However, 
considering the broad substrate specificity and the high homology to other members of the 
aspartyl protease family, i.e. β-secretase BACE1 (Dunn, 2002) we cannot exclude that pepsin 
may promote the proteolytic processing of AβPP. Our biochemical investigations in fact show 
that in isolated brain lysates and cell extracts obtained from AβPP-transfected HEK cells pepsin 
is able to completely proteolytically digest AβPP in vitro; starting from the N-terminal side 
(Supplementary Methods and Fig. 1). The control conditions using HCl only again did not 
reveal any proteolytic cleavage of AβPP, indicating that indeed pepsin digests AβPP in a time-
dependent process starting from the N-terminus into 12-15 kDa fragments in-vitro 
(Supplementary Fig. 1). The situation in fixed brain sections, however, appears to be quite 
different. Instead of a reduction in the abundance of small AβPP fragments, likely due to 
complete proteolytic digestion, we observe a significant increase in extracellular IR, again 
supporting our hypothesis of an epitope unmasking effect. It is also rather unlikely that the 
pepsin pretreatment is responsible for the acute increase in amyloid-β peptides in the 
extracellular matrix: The paraformaldehyde- or acetone-fixed brain sections are incubated at a 
very acidic pH that is expected to fully inactivate γ-secretase activity; occluding the production 
of Aβ peptides. Moreover, one would not expect to see this phenomenon in selected layers of the 
hippocampus and entorhinal cortex in the aged brain, but rather in a widespread fashion 
correlating with the expression pattern of rodent AβPP in young, adult and aged subjects.  
Further support for an antigen retrieval effect of the pepsin treatment on perfusion-fixed brain 
sections is provided by our IEM data. We observed distinct but rather weak immunoreactive 
signals using the anti-Aβ1-40/42 peptides on ultrastructural sections as compared to 
immunofluorescence, likely due to suboptimal antibody penetration and/or epitope accessibility 
in tissue processed for electron microscopy. Nevertheless, the immunoreactive signals were 
clearly identifiable in similar extracellular fibrillary granules as observed with the G10 anti-
Reelin antibody. This antibody worked very well using IEM and allowed the specific 
localization of Reelin in neuronal somata of interneurons and in the extracellular space, in close 
agreement with previous ultrastructural investigations (Pappas et al., 2001; Roberts et al., 2005). 
We were also able to confirm ultrastructurally the presence of Reelin-positive plaques in CA1 
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stratum lacunosum-moleculare using both immunoperoxidase and Fluoronanogold labeling. The 
individual granules displayed an unique fibrillary structure, potentially representing spherical 
protofibrils; small intermediates or fragments of amyloid fibrils (Caughey and Lansbury, 2003). 
These types of small oligomers were all surrounded by discontinuous membranes pointing to 
their potential to compromise membrane integrity in ways that could lead to cellular stress and 
or/apoptosis. The pronounced Reelin-IR in some of these individual granules suggests that 
Reelin forms abnormal oligomers in aged individuals. This hypothesis is in line with the 
Thioflavin-S-positive stainings of the core of Reelin-positive plaques on perfusion-fixed tissue 
sections (Fig. 1G), confirming the amyloid-like nature of the extracellular deposits. Further 
support for this hypothesis is provided by cell adhesion assays demonstrating that secreted 
Reelin can form large homomeric protein complexes via the CR-50 epitope in the N-terminal 
domain, either forming disulfide-linked dimers or larger oligomeric complexes with truncated 
fragments (Kubo et al., 2002; Utsunomiya-Tate et al., 2000). It has also been proposed that the 
multimerization of Reelin is necessary for the clustering and activation of the VLDLR and ApoE 
receptor 2 (D'Arcangelo et al., 1999; Hiesberger et al., 1999; Strasser et al., 2004; Yasui et al., 
2007). It is therefore conceivable that the proteolytic processing of Reelin may be altered during 
aging and that this affects the tertiary structure required for the proper and stable 
assembly/dimerization necessary for receptor activation. As a consequence oligomerization will 
be favored and higher-order multimerization and formation of fibrillary aggregations could occur 
as a result of aging-related impairments in clearance and proteasomal degradation of these 
deposits. On the other hand, the aggregated granular and fibrillar material could also be a result 
of degenerative processes, or reflect relatively inert dumping grounds for misfolded proteins.  
Our findings of a pronounced accumulation of Reelin-positive as well as Aβ-positive plaques in 
astrocytic end-feet are in line with this hypothesis and suggest that aging-related deficits in 
protective clearance pathways may allow abnormal protein aggregation that eventually spiral out 
and result in full-blown amyloid-β plaque pathology in aged individuals. While Reelin 
expression has been studied in human AD subjects, the putative presence of Reelin-positive 
plaques has not been investigated in postmortem tissue yet. Wirths and colleagues reported in a 
transgenic AD mouse model the presence of Reelin-IR in the neuritic component of amyloid β 
plaques (Wirths et al., 2001). However, the resolution of these investigations does not allow a 
precise identification of the localization and morphology of the Reelin-immunoreactive signals. 
With respect to changes in Reelin levels and AD, no coherent picture has emerged yet: While 
Riedel and colleagues (Riedel et al., 2003) reported only marginal changes in Reelin levels in 
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Cajal-Retzius cells in the entorhinal cortex of AD subjects as compared to normal aging, 
Baloyannis (Baloyannis, 2005) and Chin et al. (Chin et al., 2007) on the other hand reported a 
dramatic decline in the number of Cajal-Retzius cells and layer II pyramidal cells in the 
entorhinal cortex, respectively, in early cases of AD. Evidence from Saez-Valero’s group also 
suggests a link between abnormal Reelin levels and AD pathogenesis. Using a biochemical 
approach, they reported altered glycosylation and increased levels of the N-terminal 180 kDa 
Reelin fragment in the CSF and frontal cortex brain extracts of AD patients as compared to non-
demented control subjects (Botella-Lopez et al., 2006; Chin et al., 2007; Saez-Valero et al., 
2003). Interestingly, Reelin mRNA was elevated in the frontal cortex but this did not translate 
into increased levels of full-length or the 310 kDa forms in AD compared to control, suggesting 
a compensatory increase in transcription and/or altered proteolytic processing of the full-length 
protein in the diseased stage. The conflicting data may likely be due to methodological reasons, 
including differences in tissue quality and processing, age and cognitive status of the subjects. 
With respect to cell number estimates in postmortem human AD and control tissue samples, not 
all of the studies mentioned above respected the criteria of unbiased stereological counting 
principles. Moreover, biochemical analyses of the Reelin expression do not differentiate between 
the physiological, soluble (intracellular or secreted) and the putative non-physiological, 
aggregated forms. It will be therefore very important to investigate in the human hippocampal 
formation whether Reelin-positive plaques can be detected in early stages of AD using a pepsin-
pretreatment approach, whether their density and localization differs from non-demented 
individuals, and if they associate and/or co-localize with amyloid-β IR.  
In conclusion, our immunohistochemical and ultrastructural data provide first evidence that the 
formation of granular and fibrillary amyloid-β plaques is a common neuropathological 
phenomenon in the hippocampus of aged wild type mice, confirming previous biochemical and 
biophysical investigations revealing the same ability of rodent and human Aβ peptides to form 
congophilic filaments and amyloid fibers (Fung et al., 2004; Hilbich et al., 1991a). The 
observation that these amyloid-β plaques can only be detected using immunohistochemical 
methods with stringent epitope-unmasking suggests that peptide and plaque densities in short-
living animals remain much lower compared to humans, potentially due to higher protein 
turnover, less impaired clearance pathways and/or more efficient proteasomal degradation 
mechanisms in short-living laboratory mice. On the other hand, the fact that aged rodents do 
form spontaneous protein aggregations allows the investigations of the role of oligomers or 
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spherical protofibrils in neuronal malfunction and degeneration in a much more physiological 
context compared to transgenic AD animals overexpressing large amounts of foreign protein. 
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2.1 ABSTRACT 
 
Reelin is a large extracellular matrix protein essential for mediating proper neuronal positioning 
during development. In adult brain, Reelin plays a crucial modulatory role in the induction of 
synaptic plasticity and successful formation of long-term memory. Alterations in Reelin-
mediated signaling have been suggested to contribute to neuronal dysfunction associated with 
Alzheimer’s disease (AD). Aging in several species is characterized by a decline in Reelin-
expressing interneurons and concomitant accumulation of Reelin in amyloid-like deposits in the 
hippocampal formation. Previous studies of these deposits in wild type mice using electron 
microcopy revealed extracellular round to ovoid spherical deposits showing a fibrillary center 
surrounded by a discontinuous membrane and being free of any normal cell organelles. These 
data likely indicate that the investigation of dysfunctional Reelin signaling in normal aged wild 
type mice may provide us some insights into the molecular mechanism of late-onset AD. This 
data is in line with several ultrastructural investigations describing clustered structures - so called 
polyglycogen bodies (PGs) – that are highly similar to our granular structure regarding 
morphology and localization. Interestingly, a prenatal immune challenge by systemic 
administration of the synthetic cytokine releaser and viral mimic polyriboinosinic-
polyribocytidilic acid (PolyI:C) in mice during late gestation results in significant acceleration of 
these extracellular protein depositions in the adult wild type offspring. Here, immuno-electron 
microscopy was employed to elucidate whether morphological differences exist in the 
hippocampal formation between immune challenged mice (PolyI:C) compared to saline treated 
(NaCl) subjects. Moreover, we aimed to gain more information about the ultrastructural 
properties, the localization and origin of these granules as well as to clarify whether these 
granular structures are equal to the PGs described earlier by other groups. For that, we employed 
serial sectioning using serial block face scanning electron microscopy (SBF-SEM), allowing us 
to perform 3D-reconstructions of these Reelin-positive amyloid-like deposits. Using 2D-EM, we 
found differences with respect to plaque morphology following prenatal immune challenge 
compared to saline exposed mice, as indicated by the larger size and the increased presence of 
mitochondria in the granules of PolyI:C exposed subjects, as well as degenerative features. 
Surprisingly, after close examination of these granules, we found that these structures are not 
completely of extracellular origin, but closely associated with neurites and glia cells. This was 
further supported by SBF-SEM, demonstrating that the granules are not individual structures, but 
likely be connected with each other. Altogether, these results indicate that these clustered 
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deposits represent an aging phenomenon that is accelerated and exacerbated by a prenatal 
immune challenge, likely linked to dysfunctional Reelin signaling and processing. Therefore, it 
is conceivable, that these deposits represent critical early markers of pathological forms of aging, 
eventually leading to AD in aged individuals.  
Study II: Ultrastructural investigation of Reelin-positive granular deposits 
60 
2.2 INTRODUCTION 
 
Reelin is a large neuronal glycoprotein, first identified in 1995, that plays a critical role in 
cortical development, including proper neuronal migration (D'Arcangelo et al., 1995; Frotscher, 
1998). Employing the same lipoprotein-mediated signaling cascade, Reelin regulates NMDA 
receptor homeostasis and modulates synaptic function and plasticity in adult synapses (Beffert et 
al., 2005; Weeber et al., 2002; for review see also Doehner and Knuesel, 2010). Interestingly, 
the expression pattern of Reelin changes after the end of the neuronal migration phase 
(Frotscher, 1998). In the adult brain, the Reelin-expressing Cajal-Retzius cells are largely 
replaced by Reelin-expressing GABAergic interneurons (Qiu et al., 2006b). Although Reelin 
continues to be expressed in the adult brain, its complete function and changes throughout aging 
remains poorly understood, as most studies have been conducted in mouse embryos. The distinct 
expression pattern of Reelin in the adult brain and its signaling members in brain regions 
implicated in mediating learning and memory (Alcantara et al., 1998; Beffert et al., 2005; 
Frotscher et al., 2003; Pesold et al., 1998a) suggest that Reelin-mediated signaling in the adult 
brain is crucial for normal cognitive function. Human studies in the elderly imply that the 
hippocampal region, the area important for learning, and memory, is highly susceptible to 
normal aging and neurodegenerative diseases, like Alzheimer's disease (AD). Putative changes in 
Reelin expression during normal and pathological forms of aging have recently been investigated 
(Knuesel et al., 2009). These data reported that normal aging in several species is accompanied 
by loss of Reelin-expressing neurons and concomitant accumulation of Reelin- and Aβ-positive 
granular aggregates in the hippocampal formation (Doehner et al., 2010; Knuesel et al., 2009). 
The specificity of this phenomenon was further confirmed by investigating aged Reelin knock-
out mice, which do not show any Reelin-positive granular deposition. Our findings so far 
provide important information regarding putative temporal processes underlying the transition 
from normal to pathological aging (Knuesel et al., 2009); whereby the reduced density of Reelin 
expressing interneurons appears to be a consistent feature of normal aging. In line with these 
data and the critical role of Reelin in synaptic transmission and learning and memory, several 
recent findings suggest that alterations in Reelin expression and abnormal Reelin signaling may 
contribute to neuronal dysfunction. Although recent experimental evidence from our group as 
well as of several other research groups suggests this involvement of dysfunctional Reelin in 
pathological forms of aging, such as late-onset AD (Botella-Lopez et al., 2006; Doehner et al., 
2010; Durakoglugil et al., 2009; Madhusudan et al., 2009; Motoi et al., 2004; Saez-Valero et al., 
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2003; Wirths et al., 2001), the molecular mechanism by which this conserved protein contributes 
to the pathogenesis of AD remains still largely unknown. Our recent experimental approach 
provides the first evidence that a prenatal immune challenge during late gestation using the viral 
mimic and cytokine releaser polyriboinosinic-polyribocytidilic acid (PolyI:C) results in 
significant acceleration of aging-associated neuropathological alterations in non-transgenic wild 
type mice, involving reduced Reelin expression and precocious accumulation of Reelin-positive 
deposits (Knuesel et al., 2009).  
 
To investigate the role of Reelin and its aggregates in more detail in the aging brain and its 
possible role in neurodegenerative diseases like AD, we already started to investigate the 
localization and distribution of this highly conserved protein at the subcellular level in wild type 
mice using electron microscopy (Doehner et al., 2010). Several ultrastructural studies focusing 
on Reelin have been already performed in several mammalian species, including mice (Pappas 
et al., 2001), rats (Pesold et al., 1998a), non-human primates (Martinez-Cerdeno et al., 2003; 
Pesold et al., 1998b; Rodriguez et al., 2000), ferrets (Martinez-Cerdeno et al., 2003) and human 
brain (Roberts et al., 2005). In these studies, Reelin has been detected in the extracellular space, 
neuronal somata, axonal processes, dendrites and spines (Derer et al., 2001; Martinez-Cerdeno 
et al., 2003; Pappas et al., 2001, 2003; Pesold et al., 1998a; Pesold et al., 1998b; Roberts et al., 
2005; Rodriguez et al., 2000). The presence of Reelin-Immunoreactivity (IR) at synaptic sites 
fits with the important role of Reelin in normal synaptic function, including synaptic plasticity 
and dendritic remodeling in the adult brain in several species (Chameau et al., 2009; Jossin and 
Goffinet, 2007; Niu et al., 2004, 2008). Although none of these studies focused on Reelin-
positive deposits, one ultrastructural study gave evidence of intra-axonal accumulation of Reelin 
(Derer et al., 2001), with elevated appearance in reeler orleans mice. In addition, extracellular 
structures morphologically similar to our Reelin-positive granules have been already described 
earlier at the subcellular level in SAMP8 and B6 mice (Akiyama et al., 1986; Jucker and Ingram, 
1994; Jucker et al., 1992, 1994a). They are as well suggestive of an age-induced phenomenon, 
and being positive for heparan sulfate proteoglycan (HSPG) and laminin. Reelin as a major 
component of these structures was not described until recently (Doehner et al., 2010; Knuesel et 
al., 2009).  Therefore, it would be of interest to decipher if the Reelin-positive structures 
described by us are the same age-dependent phenomenon as the ones described earlier. 
 
Based on all these data and the increasing evidence of dysfunctional Reelin-mediated signaling 
as an important etiological factor in age-dependent neurodegenerative diseases, we challenged 
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non-transgenic mouse dams with PolyI:C or NaCl at gestation day 17 (GD17) and analyzed the 
appearance of the granules in the hippocampal formation across adulthood and aging using EM. 
We aimed to elucidate the ultrastructural properties of the Reelin-positive deposits and 
investigate whether morphological differences between immune challenged mice compared to 
saline treated subjects exist. Moreover, we aimed to gain more precise insights into the 
ultrastructural appearance, localization and origin of these granules to clarify if these granular 
structures are equal to the fibrillary granules described earlier (Akiyama et al., 1986; Jucker and 
Ingram, 1994; Jucker et al., 1992, 1994a). Besides immuno-electron microscopy (IEM) we also 
employed serial sectioning using serial block face scanning electron microscopy (SBF-SEM) 
(Denk and Horstmann, 2004; Leighton, 1981) for a 3D-reconstruction of the Reelin-positive 
amyloid-like deposits.  
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2.3 MATERIALS AND METHODS 
 
ANIMALS  
All procedures were approved by the local authorities of the Cantonal Veterinary Office in 
Zurich and are in agreement with the Principles of Laboratory Animal Care (NIH publication 
No. 86-23, revised 1985). All animals were housed in same sex groups of 3-4 in an optimized in-
house hygiene area (OHB, University of Zurich Irchel, Switzerland) under 12-h day-night cycle 
and ad libitum food and water. C57BL/6J mice were obtained from the breeding facility of the 
Institute of Laboratory Animal Science, University of Zurich (LTK Fuellinsdorf).  
 
POLYI:C INJECTIONS  
Pregnant mouse dams of the C57Bl/6J strain were given a single intravenous injection of 
5 mg/kg polyriboinosinic-polycytidilic acid (PolyI:C potassium salt, Sigma-Aldrich, Buchs, 
Switzerland, P9585-50mg) dissolved in 0.9 % saline with an injection volume of 5 ml/kg body 
weight or an equivalent volume of saline at gestation day 17 (GD17). The animals were mildly 
restrained during the injection procedure using an acrylic mouse restrainer and immediately 
returned to their home cage. The offspring was weaned at 3 weeks of age and housed in groups 
of 4-5 siblings of the same sex. Brain tissue was collected at the age of 6~ (n = 2), 9~ (n = 2-3) 
and 15 month (n = 3) per treatment group for the immunohistochemical and ultrastructural 
characterization of Reelin-positive plaques. 
 
PREEMBEDDING IMMUNO-ELECTRON MICROSCOPY  
One single wild type mouse (10 mo) and two to three animals per age group (6, 9 and 15mo) and 
treatment (NaCl, PolyI:C) of both gender were anesthetized as described above and perfused 
with a fixative containing 4 % paraformaldehyde, 0.2 % picric acid and 0.1 % glutaraldehyde in 
phosphate buffer (PB; 0.1 M, pH 7.4). The brains were removed and post-fixed in the same 
fixative for 5 h at 4°C, washed and stored in PB over night. Coronal sections (70 μm) were cut 
on a Vibratome, the hippocampi were dissected and cryoprotected in 30 % sucrose in 0.1 M PB 
over night at 4°C.  
To enhance antibody penetration, the sections were frozen and thawed rapidly 3 times in the 
same sucrose solution by using liquid nitrogen. They were then collected  and washed in Tris-
buffered saline (TBS, pH 7.49) and blocked for 2 h in TBS containing 10 % normal goat serum 
at room temperature (RT). The sections were then processed for immunohistochemistry using 
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DAB immunoperoxidase reactions or Fluoronanogold. Labeling was done using primary 
antibodies against mouse anti-Reelin (clone G10, 1:1000, Millipore, MAB5364) and rabbit anti-
Aβ1−40/42 (1:1000, Chemicon, AB5076) diluted in TBS containing 3 % normal goat serum and 
0.05 % sodium azide was applied for 72 h at 4°C under constant agitation. After washing in TBS 
sections were either incubated in secondary goat anti-mouse/anti-rabbit antibodies conjugated to 
biotin (1:250; Jackson ImmunoResearch Laboratories Inc., West Grove, PA) or secondary 
immunogold-conjugated antibodies (1:200; Alexa Fluor-488-Fluoronanogold-Fab, Nanoprobes 
Yaphank NY, USA) diluted in TBS containing 3 % of NGS over night at 4°C. The latter 
immunoprobe consists of a 1.4 nm gold particle conjugated with goat-anti mouse Fab-fragment 
and fluorescein. The DAB reaction product was silver-intensified and gold-toned as described 
previously (Sassoe-Pognetto et al., 1994). Briefly, sections were incubated in a solution 
containing 3 % hexamethylenetetramine (Merck, Darmstadt, Germany), 0.25 % silver nitrate 
(Merck), and 0.025 % disodium tetraborate (Merck) for 10 min at 60°C. The sections were then 
rinsed in distilled water and treated for 2 min with gold chloride (0.05 % in distilled water, 
Merck). Finally, the sections were rinsed in distilled water and incubated for 2 min in sodium 
thiosulfate (2.5 % in distilled water, Merck). Optimal visualization of the 1.4 nm gold-particles 
(FNG-labeled tissue samples) at the electron microscopic level required as well gold 
enhancement. The specimens were incubated with a commercially available kit 
(GOLDENHANCETM-EM, Nanoprobes, Yaphank NY, USA) containing four vials with 
solutions called enhancer (solution A), activator (solution B), initiator (solution C), and buffer 
(solution D). Equal volumes of each solution were mixed to form the final reagent. The samples 
were then immersed in 300 μl of this solution and incubated for 7 min at RT. After the 
enhancement for both procedures, samples were kept in Na-cacodylatebuffer (0.1 M, pH 7.4) 
overnight. Finally, sections were post-fixed for 15 min in 0.5 % OsO4 (on ice), counterstained 
with 1 % uranyl acetate for 30 min at RT, dehydrated in graded acetone and flat embedded in 
Epon812 (Science Services). The Epon812 polymerization was achieved by incubation for at 
least 48 h at 60°C. Ultrathin sections (50 nm) were cut on an ultramicrotome (Leica EM UC6, 
Leica Microsystems) and collected on adhesive-coated nickel grids (300 mesh). In addition, to 
better describe the ultrastructure of the individual granules, some sections were processed 
without any immuno-labeling. For that the mice were perfused as explained above. After cutting 
and dissecting the hippocampi, the sections were directly collected in Na-Cacodylate buffer, and 
processed without staining as described before. Before imaging, ultrathin sections were further 
contrasted in a 2 % lead-citrate solution for 10 min at RT. Ultrathin sections were examined 
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using a Philips CM100 transmission electron microscope equipped with a side mounted CCD 
camera (4k x 3k; Gatan Bioscan GmbH, Munich, Germany) and images acquired with the 
software program Digital Micrograph (Gatan Inc.). Cropping of images and adjustments of 
brightness and contrast was processed using Adobe Photoshop (Adobe Systems, San Jose, CA).  
 
QUANTIFICATION OF GRANULAR SIZE AND APPEARANCE OF MITOCHONDRIA 
The quantitative analyses of the area size of the Reelin-positive granules and the amount of 
granules associated with mitochondria were done on randomly selected granules from 4 to 6 
EM-micrographs of 3 to 4 animals per treatment group (NaCl, PolyI:C). A total of 50 to 55 
granules per treatment group were outlined and the area measured using ImageJ software. In 
addition to the size, the granules were also evaluated regarding the presence of mitochondria. 
Histograms and pie charts were composed using Microsoft Office Excel. The Box Plot graph 
was created in StatView (Abacus Concepts, Inc. Berkeley, CA). 
 
STATISTICAL ANALYSIS  
The analysis was performed using the software StatView version 5.0 (Abacus Concepts, Inc. 
Berkeley, CA). The nonparametric Kolmogorov-Smirnov test was used to statistically compare 
the size distribution of the granules and the Mann-Whitney U test was used to statistically 
compare the ratio of mitochondria in the granules between the PolyI:C and NaCl group. 
Statistical significance was set at p < 0.05. 
 
TISSUE PREPARATION FOR SBF-SEM  
To perform 3D reconstruction of the granular structure the mentioned EM protocol was slightly 
adjusted. 15 month old PolyI:C exposed mice were perfused with a fixative containing 4 % 
paraformaldehyde, 0,2 % picric acid and 2 % glutaraldehyde in phosphate buffer (PB; 0.1 M, pH 
7.4). The brains were removed and post-fixed in the same fixative for 3 h at 4°C, washed and 
stored in PB over night. Coronal sections (70 μm) were cut on a Vibratome, the hippocampi 
were dissected and washed in Na-Cacodylate buffer (0.1 M, pH 7.4). The sections were then 
postfixed in reduced osmium (1.5 % KFeCN, 1 % OsO4 in 0.1 M cacodylate buffer) for 30 min 
at RT, followed by post fixation in 1 % osmium diluted in 0.1 M cacodylate buffer for 30 min at 
RT. Subsequently, the sections were subjected to a counterstaining in 1 % uranyl acetate solution 
for 30 min at RT, dehydrated in increasing acetone concentration and flat embedded in Durcupan 
ACM (Science Services, Munich, Germany). The Durcupan polymerization was achieved by 
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incubation for at least 24 h at 60°C. The ultrastructure of the granules was investigated using 
serial block-face scanning electron microscopy (SBF-SEM), which is particularly suited to fast 
data collection from larger samples. The region of interest was mapped by light microscopy, cut 
out of the resin and mounted on a Plexiglas stub. The block was trimmed to obtain a trapezoid 
block of maximally 500 x 500 μm of size and placed in the SBF-SEM, consistent of a microtome 
(3VIEW, GATAN, Pleasanton, CA, USA) mounted in a scanning electron microscope 
(Quanta200VP-FEI, Endhoven, Netherlands). The surface of the block was imaged and cut by a 
diamond knife in alternation in order to obtain a stack of images. Once the surface was scanned 
80 nm of tissue was removed and the fresh surface imaged. In the present work, imaging was 
performed at an accelerating voltage of 4.5 kV (spot size 3) in low vacuum mode (0.25 Torr 
water pressure) and images were taken as a mosaic of 3x3 fields of view (2048 x 2048 pixel) 
with an overlap of 10 %.  For control, ultrathin sections (50 nm) were collected on adhesive-
coated nickel grids (300 mesh) and examined using a Philips CM100 transmission electron 
microscope equipped with a side mounted CCD camera (4k x 3k; Gatan Bioscan GmbH, 
Munich, Germany). All images were acquired and equalized for contrast in Digital Micrograph 
(GATAN, Pleasanton, CA, USA). Cropping of images and adjustments of brightness and 
contrast was done using ImageJ software and Adope Photoshop (Adobe Systems, San Jose, CA).  
 
TISSUE PREPARATION AND IMMUNOHISTOCHEMISTRY 
Wild type animals (15 mo) exposed prenatally either to PolyI:C or saline were deeply 
anesthetized (NembutalTM; 40 mg/kg body weight; i.p.) and transcardially perfused through the 
ascending aorta with 4 % paraformaldehyde and 15 % saturated picric acid in phosphate buffered 
saline (PBS). After postfixation in the same fixative for 4 h at 4°C, the brains were cryoprotected 
in 30 % sucrose, frozen and stored at -80°C until further processing. Free floating sections 
(40 μm) were cut coronally on a sliding microtome and stored at -20°C in cryoprotectant 
solution until immunohistochemical evaluations. A 10 min pepsin pretreatment (0.15 mg/ml in 
0.2 N HCl at 37°C) was applied to all free-floating sections and subsequently employed for 
double-immunofluorescence staining as described previously (Kocherhans et al., 2010) using the 
following antibodies: mouse anti-rodent Reelin (clone G10; Millipore; MAB5364; 1:1000) and 
rabbit anti myelin-basic protein (MBP; Chemicon, AB980, 1:200). Brain sections were incubated 
over night at 4°C in the primary antibody solution diluted in PBS containing 2 % normal goat 
serum and 0.2 % Triton X-100. After three washes in PBS, tissue sections were incubated for 
30 min at RT in the corresponding secondary antibodies conjugated to Alexa488 (1:1000; 
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Molecular Probes, Eugene, OR) and Cy3 (1:500) and processed as described (Kocherhans et al., 
2010). Brain sections were then mounted and air-dried in the dark and cover slipped with 
aqueous permanent mounting medium (Dako). 
Double immunofluorescence labelings were visualized by confocal microscopy (LSM-710, 
Zeiss, Jena, Germany) using a 40x (NA 1.3) and 63x (NA 1.4) objective and sequential 
acquisition of separate channels. Z-stacks of consecutive optical sections (1024 x 1024 pixel, 
spaced 0.5 -1 μm in z) were acquired. For visual display, Z-sections of all channels were 
summed and projected in the z-dimension (maximal intensity) and merged using the image 
analysis software Imaris (Bitplane, Zurich, Switzerland). Cropping of images and adjustments of 
brightness and contrast were identical for each labeling and done using Adobe Photoshop.  
 
SILVER STAINING 
For the detection of dystrophic neurites, extracellular and intracellular proteinaceous aggregates, 
we used the FD NeuroSilver Kit II (FD NeuroTechnologies Inc., Ellicott City, MD). Free 
floating perfusion-fixed brain slices (40 μm) prepared for normal immunohistochemistry were 
processed according to the manufacturer’s instruction with slight modifications. Here, mounted 
sections were employed and washing was carried out in PBS instead of ddH2O to prevent 
shriveling of the tissue sections.  
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2.4 RESULTS 
 
Detailed knowledge of the ultrastructural properties of the Reelin-positive granules as well as 
their origin and association with other cellular structures is expected to shed light on their 
possible function in the aging brain. Therefore, we employed electron microscopy to study the 
granules in the subcellular range to discern where the protein is localized. For this, we employed 
2 to 3 animals per age and treatment (PolyI:C/NaCl; 6, 9 and 15 months) group of both gender. 
Only the hippocampal formation was dissected for examination, as the plaque appearance is a 
highly consistent feature detectable in this region of aged animals.  
 
STRUCTURAL PROPERTIES OF AGING-ASSOCIATED REELIN-POSITIVE GRANULES  
The Reelin-positive granules have been already intensely investigated by light microscopy by 
our group (Doehner et al., 2010; Knuesel et al., 2009; Kocherhans et al., 2010; Madhusudan et 
al., 2009). These deposits are an age-dependent phenomenon starting at an age of 9 to 12 
months, primarily appearing in the hippocampal formation (Fig. 1A, arrows, adapted from 
(Doehner et al., 2010)). Moreover, first ultrastructural investigations of these Reelin-positive 
granules in wild type mice have been recently obtained in our lab (Doehner et al., 2010). These 
ultrastructural data confirmed the presence of Reelin in 1-3 μm sized extracellular spherical 
deposits in the hippocampal formation (Fig. 1B, green), most likely representing individual 
Reelin granules of the clustered amyloid-like deposits investigated already by light microscopy. 
Individual granules were typically surrounded by a discontinuous membrane (Fig. 1B-D), 
indicative of extracellular localization. Their ultrastructure exhibits distinct fibrillary material in 
the center of each granule and being largely free of any other organelles (Fig. 1C). Interestingly, 
observing these granules in more number and detail, mitochondria could be observed in a small 
portion of investigated granules (Fig. 1D, black arrows).  Moreover, these globular structures 
were also positive for Aβ1−40-42 (Doehner et al., 2010) confirming previous 
immunohistochemical staining. Still, the precise origin, if they are developing extra- or 
intracellular and the induction of these described granules has not been deciphered yet. 
 
REELIN GRANULES MIGHT BE OF DEGENERATIVE ORIGIN 
The accumulation of Reelin in this clustered granular structure might lead to degeneration of the 
surrounding tissue, or might itself be of degenerative origin. Evidence that Reelin might
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FIGURE 1: Structural properties of aging-associated Reelin-positive granules. Reelin forms clustered granular 
deposits in the aging hippocampus. A) Immunoperoxidase staining using anti-Reelin antibodies (G10) on a brain 
section of an old (15 mo) wild type mouse. Note the high density of Reelin in amyloid-like plaques (arrows) mainly 
in the CA1 sr and slm. A’) Higher magnification of a single representative Reelin-positive granular deposit (adapted 
from (Doehner et al., 2010)). B-D) Ultrastructural characterization of Reelin-positive plaques (green) in the CA1 sr 
of an aged wild type mouse (10 mo). B) Representative electron micrograph taken from a non-stained brain section. 
Individual granules revealed a distinct fibrillary structure. C) Higher magnification of one individual granule of the 
marked area in (B). D) Interestingly, in a small subset of deposits mitochondria could be observed within the 
granules (arrows). Scale bars: A = 500 μm, B = 2 μm, C, D, D’ = 500nm. 
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accumulate in some dendrites is given by the observation of Reelin-positive staining (Fig. 2A 
and C) and the same fibrillary ultrastructure in dendritic processes (Fig. 2B and C).  
 
 
FIGURE 2: Reelin granules: Linked to degenerating dendrites? Representative immuno-electron micrographs 
taken from immunoperoxidase stained (A, D), Fluoronanogold labeled (C, E) and non-labeled (B) hippocampal 
brain sections using the anti-Reelin antibody (G10) of 9 months (A-C) and 15 months (D and E) old NaCl subjects. 
The presence of Reelin-positive staining (A, C) and the highly similar fibrillary ultrastructure within the dendritic 
processes as seen in extracellular granules (B) provides evidence that Reelin potentially aggregates in dendritic 
processes. D) Signs of neurodegeneration were evident by disintegrated/dystrophic dendrites. E) Presence of cell 
debris-like structures in the granules (arrows), indicative of a degenerating process. Scale bars: A, B, C = 500 nm, 
D, E = 1 μm.  
 
Signs of neurodegeneration were evident by the presence of distinct ultrastructural changes: this 
included disintegrated/dystrophic dendrites (Fig. 2D), cell debris, swollen vacuoles, dispersed 
neurofilaments and other undefined structures indicative of neuronal degeneration. In addition, 
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evidence of ongoing neurodegeneration was given by the disrupted membranes of individual 
granules, as well as the presence of cell-debris-like structures in the granules (Fig. 2E, arrows).  
 
3D RECONSTRUCTION OF THE REELIN-POSITIVE GRANULES 
To get a better understanding of the 3-dimensional (3D) -structure of the Reelin-positive deposits 
we performed serial block-face scanning electron microscopy (SBF-SEM) (Denk and 
Horstmann, 2004; Leighton, 1981). By approaching the level of macromolecular dimensions 
(Baumeister et al., 1999), a 3D-reconstruction allows a more detailed view of the cellular and 
organelle structures. In particular, visualization and reconstruction the 3D anatomical structure of 
the individual granules in situ is crucial to clarify their origin as well determine the source of 
organelles and debris in order to understand their possible role in the aging central nervous 
system. For this, we used differently preserved (see materials and methods) and unlabeled tissue. 
The 2D investigations of the stronger fixed and higher contrasted tissue samples showed an 
amplified preservation of the subcellular structures (Fig. 3A).  Furthermore, granules could be 
detected even without labeling and it appeared that the membrane surrounding the fibrillary 
structure was more continuous (Fig. 3B). Here, the fibrillary structure of the granules appeared 
much darker and denser compared to the previous tissue sections involving only 0.1 % 
Glutaraldehyde (see materials and methods; Fig. 3B, Fig. 1). This likely also stems from the 
extended osmium treatment and the embedding in a different resin. In Figure 3C, a sequence of 
24 serial sections obtained by SBF-SEM experiments is documented, showing the appearance of 
two granules (Fig. 3C, outlined in green; supplement material). Going through the sequence it 
appeared that these granules fused at some point (Fig. 3C10) and separated again. This indicates 
that the granules might not be individual round/ovoid shaped structures, but are more likely 
connected with each other. This in turn, supports the hypothesis that they might origin from 
axons and/or dendrites through a mechanism involving some “budding”-like events.  
 
FIBRILLARY GRANULES ARE ASSOCIATED WITH GLIAL CELLS  
The fine fibrillary structure of the granules might well be of membranous origin or an 
aggregation of glial filaments, which would be in line with the close association with glia as 
previously described by immunohistochemistry as well ultrastructurally (Doehner et al., 2010; 
Knuesel et al., 2009). Reelin-positive granules have been observed around blood vessels, 
suggesting a tight association of the granules with perivascular astrocytic end-feet (Doehner et 
al., 2010; Knuesel et al., 2009), and pointing to a selective clearance of Reelin deposits through 
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the brain vasculature. Here, we extended this examination to the putative association with 
astrocytes and microglia and provide more evidence on the presence of fine gliofilaments in the 
periphery of some granules (Fig. 4A, gf) and bundles of glial filament processes/astrocytic 
processes passing around individual granules (Fig. 4B and C, gf), in aged individuals. In some 
instances, granules were also observed in the somata/cytoplasm of or in close association with 
glial cells (microglia, astrocytes) (Fig. 4D and E). 
 
 
ULTRASTRUCTURAL APPEARANCE OF THE GRANULES IN POLYI:C VERSUS NACL  
EXPOSED MICE 
In the present study, we aimed to investigate, if a prenatal immune challenge causes 
morphological differences in the granules ultrastructure and in the surrounding neuropil in 
comparison to aged matched NaCl exposed mice.  
 
TREND TOWARDS LARGER GRANULE SIZE IN THE IMMUNE CHALLENGED MICE 
Unfortunately, the 6 month old animal group (n = 2 per treatment) did not exhibit any granular 
structures in the hippocampal region, whereupon we were not able to investigate possible 
granular differences in this age group. It needs to be stressed, that normal wild type mice exhibit 
plaque deposition at an age of 9-12 months, whereas immune challenged mice show these 
granular structures already at an age of 6 months, indicative of premature aging in the 
hippocampal formation.  However, since this marks the beginning of the extracellular deposition, 
some animals are expected to show no or very few Reelin-positive granules. This decreases of 
course the chances to detect these structures with an ultrastructural analysis. Therefore, more 
animals of this age group need to be investigated in order to capture the starting phase of plaque 
deposition.  Apart from the increased numerical density, ultrastructural analysis of the granular 
structure in the 9 month old subjects revealed no overt difference between the two treatment 
groups (Fig. 5). 
 
______________________________________________________________________________ 
FIGURE 3: 3D-preparation of the granular structure 
To visualize and reconstruct the 3D anatomical structure of the individual granules in situ we used differently 
preserved and unlabeled tissue. A) 2D investigations using transmission electron microscopy of the stronger fixed 
and higher contrasted tissue samples showed an amplified preservation of the subcellular structures. B) Higher 
magnification of an individual granule. Using this protocol the membrane surrounding the fibrillary structure was 
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almost continuous and the typical fibrillary structure in the center of the granules appeared much darker and denser. 
C) Twenty-four consecutive sections through the CA1 sr region of the hippocampus obtained by SBF-SEM showing  
the appearance of two granules (outlined in green), which seem to fuse at some point (C10) and separate again. 
Scale bars: A, C = 1 μm, B = 500 nm. 
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FIGURE 4: Fibrillary granules are associated with glial cells. Ultrastructural investigation of the association of 
Reelin-positive granules with astrocytes and microglia. Note the presence of fine gliofilaments (gf) in the periphery 
of a granule of NaCl exposed mice (15 mo) processed for immunoperoxidase staining (A) and the presence of glial 
filament bundles (gf) processes/astrocytic processes passing around individual granules of NaCl processed for 
Fluoronanogold labeling (B) and PolyI:C subjects (9 mo) processed for immunoperoxidase staining (C). In some 
instances, granules were also observed in the somata/cytoplasm of glial cells of old (15 mo) NaCl (D) as well as 
PolyI:C (E) subjects (green). D’ and E’) Enlarged views of the boxed areas (green) in D and E, respectively, 
showing two fibrillary granules in the cytoplasm of glia cells. Scale bars: A, B, D’, E’ = 1 μm, C, D, E = 2 μm. 
 
Nonetheless, fibrillary granules in the PolyI:C treated subjects appeared bigger in size compared 
to the control (Fig. 5, higher magnification). However, no statistical analysis has been performed 
for this age group due to the low sample size. 
The same structures with their distinct fibrillary features were also observed in 15 month old 
animals (Fig. 6A). Morphological evaluation of the granules revealed a trend towards a larger
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FIGURE 5: Comparison of the Reelin-positive granules of 9 month old mice.  
Immuno-electron microscopy of hippocampal brain tissue obtained from NaCl- and PolyI:C-exposed mice at 9 
months of age (green) processed for Fluoronanogold labeling. A gallery of individual granules obtained from several 
(n = 3) mice with a single prenatal virus-like infection (PolyI:C) or saline (NaCl) is shown below each overview, 
respectively. Scale bars: overviews = 2 μm, small images = 500 nm. 
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size in the immune challenged cohort (PolyI:C), compared to the saline exposed group. In line, 
statistical analysis showed that in the NaCl group the highest frequency was at a size of 5 to 
10 μm2, whereas in the PolyI:C group the area size was between 10 to 15 μm2 (Fig. 6B). This 
analysis closely reached statistical significance (p = 0.0672; Fig. 6B). Initially, we described the 
morphology of the granules on the subcellular level free of any organelles (Doehner et al., 
2010). However, we observed in the PolyI:C subjects the presence of cellular organelles in these 
granules. Closer examination of the NaCl and aged wild type mice revealed these features also in 
these subjects. However, these cellular organelles, mainly mitochondria (Fig. 6A, higher 
magnifications lower panel, arrowheads), seem to be more frequently associated with the 
deposits in the immune challenged mice (PolyI:C) (Fig. 6C). This was confirmed by statistical 
analysis and yielded a nearly significant treatment effect (p = 0.0771). In NaCl subjects the 
number of individual granules (50-55 per treatment) containing mitochondria was maximally 
25 %. In PolyI:C mice, more than the double amount of granules (52 %) were associated with 
mitochondria. Interestingly, the mitochondria look healthy in their appearance (Fig. 6A, higher 
magnifications lower panel, arrowheads). However, their abundant presence following a prenatal 
immune challenge suggests elevation or dysfunction in autophagy, a cellular process required for 
efficient clearance of non-functioning organelles. In line with this hypothesis, degenerative 
changes were seen in some neurons, evident by their dark appearance due to electron dense 
cytoplasm and numerous fibrils in the cytoplasm and shrunken cell body and pyknotic nucleus 
respectively (Fig. 8A and B); they are so called dark neurons. These cells were more frequently 
observed in PolyI:C exposed mice, mainly surrounded by swollen hydropic astrocytic processes 
(Fig. 8A and B, asterisks). 
 
_____________________________________________________________________________ 
FIGURE 6: Comparison of the Reelin-positive granules of 15 month old mice 
A) Immuno-electron microscopy of hippocampal brain tissue obtained from NaCl- and PolyI:C-exposed mice at 15 
months of age (green) either processed for Fluoronanogold labeling or immunoperoxidase reaction (lower left 
image). The effect of PolyI:C administration prenatally on granule morphology was evident in a pronounced 
increase in size and the elevated presence of mitochondria associated with the granules (lower panel, black 
arrowheads). This morphological evaluation was confirmed by statistical analysis (B), which yielded a treatment 
effect that approached closely statistical significance (p = 0.0672). The analysis showed that in the NaCl group the 
highest frequency was at a size of 5 to 10 μm2, whereas in the PolyI:C group the area size was between 10 to 15 μm2 
(B). The summary of the analysis is displayed in a box plot graph. The dimensions of the box are defined by the 
75th (top) and 25th percentile (bottom) and the median line. The upper and lower error bars indicate the 90th and 
10th percentile, respectively. All observations above 90th and below 10th are represented as black dots. C) The 
increase in size was accompanied by elevated appearance of mitochondria in these granules. They seem to be more 
frequently associated with the deposits in the immune challenged mice (PolyI:C) compared to saline (NaCl) exposed 
granules (50-55 per treatment) containing mitochondria was maximally 25 %. In PolyI:C mice, more than the double 
amount of granules (52 %) were associated with mitochondria (table). Scale bars: overviews = 2 μm, small images = 
500 nm. 
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Degeneration of synapses, as already described subcellularly in degenerative diseases, i.e. prion 
diseases (Gray et al., 2009; for review see Perry and O'Connor, 2010) have not been observed 
yet in the immune challenged mice. Further investigations have to be done to elucidate if a 
prenatal immune challenge has a detrimental effects on synapse morphology in the adult brain. 
 
REELIN IS OBSERVED IN MYELINATED AXONAL PROJECTIONS 
To test whether the putative elevation or dysfunction in the autophagosome formation was 
accompanied by axonal degeneration, we performed double immunofluorescence staining of 
myelin basic protein (MBP) and Reelin. We found that the matrix protein was strongly enriched 
in myelinated axons in the immune challenged animals (Fig. 7B), whereas no Reelin-IR could be 
detected yet in the axons of saline treated mice (Fig. 7A). This indicates that Reelin is either 
present in very low levels in these axons, or the myelin sheaths might be still intact in the saline 
treated mice, and therefore the epitope for the Reelin antibody is not accessible. Support for the 
latter hypothesis is given by our previous findings in aged wild type mice (Doehner et al., 2010), 
showing axonal Reelin-positive staining after extensive pepsin treatment (60 min). It confirms 
that prolonged protease treatment is required to likely disrupt the myelin sheaths that in turn 
allows the detection of Reelin in the axonal projections even in non-immune challenged mice. 
Here, the pepsin treatment was only applied for 10 min, minimizing its effect on the myelin 
sheaths, but rather supporting an alteration of the myelin sheath due to the long-term effects of a 
prenatal infection. Note the appearance of the granular structures at the terminals of the axonal 
projections, indicating that they might be formed within the axonal compartments (Fig. 7C, 
magnified image, white arrowhead). Ultrastructurally, Reelin was not observed in myelinated 
axons yet. However, distinct granular appearances along unmyelinated axonal processes were 
detected in PolyI:C exposed mice (Fig. 7D, granule in green, axon in red), indicative of an 
axonal swelling or “budding” event. This would be in line with our 3D preparations (Fig. 3C). 
 
 
FIGURE 7: Reelin can be detected in myelinated axons 
A-C) Representative confocal images of double-immunofluorescence staining of brain sections obtained from old 
(15 mo) NaCl and PolyI:C subjects using mouse anti-Reelin (red) and rabbit anti-MBP (myelin basic protein, green) 
antibodies. A) No Reelin-IR was observed in axonal projections in saline (NaCl) treated mice. B) The matrix protein 
Reelin was strongly enriched in myelinated axons in the immune challenged animals. Note the appearance of the 
granular structures at the terminals of the axonal projections, indicating that they might be formed within the axonal 
compartments (C). C’ shows higher magnification of the boxed area outlined in C. D) Ultrastructurally, distinct 
granular appearance (green) along unmyelinated axonal processes (red) were detected in PolyI:C exposed mice, 
indicative of an axonal swelling or “budding” event. Scale bars: A, B, C = 10 μm, A’, B’ = 5 μm, D = 1 μm. 
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REELIN GRANULES MIGHT BE OF DEGENERATIVE ORIGIN 
To confirm the degenerative features, we also performed silver staining in 15 month old NaCl 
and PolyI:C exposed animals. In line with our EM data the Reelin-positive deposits in the 
immune challenged mice exhibit a distinct grayish pattern mainly in the periphery of the 
granules (Fig. 8C and D, arrows), suggestive of dystrophic neurites, whereas in the control 
animals (NaCl) a considerably weaker pattern could be observed. This supports the hypothesis, 
that a prenatal immune challenge accelerates degenerative effects. However, no overt 
progressive and widespread neurodegeneration was evident at the time points investigated in 
these mice. Nevertheless, the degenerative features in PolyI:C subjects appeared to be restricted 
to the plaque areas, as discernible by the grayish granular pattern.  
 
 
FIGURE 8: Increased neurodegeneration after prenatal PolyI:C exposure 
Electron micrographs of degenerating neuronal cells in the hippocampus obtained from 6 month (A) and 10 month 
(B) old PolyI:C exposed mice. These neurons, evident by their dark appearance and the pyknotic nucleus are more 
frequently observed in aged PolyI:C exposed mice compared to saline (NaCl) subjects, mainly surrounded by 
swollen hydropic astrocytic processes (asterisks). C, D) To confirm the degenerative features, brain sections 
obtained from 15 month old PolyI:C exposed animals were processed for silver staining. This revealed a distinct 
grayish pattern mainly in the periphery of the granules (arrows), indicative of degeneration. Scale bars: A, B = 2 μm, 
C = 50 μm, D = 10 μm. 
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2.5 DISCUSSION  
 
In summary, our electron microscopy revealed a trend towards larger granules and a significantly 
higher number of mitochondria in the granules after prenatal PolyI:C exposure. This was 
accompanied by distinct degenerative features including shrunken neurons, axonal varicosity and 
the extracellular deposits. In the following sections, these observations, as well as the possible 
origin of these granules will be discussed in more detail 
 
ULTRASTRUCTURAL APPEARANCE OF THE REELIN DEPOSITS 
In the 80s, Periodic acid-Schiff (PAS) positive granules were discovered in aged SAMP8 and B6 
mouse brains, which were primarily found in the hippocampus and the cerebellum, quantitatively 
increasing with age (Akiyama et al., 1986; Jucker and Ingram, 1994; Jucker et al., 1992, 1994a;  
Lamar et al., 1976; Mandybur et al., 1989; Mitsuno et al., 1999). Our observations of the Reelin-
positive granules are in some aspects comparable with the studies referring to these structures as 
polyglycogen bodies (PGs) in aged mice (Akiyama et al., 1986; Corsetti et al., 2008; Del Valle 
et al., 2010; Jucker et al., 1994a), concerning their morphological appearance, size, localization 
and age dependency.  The granules have been identified as mouse-strain specific, age-associated 
deposits of fibrillary material (Jucker et al., 1992). Clustered PGs in humans have been reported 
to be linked to several disorders (McMaster et al., 1979; Sugiyama et al., 1993) and have been 
suggested to be involved in human neurodegenerative diseases (Nakamura et al., 1995). These 
human PGs referred to be fairly similar to murine PGs regarding size, staining properties and 
ultrastructural features; though they differed in their anatomical distribution (human: eg. 
palladium, substantia nigra, hypothalamus; murine: eg. hippocampal formation). It was thought 
that the rodent PGs might be related to the human Corpora amylacea (Adams, 1984; Alder, 1953; 
Ramsey, 1965). Although they exhibit intriguing similarities like being PAS positive and of 
polysaccharide nature, important differences have been noted (Jucker and Ingram, 1994): 
including their ultrastructural appearance, conventional staining properties and distribution. The 
fibrillary granules observed in rodents appear in clusters primarily in the hippocampal formation, 
cerebellum and piriform cortex, whereas human corpora amylacea are more widely and 
randomly distributed and occur most frequently in the subpial region. A positive PAS reaction is 
suggestive of the presence of matrix proteins, proteoglycans and glycogen in this clustered 
granular structure.  Therefore, it has been shown that these granules are positive for heparan 
sulfate proteoglycan (HSPG), an extracellular matrix (ECM) protein (Kuo et al., 1996). Previous 
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research findings indicate that ECM molecules, in particular HSPG co-exist with Aβ in the cores 
of many senile plaques found in AD brain (Armstrong, 2006; Narindrasorasak et al., 1991; 
Snow et al., 1988; Snow and Wight, 1989; Su et al., 1992) and the deposition of such molecules 
might be a prerequisite for amyloidogenesis (Snow and Wight, 1989). Therefore, considering 
Reelin as a possible proteoglycan, which is defined by heavy glycosylation, would support our 
hypothesis that these clusters may mimic a precursor condition for amyloid deposition, as also 
supported by our positive labeling for Aβ (Doehner et al., 2010). On the other hand, it is well 
known, that several HS chains are attached in close proximity to extracellular matrix proteins 
(Lyon et al., 2000), suggesting that several HS chains trigger the aggregation of Reelin in this 
granules and facilitating Aβ or proteolytic fragments of APP to bind to this structure 
additionally. Nevertheless, although these data state a strong analogy of our observed deposits to 
the earlier described PGs based on their age dependency, clustering and localization primarily in 
the hippocampal formation, it is not deciphered yet if the Reelin-positive granules which we 
investigated are of the same origin as all the PGs described above. It is still an open question, 
whether the granules investigated by the several research groups are the same structures or may 
be indicative of different neuropathologies. One major difference, for example, to the structures 
described by Jucker (Jucker and Ingram, 1994; Jucker et al., 1992, 1994a) is the appearance of 
mitochondria in our investigated granular clusters. Indeed, Kuo and coworkers (Kuo et al., 1996) 
describe mitochondria or other organelles in the outer “submembrane space” of the granules. 
Further, both groups did not show any association of these fibrillary structures with axons, 
whereby we observed such a phenomenon in our lab. Until today, these structures were claimed 
as being extracellular. Results of the SBF-SEM approach applied in this present study, suggest 
that the granular structures are not simply round and ovoid individual structures, but that they are 
connected to each other and potentially remnants of represent dendritic or axonal compartments; 
indicative of intracellular origin. These slightly varying characteristics indicate that the structures 
described in our study are different from the granules observed by others, and likely describe a 
different pathological feature. In a recent paper described, similar granular structures in SAMP8 
mice were also positively identified by different antibodies like Tau 5 (total tau), Aβ specific 
ones, MAP2 and syndecan-2 (Del Valle et al., 2010; Kern et al., 2011; Manich et al., 2011), the 
key players in AD. This is suggestive of a very complex mixture of proteins in the granules.  
However, to entirely differentiate between the observed granules in our lab and the previously 
described PGs, additional stainings for the particular proteins need to be performed to better 
characterize these structures.  
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REELIN IS CLOSELY ASSOCIATED WITH GLIAL CELLS 
Our results obtained Reelin-IR or Reelin-positive granules in astrocytic processes, in the soma or 
in close vicinity of glia cells. This is in line with findings from several research groups (Akiyama 
et al., 1986; Jucker et al., 1994b; Kuo et al., 1996; Roberts et al., 2005). Roberts and Colleagues 
(Roberts et al., 2005) have described Reelin in the human cortex, finding Reelin-IR in the 
somata of glia cells as well as in small astrocytic processes. The reported association of the 
proteoglycan (PGs) bodies with astrocytes is in conflict with a recent study (Kern et al., 2011), 
reporting that there is no evidence of any association of the granules with neuronal and astrocytic 
processes, as their observed Tau/Reelin granules, similar to the previously described structures 
were negative for MAP2 and GFAP. Indeed, immunohistochemical and ultrastructural 
investigations of several research groups including ours showed a close association of granules 
with astrocytes or being even localized in astrocytic processes and/or somata and astrocytic 
endfeet (Akiyama et al., 1986; Del Valle et al., 2010; Doehner et al., 2010; Jucker et al., 1992, 
1994b; Knuesel et al., 2009; Kuo et al., 1996; Manich et al., 2011; Mitsuno et al., 1999), which 
is consistent with our ultrastructural observations.  This close association of the granules with 
glial cells likely indicates that the aggregated material is either produced or phagocytosed by 
astrocytes. If the granules are of astrocytic origin, one would hypothesize that they are a 
degenerative processes likely yielding to the aggregation of glial filaments, explaining the 
fibrillary appearance of the granules. Moreover, the localization around blood vessels is also 
consistent with an astrocytic origin, as is the evidence for HSPG like and laminin like molecules 
in the fibrillary material, as these are known to be secreted by astrocytes and expressed in 
activated glia cells in AD brains upon CNS injury (Ard and Bunge, 1988; Liesi et al., 1984; 
Snow et al., 1988). Further, a very recent study by the group of Vilaplana (Manich et al., 2011) 
suggests that their described granular structures in SAMP8 mice – mimicking our granular 
clusters - are not of astrocytic origin, although a few were closely associated this, the majority of 
the deposits were not. They note these clusters are suggestive of a neuronal origin as they are 
positive for NeuN. Further support of the idea that the granules might be of neuronal origin came 
from the research by Irino and coworkers (Irino and Fujita, 1994), reporting that similar granular 
structures can represent enlarged presynaptic terminals. Another supportive aspect that the 
granules might closely arise from neurons and/or glia came from the group of Hosokawa 
(Nakamura et al., 1995). They found monoamine oxidase-B-positive granular structures (MGS) 
in the hippocampus of old SAMP8. These structures were equal to the PAS positive granules 
described earlier (Akiyama et al., 1986) and therefore highly similar to the structures described 
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here. Monoamine oxidase is usually bound to the outer membrane of mitochondria, found in 
neurons and astroglia. MGS was in close anatomical relationship with astrocytic processes, 
thereby a monoamine oxidase-positive astrocyte was observed in the central area of each cluster 
of MGS (Nakamura et al., 1995). As already well described, cerebral MAO-B activity increases 
with aging and during the development of several kind of neurodegenerative disorders such as 
AD (Fowler et al., 1980; Gottfries, 1990; Jellinger and Riederer, 1984; Mann et al., 1980). This 
increase may be linked to the presence of MAO-B-rich reactive astrocytes and glial cells 
(Gottfries, 1990; Riederer et al., 1987) in response to neuronal degeneration as well as early 
infection. These data further support the assumption that the granules are of astrocytic or 
neuronal origin as this catalase could be observed in these structures.  
 
WHICH POSSIBLE ROLE DOES REELIN PLAY IN NEURODEGENERATION? 
Studies from Jucker and Kuo (Jucker and Ingram, 1994; Jucker et al., 1994a; Kuo et al., 1996; 
Mitsuno et al., 1999) reported that their subcellular structure could not be observed in detail, as 
these granules were surrounded by electron-lucent halos, suggestive of a degenerative condition 
of axonal and dendritic processes. In our study, no such observations were recognized. The 
surrounding tissue of the granules appeared healthy without any sign of neurodegeneration in the 
close proximity of the clustered structures. In contrast, our silver staining is suggestive of the 
granules most likely representing a degenerative event on its own, whereby - as evident by 
ultrastructural investigations - the core containing cellular organelles without overt evidence of 
ongoing neurodegeneration in the surrounding.  
As already mentioned before, the PGs were specifically labeled for HSPG (Kuo et al., 1996). 
Kuo and co-workers discussed that the aggregated granular and fibrillary material might be the 
result of a degenerative process. HSPG appeared only at the periphery of these granules, 
suggesting that the periphery of the granule might be the active site of degeneration, and that 
HSPG may be involved in the degenerative process. The mechanism of this degenerative process 
and the cellular compartment where the degenerative process occurs were not clear. However, 
declaring the periphery of the granules as the active site of degeneration would in fact be in line 
with our investigations, observing silver labeling as well mainly in the periphery of these 
granules.  In addition, ultrastructural analyses done by some research groups suggest that small 
quantities or fractions of microtubule-associated protein (MAP2) and Glial fibrillary acidic 
protein (GFAP) may be present as dystrophic processes in and around the granules (Kuo et al., 
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1996; Mitsuno et al., 1999), supporting the idea, that the granules are possible degenerative or of 
axonal as well neuronal origin. 
 
REELIN IN AXONAL PROCESSES 
Reelin was also found in the close proximity of axons. Further support is given by our own 
recent immunohistochemical investigations of Reelin-IR in spherical structures found in human 
brain areas (unpublished data), which potentially originate from axonal swellings. These results 
are supported by several studies. Indeed, ultrastructural deposition of Reelin inside axonal 
processes has already been described in rodents and non-human primates (Derer et al., 2001; 
Martinez-Cerdeno et al., 2003; Pappas et al., 2001). Derer and his group (Derer et al., 2001) 
present morphological evidence that Reelin is indeed secreted from local, specialized 
compartments in the axons of the Cajal Retzius (CR) cells, which look like axonal beads 
displayed throughout their length in a size of 0.5-3 μm, each containing a smooth spheroidal 
cistern or reservoir filled with fibrillar Reelin-positive material named as “axonal Reelin 
reservoirs”. They propose that Reelin and possible other products are synthesized and distributed 
in the neuropil at this sites along the axonal projection. This indicates that such an arrangement 
may favor the wide diffusion of Reelin and other factors in extracellular channels or induces 
abnormal axonal varicosities and/or degeneration. The work of Derer and Goffinet (Derer et al., 
2001) and another recent research done by the group of Phelps (Kubasak et al., 2004) suggest 
that Reelin is likely to be secreted from varicose axons. Furthermore, in 1998 it has been 
described that Reelin can be transported along cell axons (Pesold et al., 1998a), even long 
distances, explaining the appearance of the Reelin protein in the neuropil of some certain brain 
areas. The two previous studies were done in the context of development, one might consider 
that this axonal swellings filled with Reelin may also occur in the adult/aged brain in the axonal 
projection from the entorhinal cortex to the slm region of the hippocampus, as well as from 
GABAergic neurons in the hippocampal formation and not only being restricted to CR cells, 
likely explaining the Reelin positive clusters in exact these brain regions. They might as well be 
originating due to an axonal transport dysfunction yielding to the aggregation of the preserved 
matrix protein, finally leading to a disintegration of the axons. These studies and the hypothesis 
would be in agreement with our previous study (Madhusudan et al., 2009), centering around the 
hypothesis that early accumulations of Reelin deposits in the projection areas of subcortical 
neurons could impair the integrity of axonal terminals, potentially resulting in degeneration of 
cholinergic neurons in the basal forebrain, known to be early affected in AD. The occurrence of 
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Reelin labeling throughout axonal processes strongly suggests that Reelin can be transported 
long distances through axonal tracts (Derer et al., 2001; Martinez-Cerdeno et al., 2003; Perez-
Costas et al., 2002; Roberts et al., 2005). 
 
Furthermore, in our study we have challenged wild type mice prenatally with a viral-like 
infection. The applied PolyI:C is a ligand for the Toll-Like Receptor 3. TLRs are having 
emerging roles in neurodegenerative and demyelinating diseases (for review (Okun et al., 2011)). 
This is in line with our immuno-staining of MBP and Reelin, showing a disruption of the myelin 
sheaths in the immune challenged mice (PolyI:C). One might ask, if it is possible that a prenatal 
infection is capable of disrupting the myelin sheaths around axons in the adult brain? It is well 
known that for example myelin components concentrations decrease throughout the pathology of 
AD (reviewed in (Gottfries, 1990)). Based on these results, it can be hypothesized that a prenatal 
immune challenge might have a degenerative and/or disintegrating impact on the myelination of 
certain axons, likely triggering alterations in axonal transport as well as already inducing age-
related neuropathology. This in turn might be the potential region where aggregated Reelin 
develops swellings and subsequently gets secreted in the neuropil, explaining the increased 
density of clustered Reelin-positive deposits in these mice. The swellings might as well be a 
budding event of degenerative material formed in the axon – maybe as a consequence of 
abnormal Reelin signaling - which then get removed and form the described granules. Further, 
this budding might also be a protective event, to save the neuritic processes from degeneration. A 
recent paper by Nixon (Lee et al., 2011) described abnormal accumulation of lysosomes and 
autolysosomes causing axonal swellings, due to lack of the AD-linked protein presenilin. It is 
known, that in AD focal swellings can develop along the axons and dendrites of neurons 
throughout affected brain regions, like the hippocampal formation or cortex (Nixon, 2007; Nixon 
et al., 2005; Shacka et al., 2008; Yu et al., 2005). These swellings comprise typically 
accumulated organelles specifically related to the autophagic-lysosomal pathway likely 
reflecting a disruption of axonal transport (Morfini et al., 2009), as also recently supported by 
ultrastructural observations (Nixon et al., 2005), strongly implying a defect in the proteolytic 
clearance of this undigested protein accumulation. This might also support that the aggregation 
of Reelin forming clustered granules might derive from inappropriate clearance of the protein.  
In the case that lysosomal proteolysis is inhibited, the axonal transport is slowed down, most 
likely resulting in their accumulation and forming of axonal swellings (Lee et al., 2011). Based 
on these findings, it can be suggested that impaired lysosomal proteolysis and the aggregation of 
the matrix protein could be a basis for leading to neuritic dystrophy. Therefore, it will be 
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interesting to determine if lysosomal markers are present in the Reelin deposits or are formed to 
be closely associated with them.  
 
THE ROLE OF INFLAMMATION IN THE DEVELOPMENT OF THE REELIN-POSITIVE GRANULES  
In the last decades, there is accumulating evidence that inflammation contributes to AD 
pathology and can exacerbate the course of the disease (Akiyama et al., 2000; Hoozemans et al., 
2006; Lucin and Wyss-Coray, 2009; Parachikova et al., 2007; Salminen et al., 2009; Wyss-
Coray, 2006). Despite the growing number of studies linking inflammatory responses to AD 
pathogenesis, very little information is available on early inflammatory processes which might 
possess stronger disease-modifying potential than the Aβ-plaque associated inflammatory 
response. Systemic inflammation by peripheral administration of PolyI:C to pregnant dams may 
evoke pathological alterations in the brain of mice via cytokines, complement and several 
signaling molecules. However the effect of systemic inflammation on the CNS is not fully 
understood. Our recent experimental approach provides the first evidence that a prenatal immune 
challenge during late gestation using PolyI:C results in significant acceleration of aging-
associated neuropathological alterations in non-transgenic wild type mice, involving, reduced 
Reelin expression and precocious accumulation of Reelin-positive deposits (Knuesel et al., 
2009). This prenatal immune challenge suggests a role for early neurodevelopmental and 
immunological abnormalities underlying aging-related neuropathology. In addition, recent 
results (unpublished data) indicate that a prenatal viral-like immune challenge induces long-term 
alterations in critical immune modulators that potentially underlie abnormal Reelin signaling and 
proteolytic processing. This may favor the production of Aβ-peptides, impair their clearance and 
result in elevated levels of phosphorylated Tau. These changes are seen in animals as young as 3 
months of age and aggravate throughout aging. Granules also start to appear much earlier in the 
immune challenged mice compared to the saline treated ones. Evaluating all these differences by 
biochemical and immunohistochemical investigations, we further wanted to elucidate if PolyI:C 
induces differences on the subcellular level. We therefore conducted electron microscopy. 
Morphological difference between the granules of PolyI:C and NaCl exposed mice were evident 
by a trend towards larger size in the immune challenged animals accompanied by an increased 
association with mitochondria. It still needs to be elucidated if the appearance of mitochondria 
correlates with the size of the granule. However, the presence of mitochondria is indicative of a 
degenerative process of cellular structures forming these granules, going in line with the 
previous discussed data. This also indicates that PolyI:C accelerates this age effect and thus, 
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triggers neurodegeneration events, supporting our hypothesis that the granular formation likely 
results from degeneration events. Although, the phenomenon was amplified due to PolyI:C 
exposure, the origin of the granules seems to be still the same. For a definite conclusion more 
granules and animals need to be investigated and quantitatively analyzed, as granules are cut 
differently while processing and the analysis therefore might not give an appropriate estimate of 
size and amount of mitochondria associated between these two groups. A more precise analysis 
could be accomplished by volumetric measurements of the whole granules for defining possible 
differences between the two treatment groups. Moreover, the immune challenged mice revealed 
some substructural alterations in the form of neurodegenerative events. Some groups have 
discovered that the granular structures appear in increased numbers in the brain of SAMP8 mice 
(Akiyama et al., 1986; Del Valle et al., 2010). It is known that these mice are deriving from 
selective inbreeding of AKR/J strain of mice, which are viremic from birth on. This unfolds a 
role of inflammation background in these SAMP8 mice, supporting our data, that early infection 
accelerates the formation of these particular deposits.  
 
CONCLUSION AND FUTURE PERSPECTIVES 
Our current data suggest that the Reelin-positive granules are pathological, emerging as a 
function of advanced age and as a consequence of axonal degeneration (Kern et al., 2011; 
Knuesel et al., 2009; Kuo et al., 1996; Mitsuno et al., 1999). However, the exact nature/etiology 
of these deposits needs to be further elucidated by additional labelings with specific markers to 
clarify which precise cell-type or cellular compartment is involved in the formation of these 
granules. Further, it would be crucial to define their putative pathophysiological significance in 
relation to neurodegenerative disorders, especially AD. Altogether, the observed and extensively 
investigated granular structure might represent the focal deposition of ECM molecules that could 
function as an initial step in the pathogenesis. Therefore, it is of high interest to extend the three 
dimensional (3D) reconstructions approach to fully define the deposits function and possible 
origin.  
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3.1 ABSTRACT 
 
Reelin is a major extracellular matrix glycoprotein required for proper neuronal positioning 
during brain development. In adulthood, Reelin is crucial for synaptic plasticity and successful 
formation of long-term memory. Changes in Reelin-mediated signaling have been suggested to 
contribute to the neuropathology of late-onset Alzheimer’s disease (AD). Since aging is the 
major risk factor in AD, the putative changes in Reelin expression during normal and 
pathological forms of aging have been recently investigated in our laboratory. These data 
showed that aging in several species is characterized by a marked reduction of Reelin-expression 
and concomitant accumulation of Reelin in amyloid-like deposits in the hippocampal formation. 
Observations further revealed that these deposits showed a very high degree of co-localization 
with proteolytic APP fragments including Aβ-peptides, indicating a potential seeding effect of 
the Reelin deposits. The molecular mechanism underlying Reelin aggregation and its putative 
link to the pathogenesis of AD remains largely unknown. A systematic analysis of the 
biochemical nature of the Reelin-positive deposits in both normal and accelerated forms of aging 
should shed light on the potential signaling pathways that govern plaque initiation, formation and 
maintenance in mice. Therefore, in order to identify critical determinants that are potentially 
involved in the early stages of aggregation, a proteomic analysis, including mass spectrometry 
(MS), was applied. Our specific objective was to develop an efficient protocol to extract and 
identify proteins enriched and associated with Reelin-positive plaques. Here, we show that 
fluorescently labeled Reelin deposits can be isolated from fresh frozen brain sections of wild 
type mice by using laser microdissection. Furthermore, extracted proteins were systematically 
identified following western blotting and high accuracy mass spectrometry (LC-MS/MS). Our 
results revealed that the low protein amount isolated constitutes a major challenge for mass 
spectrometric detection. However, the protocol established here provides a suitable approach to 
identify larger protein deposits in tissue sections. To this end, herein we will discuss successively 
each step on our way of protocol establishment. 
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3.2 INTRODUCTION 
 
Reelin is a major extracellular matrix glycoprotein secreted by Cajal-Retzius cells and required 
for proper neuronal positioning during brain development (D'Arcangelo et al., 1999; Rice and 
Curran, 2001). In the adult brain, Reelin is crucial for synaptic plasticity and successful 
formation of long-term memory (Herz and Chen, 2006) through phosphorylation-dependent 
regulation of NMDA receptors (Beffert et al., 2005; Chen et al., 2005). Alterations in Reelin-
mediated signaling have been suggested to contribute to neuronal dysfunction associated with 
Alzheimer’s disease (AD) (Botella-Lopez et al., 2006, 2010; Durakoglugil et al., 2009; 
Hiesberger et al., 1999; Hoe et al., 2006, 2009b; Nikolaev et al., 2009; Seripa et al., 2008). This 
disease is characterized by progressive loss of cognitive abilities and severe neurodegeneration 
(Abraham and Meyer, 2003; Savla and Palmer, 2005). Histopathologically, AD is manifested by 
the extracellular aggregation of amyloid plaques, mainly composed of amyloid-β peptides (Aβ) 
and the intraneuronal neurofibrillary tangles (NFTs), consisting of hyperphosphorylated Tau 
(Glenner and Wong, 1984; Grundke-Iqbal et al., 1986). Since aging is the major risk factor in 
AD, the putative changes in Reelin expression during normal and pathological forms of aging 
have been recently investigated (Knuesel et al., 2009). This study revealed that aging in several 
species is characterized by a marked reduction of Reelin-expression and concomitant 
accumulation of Reelin in amyloid-like deposits in the hippocampal formation. Further 
observations indicated that these Reelin deposits show a very high degree of co-localization with 
proteolytic APP fragments, including Aβ peptides (Study I; (Doehner et al., 2010)), confirming 
and extending previous findings involving transgenic AD mouse models (Motoi et al., 2004; 
Wirths et al., 2001). Although all these findings imply an involvement of the Reelin signaling 
cascade in amyloid plaque deposition and potentially neurodegeneration (Durakoglugil et al., 
2009; Hiesberger et al., 1999; Hoe et al., 2006), the molecular mechanism through which this 
conserved protein contributes to the pathogenesis of AD remains largely unknown. Moreover, 
knowledge on the detailed molecular mechanism of Reelin signaling and its mechanism to form 
aggregates in the aging brain is lacking. Although it has been described using 
immunohistochemistry that Reelin is one of the main components in these granular deposits 
(Knuesel et al., 2009), their proteomic composition is unknown. Specifically, it is currently 
unclear which fragments of Reelin and APP are present in these deposits and whether these 
granules are related to a similar structure described 20 years ago in aged mice (Jucker and 
Ingram, 1994; Jucker et al., 1992, 1994a). These structures were described positive for laminin 
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and heparin sulfate proteoglycan, but were also claimed that many antibodies, primary of 
polyclonal origin, bind unspecific to this particular deposits. We find that Reelin-IR is not 
exclusively detected in the granules, but also in close proximity, likely indicating that the 
structures observed in our laboratory are not exactly equal to the earlier described granules (see 
also Study II). Nevertheless, data suggest that these extracellular deposits might represent focal 
deposition of other proteins and suggesting a role as initiator of the pathogenesis of amyloid-
plaque formation.  Hence, elucidating the identity and role of the granules components that may 
act synergistically or competitively with Reelin in aggregation and deposition would allow us to 
better understand early stages of plaque deposition during aging. Therefore, to investigate the 
critical processes that govern the formation of these deposits, we aimed at isolating the deposits 
from brain sections and analyzing them using a mass spectrometric based proteomic approach. 
This technique allows the comprehensive study of gene and cellular functions at the protein level 
(Aebersold and Mann, 2003). However, the analysis of proteins isolated from cells or tissue 
typically create challenges due to the high degree of complexity of cellular proteomes and low 
abundance of many of these proteins. Therefore, a highly sensitive analytical technique is 
required to analyze complex protein samples. To isolate the desired areas from tissue sections 
laser microdissection represents a powerful technique facilitating rapid and precise isolation of 
morphological or immunohistochemical defined structures from heterogeneous tissue sections 
(Curran et al., 2000; Johann et al., 2009; Lu et al., 2008; Simone et al., 1998; von Eggeling et 
al., 2007). This technique was first described in 1996 by the group of Liotta (Emmert-Buck et al., 
1996) and has since become an extensively used technique to analyze DNA and gene expression 
at the mRNA level (Fend et al., 1999; Goldsworthy et al., 1999; Parlato et al., 2002; Stagliano 
et al., 2001),, as well as for subsequent protein analysis (Patel et al., 2008; Rodriguez et al., 
2008). Additionally, laser microdissection approaches have also been extensively used in the 
pathogenesis of AD evaluating desired regions in the hippocampal formation, neurons and senile 
plaques (Aoki et al., 2008; Fernandez-Medarde et al., 2007; Hutchinson et al., 2005; Liao et al., 
2004a; Wilson et al., 2005; Zellner et al., 2009). Although, the subsequent analysis is vaguely 
limited by the low amount obtained by this technique, this can be overcome by the employment 
of liquid chromatography combined with tandem mass spectrometry (LC-MS/MS) (Aebersold 
and Mann, 2003; Washburn et al., 2001), a technique facilitating sensitive and reliable 
examination of the small sample amount provided by laser microdissection, indicating its high 
potential for comprehensive proteomic analysis (Schad et al., 2005).  
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The Reelin positive aggregates described above have been best investigated by 
immunohistochemistry and electron microscopy. Based on our previously obtained data and the 
increasing evidence of dysfunctional Reelin-mediated signaling as an important etiological factor 
in age-dependent neurodegenerative diseases such as AD, it is of high interest to perform a 
proteomic approach to further characterize the biochemical nature of the Reelin-positive deposits 
in order to identify critical determinants of plaque initiation, formation and maintenance. Hence, 
the aim of this study was to establish a suitable protocol to systematically analyze the protein 
composition of these structures in order to elucidate the potential signaling pathways that govern 
the formation of these granular structures during normal aging and following chronic 
neuroinflammatory conditions.  
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3.3 MATERIALS AND METHODS 
 
ANIMALS  
All procedures were approved by the local authorities of the Cantonal Veterinary Office in 
Zurich and are in agreement with the Principles of Laboratory Animal Care (NIH publication 
No. 86-23, revised 1985). All animals were housed in same sex groups of 3 - 4 in an optimized 
in-house hygiene area (OHB, University of Zurich Irchel, Switzerland) under 12 h day-night 
cycle and ad libitum food and water. C57BL/6J mice were obtained from the breeding facility of 
the Institute of Laboratory Animal Science, University of Zurich (LTK Fuellinsdorf). For the 
protocol establishment and immunohistochemical investigations we employed wild type mice of 
15 months of age exposed prenatally to polyriboinosinic-polycytidilic acid (PolyI:C), mice that 
show accelerated aging and significant enrichment of the Reelin deposits (Knuesel et al., 2009). 
In addition, mice exposed to saline (NaCl) at GD17 or 2 month old subjects were used as 
controls.  
 
BRAIN TISSUE PREPARATION FOR LASER CAPTURE MICRODISSECTION (LCM) 
The mice were decapitated and their brains snap frozen on powdered dry ice and stored at -80°C 
until further processing. Frozen brain tissue was cut coronally on a cryostate (Microm HM 560) 
and serial sections were collected throughout the hippocampal formation at 12 μm thickness, 
adhered to SuperFrost glass slides (Superfrost® Plus, Thermo Scientific, Menzel GmbH, D) and 
kept in -20°C until the cutting session was completed. Thereafter, slides were placed in a plastic 
slide box and stored at -80°C until processing for LCM. 
Immunohistochemical staining procedure: Upon removal from -80°C, slides were allowed to 
thaw for 5 to 10 min at room temperature (RT). Brain sections were outlined with a Pap Pen 
(LucernaChem) and fixed in 70 % acetone (4°C) for 1 min, briefly washed with phosphate-
buffered saline (PBS, pH 7.4) and processed immediately for immunofluorescence staining. 
Sections were incubated for 2 h at RT in primary anti-Reelin antibody solution (mouse anti-
rodent Reelin, clone G10; Millipore; MAB5364; 1:1000) diluted in PBS containing 2 % normal 
goat serum and 0.2 % Triton X-100. After three washes in PBS, tissue sections were incubated 
for 30 min at RT in goat anti-mouse secondary antibody coupled to Alexa Fluor 488 (1:1000; 
Molecular Probes, Eugen, OR). Immediately after immunostaining, sections were dehydrated in 
the following series of solutions: 70 % EtOH (30 sec), 96 % EtOH (30 sec), 100 % EtOH 
(30 sec), cleared for 2 min in xylene and air dried. To ensure efficient dehydration, fresh 
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solutions and anhydrous alcohols prior to xylene treatment were used as recommended by Ball 
and colleagues (Ball et al., 2002).  
 
LASER CAPTURE MICRODISSECTION (LCM) 
Tissue sample retrieval was achieved by the gentle cutting process and clean processing 
procedure provided by the Arcturus Biotec LCM System (Bucher Biotec AG) and was 
performed on the same day of immunostaining. Before performing LCM, tissue slides were 
cleaned from dust particles and loose tissue by the use of an adhesive Strip (Prep StripTM from 
Arcturus, Bucher Biotec AG). Individual Reelin plaques were then microdissected onto a 
CapSure Macro LCM cap (Bucher Biotec AG) using only the IR laser with the following 
settings: 7.5 μm laser spot size, power range of 60 mW and pulse duration of 10 μs. This 
combination of parameters allowed the efficient retrieval of the tissue samples and minimizing 
the area lifted per laser shot. On average, approximately 200 to 300 Reelin positive plaques were 
procured from 4 to 6 brain sections per cap. Directly after capturing the caps were placed onto 
0.5 ml microcentrifuge tubes containing 30 μl of lysis buffer for protein extraction. 
 
PROTEIN EXTRACTION 
Immediately following LCM, proteins were extracted from the Macro Caps using the following 
buffers summarized in Table 1: RIPA Buffer (20 mM Tris pH 7.2, 150 mM NaCl; 1 % Triton X-
100; 1 % DOC; 0.1 % SDS), extraction buffer adapted from Liao and colleagues ((Liao et al., 
2004a) PBS pH 7.2; 2 % SDS; 10 % Glycerol, 10 mM DTT, 1 mM EDTA) both containing 
protease (Roche, mini complete tabletsTM) and phosphatase inhibitors (Sigma-Aldrich), or 
directly SDS sample buffer (150 mM Tris, pH 6.8, 2 % SDS, 30 % glycerol, bromophenol blue, 
15 % βME). For MS sample preparation, a 50 mM ammonium bicarbonate (Sigma-Aldrich) 
buffer containing the MS compatible 0.1 % RapiGest detergent (kindly provided by Dr. B. 
Wollscheid, ETH Zurich, Switzerland) was used for protein extraction. To solubilize the 
captured material, the tube was inverted to cover the cap surface with lysis buffer and incubated 
for 30 min at RT while gently mixing the cap every five minutes so that the extraction buffer 
moved over the cap surface. Subsequently, the lysates were collected using a brief centrifugation 
(12’000 rpm for 1 min) and stored at -80°C until further processing. 
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TABLE 1: Protein Extraction buffers.  
Buffer Content          Application 
RIPA buffer 20 mM Tris pH 7.2, 150 mM NaCl; 1 % Triton X-100; 1 % 
DOC; 0.1 % SDS 
Protease and phosphatase inhibitor 
IB 
Buffer adapted from 
Liao and coworkers 
(Liao et al., 2004a) 
PBS pH 7.2; 2 % SDS; 10 % Glycerol, 10 mM DTT, 1 mM 
EDTA 
Protease and phosphatase inhibitor 
IB 
SDS sample buffer 150 mM Tris, pH 6.8, 2 % SDS, 30 % glycerol, 
bromophenol blue, 15 % βME 
IB 
0.1 % RapiGest 0.1 % RapiGestTM in 50 mM NH4HCO3 MS 
IB: Immunoblotting; MS: mass spectrometry 
 
PROTEIN SEPARATION BY GEL ELECTROPHORESIS 
Silver staining: Extracted protein samples were mixed with SDS-sample buffer (250 mM Tris-
HCl pH 6.8; 10 % SDS, 30 % glycerol, bromophenol blue; 5 % βME) and boiled at 90°C for 
5min. A volume of 15 μl of each sample was resolved electrophoretically on a 8 % SDS-
polyacrylamid gel with 5 % stacking gel in SDS-running buffer (25 mM Tris, 192 mM glycine 
and 0.1 % SDS, pH approx. 8.6) at 25°C. An initial current of 100 V constant was applied for the 
first 20 min, and the separation was run at 150 V constant for 45 min. Subsequently, the gels 
were subjected to silver staining, which was performed according to the SilverQuestTM Silver 
Staining kit compatible for MS (Invitrogen) with slight modifications. Briefly, after a short rinse 
in ultrapure water, the gel was fixed for 20 min (40 % EtOH, 10 % acetic acid in ddH2O), 
washed in 30 % EtOH, incubated for 10 min in sensitizer solution (Invitrogen), followed by two 
washing steps in 30 % EtOH and ultrapure water. Due to the low protein content obtained by 
LCM, the silver incubation was extended to 2 1/2 h. The gel was shortly washed in ultrapure 
water followed by incubation in developing solution (Invitrogen) until bands started to appear. 
After the desired intensity was reached, the reaction was stopped, once more washed in ultrapure 
water and either dried on a gel dryer (Bio-Rad) or processed for in-gel digest as described in the 
MS sample preparation section.  
Immunoblotting: Western blots were performed using the following antibodies (Table 2): mouse 
anti-amyloid precursor protein A4 (close 22C11, Millipore, 1:1000; recognizing full-length APP, 
the soluble α- or β-secretase cleaved APP ectodomain (sAPP), as well as a shorter N-terminal 
fragment of 36 kDa), mouse anti-β-amyloid (1-17, clone 6E10, Covance, 1:500, recognizing Aβ 
peptides and the β-cleaved C-terminal APP fragments (15 kDa), mouse anti-rodent Reelin (clone 
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G10, Millipore; 1:500, recognizing the full-length of 400 kDa and the two N-terminal products 
of 300~ and 180 kDa) and rabbit anti-β-actin (A2066, Sigma-Aldrich, 1:5000).  
 
TABLE 2: Primary antibodies used in this study 
Antibody Manufacturer Species, type, cat.no Dilution  
β-Actin Millipore, Billerica, MA, USA mouse monoclonal, clone 4,  
#MAB1522 
1:5000 (WB) 
α-Synuclein Abcam, Cambridge, UK rabbit polyclonal,  
#Ab52168 
1:1000 (IHC) 
1:500 (WB) 
APP (A4) Millipore, Billerica, MA, USA mouse monoclonal, clone 22C11, 
#MAB348  
1:500 (WB)  
Amyloid-β1-17 Covance, Princeton, NJ, USA mouse monoclonal, clone 6E10, 
#MAB5075 
1:500 (WB) 
Reelin Millipore, Billerica, MA, USA mouse monoclonal, clone G10, 
#MAB5364 
1:1000 (IHC) 
1:500 (WB) 
IHC: Immunohistochemistry; WB: Western blotting 
 
For Reelin immunoblotting, extracted protein samples were mixed with NuPAGE LDS sample 
buffer (Invitrogen, LA0041, Carlsbad, CA) and NuPAGE sample reducing agent (Invitrogen, 
NP0004) and boiled at 90°C for 5 min. Samples were then separated by SDS-PAGE using 3-8 % 
Tris-Acetate gels (NuPAGE Invitrogen, Carlsbad, CA) in Novex Tris-Acetate SDS running 
buffer (Invitrogen) applying 150 V constant for 1h. Separated proteins were transferred (25 mM 
Tris, 190 mM glycine, 20 % MeOH) onto PVDF (Amersham HybondTM-P) applying 30 V 
constant at 25°C for 90 min. For Aβ and APP immunoblotting, extracted protein samples were 
mixed with SDS-sample buffer (250 mM Tris-HCl pH 6.8; 10 % SDS, 30 % glycerol, 
bromophenol blue; 5 % βME) and boiled at 90°C for 5 min. A volume of 15 μl of each sample 
was resolved electrophoretically on 10-20 % Novex NUPAGE Tris-Tricine gels (Invitrogen, 
Carlsbad, CA) in Novex Tris-Tricine SDS running buffer (Invitrogen) applying 125 V constant 
for 90 min. Separated proteins were transferred (25 mM Tris, 190 mM glycine, 20 % MeOH) 
onto Protran 0.1 μm nitrocellulose membranes (Sigma-Aldrich) applying 30 V constant at 25°C 
for 90 min. Both types of membranes were then blocked in TBS containing 5 % western 
blocking reagent (Roche) for 30 min. Primary antibodies (Table 2) were incubated over night at 
4°C. The next day the membranes were washed in TBS, probed with conjugated secondary 
antibody (HRP conjugated 1:15’000) diluted in TBS containing 5 % western blocking reagent 
for 45 min at room temperature (RT). Bands were visualized by the enhanced 
chemiluminescence reaction (Amersham Biosciences Europe, Freiburg, Germany). To verify the 
presence of protein and their amount, the same blots were stripped (100 mM Tris-HCl pH 7.5, 
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2 % SDS) at 56°C for 30 min and probed with anti-actin antibody (Table 2) according to the 
protocol described before. 
 
SAMPLE PREPARATION FOR MASS SPECTROMETRY  
In gel digest: In-gel digestion of proteins for MS characterization was performed in principle as 
described elsewhere (Shevchenko et al., 2006). In brief, after the silver staining the gel was 
washed thoroughly with ultrapure water. The gel was placed on a clean glass plate and the entire 
lanes were carefully excised into 8 pieces using a clean scalpel, cut into small pieces of 
approximately 1 mm in size and transferred into 1.5 ml sterile microcentrifuge tubes. Destaining 
was performed according to the SilverQuestTM Silver Staining kit (Invitrogen). Once the 
destaining was completed, the gel pieces were dehydrated in 100% acetonitrile (ACN) for 
10 min at 25°C. The procedure was repeated until the gel pieces were hard and white. After 
drying the sample in a vacuum concentrator, the gel pieces were rehydrated in reduction buffer 
(10 mM DTT in 50 mM ammonium bi-carbonate [ABC]) sufficient to cover the gel pieces and 
incubated at 56°C for 1 h to remove disulfide bridges. The DTT solution was replaced by the 
same volume of alkylation buffer (55 mM iodoacetamide [IAA] in 50 mM ABC) and incubated 
in the dark at 25°C for 45 min to alkylate cysteines. After discarding the liquid, the gel pieces 
were washed in digestion buffer (50 mM ABC in water, pH 8.0) for 10 min at 25°C. The gel 
pieces were dehydrated twice in 100 % ACN for 10min at 25°C. Following that, they were dried 
in a vacuum concentrator and rehydrated in trypsin solution (12.5 ng/μl in 50mM ABC) at 37°C 
over night. The digestion was stopped by adding 10 % TFA (trifluoroacetic acid). The samples 
were briefly vortexed and centrifuged at maximum speed. The liquid was transferred to a fresh 
sterile tube. Peptides were extracted from the gel matrix by incubating the gel pieces twice with 
extraction buffer (3 % TFA, 30 % ACN) at 25°C under vigorously shaking for 10 min. After 
each extraction cycle the samples were centrifuged and the supernatant was combined with the 
one already obtained. The gel pieces were dehydrated twice in 100 % ACN under vigorously 
shaking at 25°C for 10 min and the supernatant was combined with the previous ones. Finally, 
the peptide mixture volume was reduced to approximately 5 μl in a vacuum concentrator. Buffer 
A (2 % ACN, 0.1% formic acid, in HPLC grade H2O) was added to the nearly completely dried 
sample and the peptide mixture was solubilized by indirect sonication (Hielscher) for around 10 
seconds. The sample was centrifuged (14680 rpm, 16000 g respectively) for 10 min and the 
supernatant was kept at -20°C until further analysis. 
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In solution digest: In solution digest was performed for 2-3 Macro Caps at a time and digested 
peptide mixtures pooled for further MS analysis. For the removal of disulfide bridges the lysates 
were incubated with 5mM TCEP (tris-2-carboxyethyl-phosphine) in ABC at RT for 5 min. After 
briefly vortexing and 30s centrifuging at maximum speed, samples were subjected to 
carbamidomethylation by adding 10mM IAA in water to each tube and incubated in the dark at 
4°C for 10 min. First enzymatic digestion (predigest) was carried out by adding 0.1 μg of the 
serine protease Lys-C (Wako) at pH 7.8 and 37°C for 3 h. Subsequently, 1 μg sequencing grade 
trypsin (Promega) was added to the solution and incubated over night at 37°C. Trypsin was heat 
inactivated by incubation at 95°C for 10 min. For the reversed phase purification, the plaque 
digests were pooled. Each single tube was then washed with 50 μl of HPLC-A buffer (2 % ACN, 
0.1% formic acid) and combined with plaque digest. The peptide mixture was desalted on a Ultra 
MicroTIP C18 column (The Nest Group) and further dried in a vacuum concentrator. Purified 
peptides were solubilized in LC-MS grade water (Fisher Scientific) containing 2 % ACN (Fisher 
Scientific) and 0.1 % Formic Acid (Merck) prior to MS-Analysis. 
 
MASS SPECTROMETRIC ANALYSIS 
The plaque derived peptide mixture was analyzed on a LTQ-Orbitrap XL mass 
spectrometer (Thermo Scientific). Peptides were retained on a 10cm RP-HPLC column of 75μm 
diameter packed with Magic C18 AQ 3μm stationary phase (Michrom Bioresources) and eluted 
over a linear gradient of 60 min from 5 % -30 % Buffer B (2 % H2O, 0.1 % Formic Acid in 
ACN) in Buffer A (2 % ACN, 0.1 % Formic Acid, in H2O) at 0.3 μl flow per minute into the 
mass spectrometer. Peptide ion mass to charge range (m/z) of 350-1600 was monitored in one 
high resolution (60000) MS1 scan followed by five MS2 fragmentation scans on the most 
intense ions in collision induced dissociation (CID) mode. Singly charged ions were excluded 
from CID analysis. Precursor ion masses were dynamically excluded from fragmentation after 
CID for 30 seconds. The peptide mixture was analyzed in triplicates. The MS was operated in 
two different analysis modes. For first and second injection a data dependent acquisition 
(shotgun mode) was used for analysis. For the second injection, additionally theoretical Reelin 
peptide masses were included as preferred masses for fragmentation. Reelin peptide masses were 
derived by in silico digest from the ExPASy proteomics server (http://expasy.org/cgi-
bin/peptide-mass.pl). The third injection exclusively used the theoretical Reelin peptide masses 
in targeted mode. The in silico tryptic digest was performed by the use of the UniProt sequence 
of Reelin (RELN_MOUSE) allowing for carbamidomethylated cysteines and one missed 
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cleavage. Peptides with a monoisotopic mass range of 800-4000 Da were considered in the 
targeted mode. Targeted Reelin peptide masses are listed in the inclusion list in Suppl. Table 1. 
 
MS DATA SEARCH AND ANALYSIS 
RAW data files were converted to the open mzXML data format (Pedrioli et al., 2004) and 
searched with the Sorcerer™-SEQUEST® platform against the mouse UniProt/SwissProt protein 
database (Apweiler et al., 2010; Jain et al., 2009) (version 57.15) containing common 
contaminants and reversed sequence entries search. The search allowed for a 40 ppm mass 
window and stable amino acid modification of cysteine (carbamidomethylation: +57.021464 Da) 
and variable modification of methionine (oxidation: +15.994915 Da). Semitryptic peptide 
isoforms and two missed cleavages were allowed for the search. 
Peptide search results were statistically evaluated using software tools from the Trans Proteomic 
Pipeline (TPP) (Keller et al., 2005) including Peptide Prophet (Keller et al., 2002) and Protein 
Prophet (Nesvizhskii et al., 2003) for determination of correct peptide and protein identification. 
A peptide and protein false discovery rate (FDR) of 1% was used for the overall data set. Plaque 
derived proteins were grouped into protein classes according to the PANTHER database 
(www.pantherdb.org) (Mi et al., 2005; Thomas et al., 2003). 
 
IMMUNOHISTOCHEMICAL EVALUATION 
A 10min pepsin pretreatment (0.15 mg/ml in 0.2 N HCl at 37°C) was applied to perfusion fixed 
(4 % Paraformaldehyde, 0.2 % picric acid in 0.1 M phosphate buffer, pH 7.4) free-floating 
sections and subsequently employed for double-immunofluorescence staining as described 
previously (Kocherhans et al., 2010). Brain sections were incubated over night at 4°C in the 
primary anti-α-synuclein antibody solution (Table 2) diluted in PBS containing 2 % normal goat 
serum and 0.2 % Triton X-100. After three washes in PBS, tissue sections were incubated for 
30 min at RT in corresponding to secondary antibodies coupled to Alexa488 (1:1000; Molecular 
Probes, Eugene, OR) and Cy3 (1:500) and processed as described (Kocherhans et al., 2010). 
Brain sections were then mounted and air-dried in the dark and cover slipped with aqueous 
permanent mounting medium (Dako). 
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3.4 RESULTS  
 
Here we are going to explain in detail the most relevant steps in the protocol establishment and 
optimization steps achieved so far as well discuss major problems faced during accomplishment, 
concerning sample preparation, protein extraction and final mass spectrometric analysis.  
 
A first set of experiments was performed on 15 month old wild type mice prenatally exposed to 
NaCl. As the amount of captured protein was not sufficient, and the whole protocol still needed 
to be established, PolyI:C exposed wild type mice were employed, as they show a higher Reelin 
plaque load (Knuesel et al., 2009) and hence, enriched protein samples were captured per 
sample.  
 
One key factor in biochemical and molecular research is sample purity and the preparation and 
staining of the sample are highly critical processes for reliable proteomic analyses. For the 
successful analysis of the Reelin deposits, they needed first to be isolated from the neuropil. 
Indeed, isolation of low density and protease-resistant plaques and proteins to homogeneity from 
heterogeneous tissue specimen is a fairly challenging task. For the extraction of proteins used for 
proteomic analysis, it is required to obtain the desired sample free of contamination and 
preservation of the material should be guaranteed. Therefore, laser microdissection is an 
uncomplicated technique that allows the collection of specific tissue regions. There are several 
different systems for laser microdissection commercially available. Considering a gentle 
isolation process, good sample retrieval, qualitative preservation of the tissue and low risk of 
contamination we chose the Arcturus from Bucher Biotec, which is based on capturing the 
sample (laser capture microdissection – LCM) (Fig. 1). Importantly, this apparatus allowed the 
isolation of mounted tissue directly from glass slides. An additional infrared (IR) laser beside an 
ultraviolet (UV) laser facilitated a more precise dissection. The cap is placed directly on the 
tissue and hence, not exposed to the environment for long times which would enhance the risk of 
dust and Keratin contamination. Employing the IR laser, the thermoplastic film on the surface of 
the cap is annealed to the desired areas of interest of the specimen. Upon removal of the cap, the 
marked desired tissue samples get isolated from the whole specimen and can then be processed 
for extraction (Fig. 1A). Although the system consists of two lasers, sample achievement was 
already sufficient by using the IR laser alone in this study. This method creates a gentle, non-
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damaging microdissection that preserves the integrity of the captured material, as the film 
absorbs the laser radiation.  
 
 
 
FIGURE 1: The Arcturus system – laser capture microdissection (LCM) technology 
(A) Schematic four-step representation of the laser capture microdissection process. The cap is placed directly on a 
targeted area of the tissue fixed onto a glass slide and the low power IR laser melts the thermoplastic film on the 
lower surface of the cap directly to the desired areas of interest of the specimen.  The region of interest is lifted from 
the section upon removal of the cap, and can be retrieved for subsequent analysis (Diagram obtained from Arcturus 
Engineering, Inc.; www.arctur.com). (B) Isolation of Reelin-positive granular clusters by LCM. As the sample was 
fluorescently labeled, a tiled image of the whole hippocampal area was taken and the selection of desired areas was 
accomplished on the offline image to prevent bleaching of the sample. The fluorescently labeled granular clusters 
were easily distinguishable under the microscope attached to this LCM system. The circles in the target area 
represent the IR annealing points. The “after image” demonstrates that the capturing with the IR laser alone is 
sufficient to capture the outlined tissue. After collecting all the plaques, the cap was observed in the control station 
to verify the capturing process. The isolated plaques were attached to the cap as shown in the lower panel. The 
higher magnification images using brightfield or epifluorescence microscopy were used to visualize and identify the 
captured material on the cap. 
 
 
1. STEP: OPTIMIZATION OF TISSUE SAMPLE PROCESSING AND LCM 
For the proteomic analysis special requirements have to be taken into account for the sample 
preparation. Antibodies or other staining components most likely complicate MS analysis 
because they introduce additional complexity to the sample due to their high abundance. 
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Therefore, in order to obtain high purity samples, one way to do so is to cut individual plaques 
from unstained sections. An adjacent antibody-labeled section could serve as a reference in order 
to identify the precise localization and cutting position. Unfortunately, this serial sectioning is 
not applicable with the chosen Arcturus System. Thus, the tissue sections were fluorescently 
labeled using an antibody against Reelin, as the granular structures were not discernible without 
any staining. Despite dehydration and no cover slipping, which significantly decrease the optical 
resolution, the plaques were easily distinguishable under the microscope attached to this LCM 
system (as also demonstrated in Fig. 1B). We adjusted the immunohistochemical protocol to a 
one day procedure, to capture as fresh material as possible. Briefly, the 1st antibody incubation 
was reduced to 2h at RT instead of an over night incubation at 4°C. With that the preparation, 
capturing and protein extraction could be accomplished in one day, which was necessary to gain 
qualitative and quantitative adequate results for the proteomic analysis. The staining procedure 
was then followed by a dehydration step, which is another significant factor in sample 
preparation when working with the Arcturus system, thereby facilitating efficient capturing. 
Without clearing in xylene, we were not able to detach the desired tissue from the glass slides, as 
xylene provides sufficient desiccation of the section to achieve effective lifting of the targeted 
tissue. After dehydration the sample was directly processed for LCM. Importantly, keeping the 
dehydrated slides for longer at RT or placing them back into -20°C will rehydrate them slowly 
and interfere later with the dissection process; re-dehydration does not work as efficiently 
anymore. Approximately every third time of dehydration, fresh solutions were prepared, to 
guarantee proper dehydration. Subsequently, after ensuring clean processing, dust and loose 
tissue was easily removed from the slides before capturing by using Prep Strips. After LCM, the 
caps containing the retrieved tissue were directly subjected for protein extraction. The lysates 
then could be stored for several days and months at -80°C as confirmed by silver stainings and 
western blotting. 
 
2. STEP: APPLYING SILVER STAINING FOR OPTIMIZATION OF PROTEIN EXTRACTION 
SAMPLING DIFFERENT LYSIS BUFFERS  
Dissected Reelin positive granules from the hippocampus of mouse brain sections by LCM were 
then processed for biochemical/proteomic analysis to determine the plaque components. 
Therefore, an efficient protein extraction protocol was established regarding buffers and 
processing conditions. The total extracted protein samples captured by LCM were first resolved 
by SDS-PAGE (Fig. 2A, C). Subsequently, silver staining was applied to the SDS-gels for 
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visualization of the protein content of the isolated material to determine the extraction efficiency 
and to further optimize the protocol. As the protein amount captured by LCM was very low and 
was below detection limit of standard protein determination assays, we loaded at least half of the 
lysis volume (15 μl) on the gels. The silver staining method was chosen as it is more sensitive 
than the colloidal Coomassie blue (detection limit: 50-100 ng). Silver staining has a detection 
limit between 1 and 10 ng (Kocherhans et al., 2010; Rabilloud, 1990, 1992; Switzer et al., 1979). 
Notwithstanding, the low amount of the protein captured prompted us to prolong the silver 
incubation time to 2 ½ h.  
Applying RIPA-buffer for protein extraction from the microdissection caps did not yield 
efficient results, as tissue was still present on the cap surface. Correspondingly, very weak to no 
protein bands were visible in the silver stained gels (Fig. 2A, lane 5). Different extraction times 
and temperatures did not reveal any improvement of protein yield using this buffer. After several 
and different trials of extraction with RIPA-buffer, we adapted a lysis buffer from Liao and his 
group (Liao et al., 2004a), who were using this buffer for extraction of Aβ-plaques after LCM. 
Working on extraction times and temperatures, it turned out that 30 min at RT were already 
sufficient. Comparing different extraction methods, using the buffer adapted from the group of 
Peng (Liao et al., 2004a), RIPA-buffer or directly 2x SDS sample buffer for 30 min at RT, 
neither RIPA-buffer nor SDS sample buffer were working sufficient as visualized by silver 
staining after SDS-PAGE (Fig. 2A, lane 1, 2 and 5). Best results were gained by using the lysis 
buffer adapted from Liao and collegues (Liao et al., 2004a) as can be seen in the silver stained 
SDS-gel (Fig. 2A, lane 3 and 4). As control for non-specific protein contamination (i.e. Keratin), 
the different sample buffers were also separated alone by SDS-PAGE, without any protein lysed. 
Silver staining did not reveal any protein contamination of the lysis buffers (data not shown).  
 
The silver staining of the extracted proteins revealed some distinct protein bands, confirming that 
the tissue collection and current protein extraction worked. However, checking the captured caps 
under a microscope revealed that a small amount of tissue still remained on the cap. Therefore, 
the extraction protocol was extended by pipetting approximately 10 μl of the already applied 
lysis buffer on the cap surface and gently scratching the membrane surface with the pipette tip 
without destroying the membrane. Subsequently, the lysis buffer used was pipetted up and down 
in the microfuge tube, to ensure no protein was left in the pipette tip and the whole sample was 
finally centrifuged again. This additional step should remove remaining material from the cap 
leading to higher extraction efficiency. This was further confirmed by microscopy showing the 
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caps free of any captured material as illustrated in Figure 2 (Fig. 2B). After establishing a 
sufficient extraction method different amounts of captured protein were separated by SDS-PAGE 
and subsequently silver stained (Fig. 2C). It can be demonstrated that a higher amount of protein 
yielded stronger protein bands in the silver stained gel. Further, in the first two lanes, protein 
samples originated from an over night sample preparation. The adjustment to a one day 
procedure resulted in much better protein recovery, as can be seen in Figure 3C (Fig. 2C, lane 3). 
As already mentioned, silver staining of the gels revealed many but clear bands. Accumulation 
on top of the gel and bands in the high mass range might correspond to full-length Reelin, N-
terminal fragments or even aggregated portions of the protein (Fig. 2A and C, arrows). 
Moreover, the dense strong band at around 50-68kD across the gel (Fig. 2A and C, arrowhead) 
might either originate from Keratin contamination, or more likely the heavy chain of the 
antibody IgGs used for tissue staining. 
 
3. STEP: EVALUATION OF THE EXTRACTED PROTEINS BY WESTERN BLOTTING 
Having established an efficient protein extraction, a selected number of Reelin positive plaques 
excised by LCM was further processed for western blotting using the buffer adapted from the 
group of Peng (Liao et al., 2004a). Albeit the protein amount was very small, full-length Reelin 
(420 kDa) and the N-terminal fragment (N-R2, 180 kDa) could be detected in these extracted 
samples (Fig. 2D). Furthermore, biochemical analysis of the extracted samples revealed that 
APP can be also found in this granular structure or in close vicinity, as western blots show a 
double band at 110 kDa corresponding to the immature and full developed APP, detected by the 
N-terminal specific antibody 22C11 (Fig. 2E). Although, no results have been obtained by 
probing these samples for other APP fragments using antibodies displayed in Table 2, it can not 
be ruled out that other proteolytic fragments of APP are present in these granular structures. The 
low amount of captured material is rather the limiting factor here.  Actin was used as a loading 
control, to verify if protein was present in the sample and how the samples differentiate in 
protein amount, representing the success of the protein extraction from the captured material 
(Fig. 2D, E). 
 
4. STEP: SAMPLE PREPARATION FOR MASS SPECTROMETRIC ANALYSIS  
Western blotting confirmed the presence of Reelin and even APP in the dissected material, 
demonstrating that the capturing and protein extraction was satisfactory to process these samples 
further for mass spectrometric analysis. Therefore, 0.1 % RapiGestTM in 50 mM ABC was used
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FIGURE 2: Biochemical investigation and evaluation of the captured material 
(A) The total extracted protein samples captured by LCM were first resolved by SDS-PAGE and subsequently silver 
stained. Applying RIPA-buffer for protein extraction yielded very weak to no protein bands (lane 5; 30min 
extraction). Further, extraction by SDS sample buffer (SB) did not reveal any protein bands or very weak ones (lane 
1, 30min extraction; lane 2, 2½ h extraction). Best results were obtained by using the lysis buffer adapted by Liao 
and collegues (Liao et al., 2004a), showing no overt difference in extraction time (lane 3, 2½ h; lane 4, 30min). (B) 
View from the control station following the capturing of Reelin-positive clusters from the hippocampal formation 
before and after the protein extraction directly from the cap. Note the almost empty surface after the extraction using 
the buffer adapted by Liao and collegues; caps were free of any captured material. (C) SDS-PAGE of different 
amounts of captured Reelin plaques with subsequent silver staining (lane 1 = protein recovered from 1540 laser 
shots, lane 2 = 3170 laser shots, lane 3 = 2106 laser shots lane 1 and 2 sample preparation overnight, lane 3 sample 
preparation in one day). (A and C) Accumulation on top of the gel and bands in the high mass range might 
correspond to full-length Reelin, N-terminal fragments or even aggregated portions of the protein (arrows). The 
dense band appearing at 50-68 kDa across the gel (arrowhead) might either originate from Keratin contamination, or 
the heavy chain of the antibody IgGs used for tissue staining. (D)  Anti-Reelin western blot (left) of proteins 
extracted from individual caps with different amounts of captured material (lanes corresponding to the silver stained 
samples in C). Anti-Reelin western blot (right) of a PolyI:C exposed 15 month old wild type mouse; sample was 
pooled from 3 caps (protein recovered from 10957 laser shots). Albeit the protein amount was very small, full-
length Reelin (420 kDa) and the N-terminal fragment (N-R2, 180 kDa) could be detected in these extracted samples. 
Molecular mass was estimated by using pre-stained markers. (E) APP can be also found in this granular structure or 
in close vicinity, as western blots show a double band at 110 kDa corresponding to the immature and full developed 
APP, detected by the N-terminal specific antibody 22C11.  
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for protein extraction. RapiGestTM is a MS-compatible detergent because it can be easily 
removed before sample analysis in the MS. It further enhances enzymatic digestion without 
inhibiting enzyme activity, as well as not modifying peptides or suppression of endoprotease 
activity.  
 
For a first mass spectrometric pilot experiment, laser microdissection was carried out on PFA 
fixed brain tissue. Around 500 deposits were collected per animal. Reelin itself could not be 
detected in the spectrogram, likely due to irreversible and covalent protein-protein cross links 
(Fox et al., 1985) and the high molecular weight of Reelin. Furthermore, the tissue might have 
not come off the Capture Cap. Checking these caps under a light microscope revealed that still 
fluorescent tissue could be detected on these caps. Finally, as formalin fixed tissue is not easily 
applicable for MS spectrometry and complicating protein extraction and analysis respectively 
(Ahram et al., 2003), albeit several studies have already been achieved using fixed tissue in 
combination with MS analysis (Crockett et al., 2005; Hwang et al., 2007; Patel et al., 2008; 
Rodriguez et al., 2008; Scicchitano et al., 2009), further experiments were carried out using fresh 
cryotissue. An overview of the different preparative steps for the following mass spectrometric 
analysis, which will be explained in more detail in the following sections, are outlined in a 
workflow chart (Fig. 3).  
 
Here, for one experimental trial, the proteins extracted by RapiGestTM were separated 
electrophoretically, subsequently visualized by the MS-compatible silver stain method and the 
entire gel lanes of one sample were processed for in-gel digest (Fig. 4A), followed by tryptic 
digestion to be subsequently analyzed by MS.  One advantage of conducting in-gel digest MS is 
that the molecular weight of the proteins in the chosen areas is known, providing further 
information for the data analysis and it is quite resistant towards impurities. The eight excised 
areas were chosen randomly, depending on the density of protein bands and the potential 
presence of Reelin (expected in the excised areas 1-4) (Fig. 4A). Additionally, and for 
comparison, MS analysis has been performed in parallel on a sample processed for in-solution 
digest. Indeed, this MS trial with the captured and extracted material of fresh tissue processed 
either by in-gel~ or in-solution digestion did not reveal any Reelin spectra in any of the nine 
samples; however a high amount of Keratin was detected once more. If not present 
endogenously, Keratin is often introduced during sample preparation as an external contaminant. 
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FIGURE 3: Workflow of the proteomic approach 
An overview of the different preparative steps for the mass spectrometric analysis is outlined in this workflow chart. 
After LCM, the captured material was subjected to protein extraction with RapiGestTM, compatible for MS. In the 
first MS trial, two strategies were pursued. Either the proteins were separated by SDS-PAGE and prepared for MS 
by in-gel tryptic digestion, or the extracted proteins from one cap were directly digested by trypsin and subsequently 
analyzed by MS. Since the in-gel digest was more prone to contamination, the second strategy was chosen. As the 
protein amount was not sufficient in the first run, samples and caps were pooled for the second MS run.  
 
 
It mostly comes from dust particles, human hair or skin. As previously described for the MS-
compatibility of affinity reagents such as antibodies, Keratin likewise complicates MS analysis 
by adding a high layer of complexity to the sample due to its high abundance. Keratin abundance 
in every sample of the gel excised bands is illustrated as a bar chart (Fig. 4B), demonstrating that 
no conclusion on any protein amount and presence in this sample could be drawn due to this high 
abundance of contamination. Detected protein signals were significant low (detection below 
10 %) and thus, not evaluable. Hence, no data interpretation was possible, as either the 
contaminant or the complexity of the sample highly suppressed lower signals of proteins of 
interest. Comparing this Keratin contamination of the in-gel digested samples to the 
contamination in the in-solution processed one no quantitative conclusion could be drawn, as 
preparation steps are completely different regarding time and handling steps. But as the 
processing time in the latter one is much shorter, the likelihood of Keratin contamination 
decreases. Reasons for Reelin not being identified in these samples might include: 1) the amount 
of captured protein was too low, as indicated by the disproportionate contaminations of Keratin. 
The Keratin contamination was higher in the in-gel digested samples compared to the in solution 
digest, which might indicate that contamination occurred throughout the sample processing steps 
as already outlined above. 2) Since Reelin is a very large protein and highly accumulated in these 
deposits, the Reelin granules might have not been sufficiently solubilized during the extraction 
step and therefore the following tryptic digestion of the sample could have been insufficient, 
whereupon a complete trypsin digest is a prerequisite for optimal MS analysis. To assess the 
efficiency of tryptic digestion small samples were taken before and after the digestion, separated 
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by SDS-Page and processed for silver staining. No protein bands were detectable after the 
digestion, confirming the efficiency of the used protease. Additionally, Reelin consists of 
sufficient Arginin and Lysin, therefore enough detectable peptides should have been generated. 
3) Moreover, a loss of protein during the sample processing might have occurred, and it needs to 
be stressed that the amount of protein is already rather low. 4) Further, the high contamination 
might be due to many sample processing steps in the in-gel digest. Additionally, the fact that the 
recovery of peptides is much lower in in-gel digest preparations compared to an in-solution 
digest, lead us to the conclusion that in-solution proteolytic digestion was the most preferable 
approach for the MS experiments.  
 
 
FIGURE 4: In gel-digestion mass spectrometry 
(A) The protein in the captured plaques was extracted by 0.1% RapiGestTM, run on a SDS gel (8%) followed by an 
MS-compatible silver staining. Each sample lane was cut into 8 pieces that were subsequently subjected to in-gel 
trypsin digestion and MS based analysis. The eight excised areas were chosen randomly, depending on the density 
of protein bands and the potential presence of Reelin (expected in the excised areas 1-4). The sample loaded 
contained protein recovered from 2 caps (2862 laser shots). (B) The contamination density in every gel sample is 
illustrated in the bar charts. High contamination prevented gel-based Reelin analysis by MS. High amounts of 
Keratin contaminants (> 75 % in all samples) preclude the meaningful analysis of the protein content in the SDS-
PAGE gel. 
 
Another critical and also limiting factor in this analysis was the protein amount captured by 
LCM. Therefore, to achieve higher quantity of protein, MS was carried out by pooling the 
samples from several captures (Fig. 3). This was easily accomplished by extracting proteins from 
2 to 3 caps using the same 30μl of lysis buffer. Additionally, several extracted samples were later 
combined during the final preparations steps for MS (explained in detail in the material and 
methods sections). Additional care was taken during the complete preparation steps to reduce 
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Keratin contamination by using nitril gloves, cleaning working areas with 100 % EtOH or 
MeOH as well as using single packed microfuge tubes, which are generally used for RNA 
extraction.  Moreover, observing these higher concentrated samples by silver staining, denser 
protein bands were detected despite increased background (as seen in Fig. 2C), most likely 
resulting from the still low protein load and the increased silver incubation time as explained 
previously. However, this demonstrated that the protein amount was increased in the pooled 
samples compared to single samples and increased the likelihood to identify the desired proteins 
by MS.  
 
Mass spectrometric analysis of the in-solution sample revealed that the purified plaque samples 
still consisted of a very complex protein mixture, with the majority belonging to intracellular 
compartments. Entirely, 448 mouse proteins from 1636 tryptic peptides were identified 
throughout three technical replicates (detailed description in material and methods) on a high 
mass accuracy MS instrument (LTQ-Orbitrap XL). A list of the total identified proteins can be 
found in the supplement material. The identified proteins were classified into multiple 
categories based on protein and gene ontology analysis (PANTHER functional protein database), 
as demonstrated in Fig. 5 A and B. The large diversity in protein function and protein location 
reveals a still high complexity of the plaque-enriched sample. Moreover, the Keratin amount 
detected was low and therefore, remained in a negligible range (Fig. 5C), meaning that this 
contamination was not an issue anymore in the analysis.  Nevertheless, mouse derived Reelin 
could not be identified in the pooled sample via MS analysis, although an inclusion list for 
inclusion list for theoretical peptides of Reelin was applied to boost sensitivity of the analysis by 
a targeted MS strategy. This might have several reasons: 1) It needs to be stressed, that the 
analyte not only consists of plaque material, but also of attached debris/cytoskeleton which is 
surrounding the individual granules. This might have added a high layer of complexity to the in-
solution MS sample as cytoskeleton and cytoplasmic proteins are usually of very high abundance 
compared to membrane associated proteins such as Reelin. The attached debris therefore might 
have partly foiled our efforts to highly purify for the low abundant Reelin protein by LCM. 
Although we enriched for low abundant plaques by LCM, the MS sample was still too complex 
for a positive identification, even in an inclusion list targeted mode. 2) One other possibility 
might be that the Reelin peptides are poorly digested or do not fly well in the Mass spectrometer. 
However, predicting from the in-silico digestion, the chance that no suitable Reelin peptide 
exists is rather low. 3) Reelin is not present in the sample, which, taking the western blot results 
into account, was very unlikely to be the case, as Reelin fragments were well detectable in the 
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captured material. Additionally, although, the whole protocol from staining to the point of 
protein extraction was performed at RT, it can be excluded that Reelin was degraded over time 
and therefore not detected anymore in the MS, as it was recently confirmed by us that Reelin is 
stable at 37°C for several days (D. Krstic, unpublished data). Beside, the database search for 
APP and its proteolytic fragments did not reveal any positive results, either. However, a specific 
database search after MS analysis revealed a positive identification for the axonal protein α-
synuclein. 
  
 
FIGURE 5: Distribution of proteins identified from the pooled captured samples 
Illustration of the protein annotation by the PANTHER functional protein database: (A) protein classification by 
cellular component, (B) classification by protein class. The large diversity in protein function and protein location 
reveals a very high complexity of the Reelin plaque enriched sample. In total, 448 mouse proteins from 1636 tryptic 
peptides were identified. (C) Although the sample was highly complex, the amount of keratin was low, remaining in 
an acceptable range in MS-based experiments, as illustrated in the pie chart, with light gray demonstrating the non-
keratin proteins identified in the samples and the dark grey the keratin proteins. The sector size is the sum of 
percentage share of spectrum identifications normalized to proteins filtered with 1 % false discovery rate. The 
sample applied to LC-MS/MS contained protein recovered from 35’548 laser shots. 
 
 
5. STEP: IMMUNOHISTOCHEMICAL CONFIRMATION AND EVALUATION 
As α-synuclein was detected in the dissected granular structure by MS and our latest 
investigations on human tissue showed a co-association of this protein with Reelin (unpublished 
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data), we performed a double labeling in brain tissue of wild type mice. Double-
immunofluorescent stainings of Reelin and α-synuclein showed that the latter one can also be 
found in these particular granular structures in the mouse brain hippocampal formation (Fig. 6), 
as well as in close proximity, supporting the findings by MS.  
 
 
FIGURE 6: α-synuclein partially co-localizes with the Reelin-positive granular structures 
Representative confocal images of hippocampal brain sections obtained from wild type mice (12 months), processed 
for double-immunofluorescence staining using anti-Reelin (red) and anti-α-synuclein (green) antibodies. Note the 
partial co-localization of α-synuclein in two different Reelin-positive granules. Scale bar = 10 μm. 
 
 
6. STEP: MS RESULTS AND POSSIBLE OPTIMIZATION STEPS – TECHNICAL DISCUSSION 
An essential factor in MS-based molecular research is sample purity, implying low levels of 
dust/Keratin contamination. However, the introduction of significant amounts of plaque 
surrounding tissue (neuropil, cytoskeletal molecules) to the sample could not be avoided by the 
methods used in this study. Unfortunately, our proteomic analysis was hampered by the 
difficulty in obtaining homogenous and highly enriched Reelin deposits in adequate amounts, 
explaining its limited abundance in the MS analysis compared to the cytoskeletal 
components/proteins detected. Although, the Reelin plaques look very dense, the size of the 
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applied laser spot in the LCM exceeded the size of the individual granule and the material 
between each is enormous, as clearly seen by ultrastructural investigations (Study II; Study I 
(Doehner et al., 2010)). Thus, the amount of granular material was most likely much lower 
compared to the amount of the neuropil coming along with the granules during capturing.  The 
identification of a variety of cytoskeletal molecules in the second MS analysis (Fig. 5A, B) 
reflects the previous statement and confirming the very complex protein mixture captured by 
LCM. Nevertheless, it can not be excluded that this detected cellular structural elements might 
be as well components of these deposits, as already discussed in chapter II (Study II).  
 
The problem we faced in analyzing the captured material by MS was the lack of identifying 
Reelin. Though, it should be stressed, that not identifying Reelin in all the tested samples does 
not imply that the protein is not present in the captured material due to the discovery-driven 
mode of operation (shotgun analysis), keeping clearly in mind the positive detection via western 
blotting. We believe that two main factors were a major challenge in our approach and interfered 
with a positive MS-identification of Reelin: 1) general low abundance of the Reelin protein, 
2) still too high complexity of the study material after purification for shotgun analysis. 
However, even a targeted inclusion list based MS approach did not successfully lead to Reelin 
identification, most probably due to the still high complexity and high dynamic range of the 
peptide mixture after isolation by LCM. Although various sample preparation efforts were 
performed to reduce the sample complexity, the remaining high presence of multiple abundant 
protein species might have interfered with a successful identification of the lower abundant 
Reelin protein, as MS-based shotgun approaches are generally biased towards high abundant 
molecules. An additional disproportionate level of sample complexity was further introduced by 
contaminations of Keratin. Human Keratins which mainly originate from chemicals and/or 
sample handling often become ubiquitous at these low protein levels and it is not predictable 
how much Keratin will be included in the sample throughout preparation steps. It is common that 
the Keratin-polluted environment necessarily leads to contamination of the samples and hence, 
creates a significant problem for the analysis of low abundance proteins as it emerged in our 
study. Therefore, it was and is a prerequisite to work as clean as possible. 
Successful mass spectrometric analysis of proteins in protein mixtures is dependent on sample 
complexity and sufficient presence of study material. For low abundant proteins, the reduction of 
sample complexity is a prerequisite for a successful analysis. Protein characteristics such as 
hydrophobicity and solubility have to be taken into account during sample preparation to 
minimize losses of the protein of interest. Even a small loss of sample during processing can 
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decide about success or failure of the whole analysis. Taking the second MS analysis into 
account (Fig. 5), despite pooling many samples to increase protein amount, it seems that either 
the quantity of captured Reelin protein was still not sufficient and/or in combination, the high 
complexity of the sample might have suppressed the low abundant, present Reelin peptide ions 
from identification. Comparing the amount of sample processed in our study with other studies 
using LCM followed by MS, it appears they have applied much higher amounts for such an 
approach. For instance, one study performed by Miravella and colleagues (Miravalle et al., 
2005) captured a total of about 100’000 amyloid plaques for MS analysis and around 2500 for 
WB analysis. In our study, only 5000 Reelin positive plaques (approx. 35’000 7.5μm laser shots) 
were captured for the last MS trial. Cheng and his group (Cheng et al., 2008) claim that at least 
20’000 to 25’000 cells are considered to be necessary to perform western blotting (for review 
Mustafa et al., 2008). Therefore, achieving a more complete view of the granular structure, a 
specific enrichment after LCM is highly required to significantly increase the amount of protein. 
Taken together, isolating the Reelin deposits by laser microdissection and applying them 
subsequently to MS might not be feasible in the current state. Additional purification steps need 
to be involved, as a pull-down assay using anti-Reelin antibodies, sorting the proteins with the 
COPAS technology (Complex parametric analyzer and sorter – cytometric sorting) or by 
magnetic beads (e.g. Dyna beads), or applying ultracentrifugation to separate the sample into 
soluble and insoluble fractions. One might also consider, after increasing the protein amount to 
detectable levels, to adapt a pepsin pretreatment (Doehner et al., 2010) prior LCM and any 
purification steps in order to already reduce unspecific protein detection by partially digesting 
plaque-surrounding material. Post-translational modifications (PTMs) such as glycosylation 
remain difficult to analyze by MS (Zaia, 2004) and might have impeded our analysis 
additionally. Glycosylation is a common PTM applied to cell surface and common extracellular 
matrix proteins (Roth, 2002), such as Reelin, which shows mainly N-linked carbohydrates 
(D'Arcangelo et al., 1997). This glycosylation sites might have interfered or even inhibited 
trypsin digestion, as well as altered the ion mobility in the mass spectrometer. Although, tryptic 
digestion should have yielded also many unglycosylated peptides of Reelin, one might still use 
PNGase F (Peptide:N-glycosidase F) to remove all N-linked oligosaccharides, to further increase 
the amount of Reelin peptides that are available to the mass spectrometer. 
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3.5 CONCLUDING REMARKS AND FUTURE PERSPECTIVES – BIOLOGICAL 
RELEVANCE 
 
This current study aimed to establish a protocol to identify the proteins involved in the granular 
plaque formation. Here, we provided a detailed step by step procedure for the isolation and 
proteomic analysis of the Reelin positive granular structures.  
 
Although further optimization with respect to sample purity, sample processing and reduction of 
sample complexity will be required, we were able to confirm for the first time the presence of 
full-length Reelin and the N-terminal fragment in these deposits by western blotting (WB). 
These findings verified our immunohistochemical and -electron microscopy findings in aged 
species (Fig. 2; (Doehner et al., 2010)).  Moreover, WB analysis corroborates the presence of 
mature and immature APP in the microdissected samples. Though, this does not imply their 
exclusive presence in the granular deposits. APP and Reelin might derive as well from the 
surrounding neuropil, or regarding our recent ultrastructural investigations (Study I (Doehner et 
al., 2010); Study II) might derive from neuronal dendritic structures that most likely surround the 
Reelin positive granules. As previously demonstrated by a few research groups (Kubo et al., 
2002; Utsunomiya-Tate et al., 2000) it was proposed that Reelin fragments are prone to 
aggregate. Discovering the N-terminal fragment of Reelin in these dissected granular structures 
confirmed these previous studies and might indicate that this fragment of Reelin may 
preferentially oligomerize and aggregate in the extracellular matrix during aging. Furthermore, 
Hibi and Hattori (Hibi and Hattori, 2009) showed that the N-terminal fragment of Reelin is re-
secreted into the extracellular space after internalization of the full-length protein and specific 
proteolysis. After release, the N-terminal fragment does not bind to its receptors anymore 
(Hiesberger et al., 1999; Yasui et al., 2007), but neither the fate after endocytosis nor the 
physiological significance of the endocytosis and re-secretion is understood yet. Hence, one 
might suggest that an excess of the N-terminal fragment of Reelin in the extracellular space leads 
to its aggregation into the granular structures observed by immunohistochemistry and electron 
microscopy. 
 
Although Reelin and APP were not detected by MS, data analysis revealed the presence of α-
synuclein. It is known that this axonal protein is largely expressed in the neocortex, 
hippocampus, substantia nigra, thalamus and cerebellum, primarily found in neural tissue, 
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making up to 1 % of all proteins in the cytosol, but its function is largely unknown (Iwai et al., 
1995). Identifying now this particularly protein in the dissected samples, demonstrates on one 
hand, that the whole process of sample preparation for the proteomic approach is promising and 
on the other hand supports our immunohistochemical staining and EM data, suggesting a 
possible involvement of α-synuclein in the granular formation, as well as in axonal dystrophy. 
Although α-synuclein was identified in the captured samples, it is not fully clear if the protein 
originated from the granules or from the neuropil which surrounds the structures and came along 
while microdissecting. To fully elucidate the plaque formation considering as well the 
surrounding neuropil, plaque free areas need to be isolated and investigated, as the proteome is 
likely to be different. Therefore, the specific attempt would be to compare the proteome of 
normal deposit free tissue to the plaque dense areas, which is already highly employed in tumor 
research (Guo et al., 2005; Melle et al., 2003; Shekouh et al., 2003; for review Mustafa et al., 
2008). Additional control for deciphering plaque components would be the analysis of dissected 
tissue obtained from young animals for subsequent comparison with aged animals. 
 
Taken together, these findings indicate that LCM is a practical and precise method for rapid and 
efficient isolation of specific proteins from tissue for sample pre-purification. Combining LCM 
subsequently with MS provides a valid approach in studying proteins involved in event of this 
plaque formation as it permits identification of proteins present in a specific microscopic region 
with high sensitivity. However, purification of the granules remains a considerable challenge in 
this approach. Our current proteomic approach involves further technical improvements in order 
to characterize the plaque components with high fidelity, including the confirmation of the 
accumulations of several proteolytic APP species, including rodent amyloid-β peptides (Doehner 
et al., 2010), as well as identification of putative differences in plaque composition between aged 
PolyI:C and NaCl-exposed subjects. After having achieved an efficient protocol for this 
approach, a longitutional study would be of high interest to determine proteins involved in the 
early stages of aggregation, to analyze several types of plaques species, and compare the protein 
composition relative to their temporal and spatial distribution as well as their morphology: i.e. 
early vs late, hippocampal vs cortical, granular vs fibrillary plaques in order to characterize the 
critical initiating factors of plaque formation in distinct brain areas. This proteomic 
characterization would be expected to reveal important novel information on the nature and 
abundance of certain proteins during different phases of plaque formation.  Furthermore, these 
results will help to design in-vitro studies focusing on the molecular events and protein 
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interactions that are involved in the early stages of aggregation and initiation of plaque 
formation.  We think that the ability to detect qualitative and quantitative differences from Reelin 
positive aggregates according to their protein composition at different ages represent an 
important asset to improve understanding the molecular basis of unique age-related 
neuropathology in several species. 
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The contribution to this work was a double-immunofluorescence staining to investigate the 
accelerated aggregation of Aβ as well as its association with the vasculature. These findings 
were further statistical analyzed by myself.  
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4.1 ABSTRACT 
 
Besides the fundamental role of the extracellular glycoprotein Reelin in neuronal development 
and adult synaptic plasticity, alterations in Reelin-mediated signaling have been suggested to 
contribute to neuronal dysfunction associated with Alzheimer’s disease (AD). In vitro data 
revealed a biochemical link between Reelin-mediated signaling, Tau phosphorylation and 
amyloid precursor protein (APP) processing. To directly address the role of Reelin in amyloid-β 
plaque and Tau pathology in vivo, we crossed heterozygous Reelin knockout mice (reeler) with 
transgenic AD mice to investigate the temporal and spatial AD-like neuropathology. We 
demonstrate that a reduction in Reelin expression results in enhanced amyloidogenic APP 
processing, as indicated by the precocious production of amyloid-β peptides, the significant 
increase in number and size of amyloid-β plaques, as well as age-related aggravation of plaque 
pathology in double-mutant compared to single AD mutant mice of both sexes. Numerous 
amyloid-β plaques accumulate in the hippocampal formation and neocortex of double-mutants, 
precisely in layers with strongest Reelin expression and highest accumulation of Reelin plaques 
in aged wild type mice. Moreover, concentric accumulations of phosphorylated Tau-positive 
neurons around amyloid-β plaques were evident in 15 month-old double- versus single-mutant 
mice. Silver stainings indicated the presence of neurofibrillary tangles, selectively associated 
with amyloid-β plaques and dystrophic neurites in the entorhinal cortex and hippocampus. Our 
findings suggest that age-related Reelin aggregation and concomitant reduction in Reelin-
mediated signaling plays a proximal role in synaptic dysfunction associated with amyloid-β 
deposition, sufficient to enhance Tau phosphorylation and tangle formation in the hippocampal 
formation in aged Reelin-deficient transgenic AD mice. 
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4.2 INTRODUCTION 
 
Alzheimer’s disease (AD) is characterized by progressive cognitive decline and severe 
neurodegeneration (Savla and Palmer, 2005). Neuropathological hallmarks include 
neurofibrillary tangles, consisting of hyperphosphorylated Tau (Grundke-Iqbal et al., 1986) and 
senile plaques, mainly composed of amyloid-β peptides (Glenner and Wong, 1984); the 
amyloidogenic cleavage product of amyloid precursor protein (APP, (Estus et al., 1992; Haass et 
al., 1992). Non-amyloidogenic cleavage produces fragments with neuroprotective and 
transcriptional functions (Furukawa et al., 1996; Gao and Pimplikar, 2001; von Rotz et al., 
2004). Rare early-onset AD is caused by mutations in app and presenilin1/2 genes, all favoring 
amyloidogenic APP processing (Goate et al., 1991; Levy-Lahad et al., 1995; Rogaev et al., 
1995b; Sherrington et al., 1995). No apparent familial segregation is evident in the frequent late-
onset AD cases. Combinations of genetic, such as apolipoprotein E (ApoE) ε4, and non-genetic 
risk factors likely determine disease predisposition, age-onset, and progression (Bertram and 
Tanzi, 2008). The effect of ApoEε4 in late-onset AD neuropathology remains to be elucidated. 
ApoE isoforms bind to neuronal lipoprotein receptors, involved in a variety of brain functions 
(Herz, 2009), indirectly implicating ApoE receptors in AD pathophysiology. Two, including 
very-low-density lipoprotein receptor (VLDLR) and ApoE receptor 2 (ApoER2) bind also the 
extracellular signaling molecule Reelin, a conserved glycoprotein required for neuronal 
migration and positioning during development (D'Arcangelo et al., 1995). In adult neurons, 
Reelin-mediated signaling modulates synaptic NMDA receptor activity and is required for 
learning and memory (Beffert et al., 2006a, 2005; Chen et al., 1998; Qiu et al., 2006a; Qiu and 
Weeber, 2007; Weeber et al., 2002). Besides its role in synaptic plasticity and mnemonic 
functions, Reelin-mediated signaling controls several AD-relevant pathways: It inhibits key 
mediators of Tau phosphorylation (Beffert et al., 2002, 2004; Hiesberger et al., 1999; Ohkubo et 
al., 2003) and decreases amyloidogenic APP processing in vitro (Hoe and Rebeck, 2008; Hoe et 
al., 2006), potentially mediated by direct Reelin-APP interactions (Hoe et al., 2009b). In AD 
patients, increased proteolytic Reelin fragments, Reelin depletion in the entorhinal cortex 
(Botella-Lopez et al., 2006; Chin et al., 2007; Saez-Valero et al., 2003), and significant 
differences in two RELN polymorphisms have been described (Seripa et al., 2008).  
We have reported in aged rodents and non-human primates a pronounced reduction of Reelin-
expressing interneurons and concomitant accumulation of Reelin in amyloid-like deposits, co-
localizing with proteolytic APP fragments and associated with a reduction in basal forebrain 
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projection neurons that selectively target Reelin-positive hippocampal interneurons (Doehner et 
al., 2010; Knuesel et al., 2009; Madhusudan et al., 2009). The course and magnitude of the 
plaque load correlated with cognitive performance and was modulated by exacerbated 
inflammatory responses and genetic mutations favoring Aβ peptide production (Knuesel et al., 
2009). Based on these findings, we hypothesized that reduced Reelin-dependent signaling is a 
critical upstream factor able to promote amyloidogenic APP processing and Tau 
hyperphosphorylation. We directly tested this putative association by characterizing AD-like 
neuropathology in the offspring of transgenic AD mice crossed with heterozygous reeler mice in 
biochemical, histological and immunohistochemical experiments across aging.  
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4.3 METHODS AND MATERIALS 
 
ANIMALS 
All procedures were approved by the local authorities of the Cantonal Veterinary Office in 
Zurich.  All animals were housed in groups of 3 - 4 in an optimized in-house hygiene area (OHB, 
University of Zurich Irchel, Switzerland) under 12-h day-night cycle and ad libitum food and 
water. Heterozygous Reeler (C57BL/6J-Relnrl-7J/J+/-) mice were obtained from Jackson 
Laboratories, Maine, USA and crossed with transgenic animals expressing the human APP695 
gene containing the Swedish (K670N+M671L) and Arctic mutations (E693G) in a C57BL/6 
background (Knobloch et al., 2007b). The F1 offspring demonstrated Mendelian inheritance, 
carrying one of the following genotypes at expected frequencies: reln+/+;appwt (wt, 28.6%), 
reln+/-;appwt (reln, 26.1%), reln+/+;tghappswe,arc (app, 27.6%), reln+/-;tghappswe,arc (reln/app, 
17.7%). Genotype determination was done with postmortem tail biopsies using the following 
primers to detect the mutant reln gene product (363 bp): forward 5’ 
TAATCTGTCCTCACTCTGCC 3’, and reverse 5’ TGCATTAATGTGCAGTGT 3’. The 
presence of a human 180 bp app gene product was confirmed with the following primers: 5’ 
CAGAACTGAACCATTTCAACCGAGC 3’ and 5’ TCAGTGGGTACCTCCAGCGCCCGA 
3’. The number of animals employed in this study is summarized in Table 1. 
 
TABLE 1: Animals used 
Genotype Abbreviation Age Number/Experiment 
3 mo 4 IHC 
6 mo 5 IHC Reln+/+; APPwt wt 
9 mo 6 IHC 
3 mo 4 IHC 
6 mo 4 IHC Reln+/-; APPwt reln 
9 mo 9 IHC 
3 mo 4 IHC 
6 mo 4 IHC 
9 mo 8 IHC/ 8 WB 
Reln+/+; tghAPPswe,arc app 
15 mo 3 IHC 
3 mo 4 IHC 
6 mo 4 IHC 
9 mo 8 IHC/8 WB 
Reln+/-; tghAPPswe,arc reln/app 
15 mo 3 IHC 
IHC: Immunohistochemistry, including DAB immunoperoxidase and fluorescence, as well as silver staining; WB: 
Western blotting and ELISA 
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MOUSE BRAIN TISSUE PREPARATION 
Animals were deeply anesthetized with Nembutal (40 mg/kg i.p.). The tissue was perfusion-fixed 
and processed as described (Doehner et al., 2010; Knuesel et al., 2009). Random sampled serial 
sections were collected throughout the hippocampal formation starting at Bregma level -0.85 to 
-3.5 and stored at -20°C in cryoprotectant solution until immunohistochemical or histological 
evaluations (Knuesel et al., 2009). 
 
IMMUNOHISTOCHEMISTRY 
A 15 min pepsin pretreatment (0.15 mg/ml in 0.2 N HCl at 37°C) was applied to all the free-
floating sections for epitope unmasking and reduction of non-specific staining (Doehner et al., 
2010). Sections were then briefly washed with phosphate-buffered saline (PBS, pH 7.4) and 
processed for immunohistochemistry. The following antibodies were used: Mouse anti-rodent 
Reelin (clone G10, Millipore, Billerica, MA MAB364, 1:1000), rabbit anti-human β-Amyloid 
(1-40/1-42, Millipore, AB5076, 1:2000), mouse anti-human β-Amyloid (1-17, clone 6E10, 
Covance, Princeton, NJ, SIG-39320, 1:2000), mouse anti-mouse NeuN (clone A60, Millipore, 
MAB377, 1:1000), rabbit anti-human phosphorylated Tau (phospho-T205, Abcam, Cambridge, 
UK, ab4841, 1:1000), rabbit anti-rat α1 syntrophin (polyclonal affinity purified serum, 1:500, 
(Haenggi et al., 2005), and rat anti-mouse CD68 (AbD Serotec Ltd, Oxford, UK, MCA 341R, 
1:2000). After completion of the double-immunofluorescence stainings, GFAP-positive 
astrocytes were visualized with direct immunofluorescence using Cy3-conjugated rabbit anti-
GFAP IgG (kindly provided by Wolfgang Härtig, University of Leipzig, Germany, at 10 μg/ml 
in Tris buffer, pH 7.4, containing 2 % BSA and 10 % normal rabbit serum). For the nuclear 
counterstaining, sections were incubated for 5 min in 10 nM SYTOX green™ nucleic acid stain 
(Invitrogen, Carlsbad, CA) dissolved in PBS. ThioflavinS counterstaining involved 10 min 
incubation in filtered 1 % aqueous ThioflavinS (Sigma-Aldrich, Buchs, Switzerland) solution at 
RT, followed by 2 washes for 5 min in 80% EtOH, 5 min wash in 95 % EtOH, and 3 times 5 min 
washes in distilled water. Brain sections were then air-dried in the dark and mounted with 
aqueous permanent mounting medium (DAKO, Carpinteria, CA). Double-and triple-
immunofluorescence labelings were visualized by confocal microscopy (LSM-710, Zeiss, Jena, 
Germany) using a 40x (NA 1.3) and sequential acquisition of separate channels. Z-stacks of 
consecutive optical sections (6 – 12; 512 x 512 pixel, spaced 1 μm in z) were acquired at a 
magnification of 0.11 - 0.22 μm/pixel. For visual display, Z-sections of all channels were 
summed and projected in the z dimension (maximal intensity) and merged using the image 
Materials and Methods 
 127
analysis software Imaris (Bitplane, Zurich, Switzerland). Cropping of images, adjustments of 
brightness and contrast were identical for each labeling and done using Adobe Photoshop.  
 
SILVER STAINING 
For the detection of dystrophic neurites, extra- and intracellular proteinous aggregates, we used 
the FD NeuroSilver™ Kit II (FD NeuroTechnologies Inc, Ellicott City, MD). Free-floating 
perfusion-fixed brain slices (40 μm thick) prepared for normal immunohistochemistry were 
processes according to the manufacturer’s instruction. Control sections obtained from adult wild 
type mice that received unilateral intrahippocampal injections of kainic acid; a procedure which 
results in rapid degeneration of hippocampal interneurons and CA1 pyramidal cells (Knuesel et 
al., 2002), served as controls. 
 
QUANTIFICATION OF REACTIVE ASTROCYTES, MICROGLIA ACTIVATION, AND CO-
LOCALIZATION BETWEEN THIOFLAVIN S, α1-SYNTROPHIN, AND Aβ 
Quantitative analyses of the immunohistochemical stainings were done on one randomly selected 
hemisphere and performed blind to the genotype of the animals. Eight single- (GFAP/CD68) or 
Z-stacks (Aβ/ThioS/α1-syn) of digital images from 6-8 brain sections per genotype and age (n = 
4-6) were acquired neocortical areas including LI to LVI, lateral entorhinal cortex, and 
hippocampus, focusing on the CA1 stratum lacunosum moleculare. Area fractions of the GFAP- 
or CD68 immunoreactive cells, ThioflavinS-, anti-Aβ−, and anti-α1 syntrophin-IR were 
quantified using a fixed threshold algorithm of ImageJ software. Co-localization of ThioflavinS 
and Aβ−immunoreactive signals in amyloid-β plaques in the same brain areas were measured on 
projected z-sections. Red and green channels were first individually segmented and then 
analyzed with regard to pixel overlap within outlined plaques using a co-localization plug-in of 
ImageJ. Signals obtained from the green channel were set as 100%. To examine a putative 
preferential vascular association of amyloid-β plaques in reln/app mice, we measured using the 
same approach the degree of pixel co-localization between α1-syntrophin- and Aβ-IR with 
respect to the ThioflavinS signals, again set as 100%.  
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QUANTIFICATION OF NEUN-POSITIVE NEURONS AND REELIN- AND Aβ-POSITIVE PLAQUE 
SEGREGATION  
Quantitative analysis of the neuronal density associated with amyloid-β plaques as well as the 
Reelin/Aβ plaque segregation in 9 and 15 month old mice were performed on one randomly 
selected hemisphere in a blinded fashion. Eight single- (NeuN density) or Z-stacks (Reelin/Aβ 
plaque segregation) digital images from 4 brain sections per genotype and age (n = 6, 9 mo; n = 
3, 15 mo) were acquired in the neocortex (motor and somatosensory areas) as well as in the 
lateral entorhinal cortex. The numerical density of NeuN-positive neurons around plaques was 
assessed using a threshold algorithm using ImageJ software to individually outline and quantify 
the number of cells in 512 x 512 pixel images. Co-localization of Reelin- and 
Aβ−immunoreactive signals in extracellular plaques were measured on projected z-sections in LI 
of the lateral entorhinal cortex. Red and green channels were first individually segmented and 
then analyzed with regard to pixel overlap and segregation within outlined individual plaques 
using the co-localization plug-in of ImageJ. Signals obtained from both channels (Reelin- and 
Aβ-IR) were calculated as total plaque area and set as 100 %. 
 
VOLUME ANALYSIS AND QUANTIFICATION OF REELIN-POSITIVE AND AMYLOID-β PLAQUES 
Volumetric analysis was performed with the Mercator software (Explora Nova, LaRochelle, 
France). Five to seven sections per series were measured per animal. One hemisphere (for plaque 
analysis) or individual brain areas included in the volumetric assessments in 15 mo-old mice (i.e. 
neocortex, entorhinal cortex, hippocampus) were delineated with a 2.5x objective (NA 0.075). 
The volumes were estimated according to the formula V = ∑A×tnom×1/ssf, where ∑A = the 
summed area of one hemisphere or brain area, tnom = the nominal section thickness of 40 µm, and 
ssf = the section sampling fraction (1/12). Amyloid-β plaques, classified as either granular or 
fibrillar based on their morphology, were counted exhaustively and their diameter measured 
within the neocortical layers I, II-VI, entorhinal and piriform cortex, and hippocampus using a 
graphic tool of Mercator. Reelin-positive neurons and plaques were counted exhaustively within 
the outlined hippocampus using the 40x objective (NA 1.3). The total number of neurons (N) and 
plaques (P) were estimated according to the formula N or Ptot = ∑N or P×1/ssf, where ∑N or P is 
the sum of neurons or plaques, respectively. 
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PROTEIN EXTRACTS AND WESTERN BLOTTING 
Dissected hippocampi and neocortex samples (Table 1) were sonicated on ice in 10 volumes of 
RIPA buffer (20 mM Tris, 150 mM NaCl, 1% Triton X100, 1% Na-Deoxycholate, 0.1% SDS) 
containing protease (Roche, mini complete tablets™) and phosphatase inhibitors (Sigma-
Aldrich). Soluble and membrane-associated/insoluble fractions were separated by centrifugation 
at 20’000 g at 4°C for 20 min. Pellets were resolved in 70% formic acid and neutralized with 8 N 
NaOH. Total protein concentrations were measured with Bradford assays (BioRad laboratories 
Inc, Hercules, CA). Protein samples (20 μg) were separated by SDS-PAGE using 10-20% Tris-
Tricine gels (Invitrogen, Carlsbad, CA), blotted onto Protran 0.1 μm nitrocellulose (Sigma-
Aldrich), and blocked in TBS containing 5% western blocking reagent (Roche) for 10 min - 1 h 
at RT. All Western blots were run in duplicates for semi-quantitative analysis. Primary 
antibodies (mouse anti-β-Amyloid [clone 6E10, 1:500], mouse anti-amyloid precursor protein 
A4 [clone 22C11, Millipore, 1:1000], rabbit anti-human phosphorylated Tau [phospho-T205, 
1:1000], rabbit anti-β-actin [A2066, Sigma-Aldrich, 1:15’000]) were incubated over night at 4°C 
and visualized by the enhanced chemiluminescence reaction (Amersham Biosciences Europe, 
Freiburg, Germany). Semi-quantitative analyses of the immunoreactive bands were performed 
on digitalized films using ImageJ software (NIH, Bethesda, MD). Sum pixel brightness values 
(i.e. integrated density) corrected for non-specific background and equal loading using β-actin as 
a control were included in the statistical analysis. 
 
ELISA 
Human-specific amyloid-β1-40 and 1-42 ELISA microtiter plates were obtained from The 
Genetics Company (Schlieren, Switzerland) and the assays performed according to the 
manufacturer’s protocol. 50 μl samples of the brain extracts (supernatant, pellet) or blood plasma 
samples of mutant and wild type mice (Table 1) were used and run in duplicates. Following 30 
min incubation in the substrate solution (TMB/peroxide mixture), the reaction was stopped and 
the absorption quantified using the Synergy HT Multi-Mode Microplate Reader (BioTek 
Instruments Inc, Winooski, VT) measuring the difference at 450 nm and 650 nm.  
 
STATISTICAL ANALYSES 
All analyses were performed with the software StatView version 5.0 (Abacus Concepts, Inc., 
Berkeley, CA). ANOVA with Age and Genotype as the main between-subjects factors was 
performed for the immunohistochemical analyses of the GFAP, CD68, NeuN, and Aβ/Reelin 
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plaque stainings. Fisher’s LSD tests were used for post hoc comparisons. Planned comparisons 
(app vs reln/app) with Mann-Whitney U tests were used for the analysis of the total number of 
plaques estimated separately for each brain region, the volumetric analysis of the hippocampal 
formation and neocortex at 15 months of age, the levels of full-length APP, sAPP/N-APP, β-
stubs, Aβ40 and Aβ42 (Western blotting and ELISA), full-length Reelin and N-terminal Reelin, 
phosphoTau (T205), as well as for the size and area fraction of co-localized ThioflavinS and 
anti-Aβ−, and ThioflavinS and α1-syntrophin-IR, respectively. The two-sample Kolmogorov-
Smirnov test was used for comparing plaques size distribution in app and reln/app subjects. One 
(out of 8) app animal was excluded from the statistical evaluation of the ELISA Aβ42 levels 
since the measured value was more than 3 SD above the mean. In addition, one 9 mo-old app 
subject (out of 6) did not show any amyloid-β plaque staining and was therefore excluded for the 
statistical analysis of the Reelin/Aβ plaque segregation. Statistical significance was set at 
p < 0.05. 
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4.4 RESULTS 
 
EARLY NEUROPATHOLOGICAL CHANGES IN THE HIPPOCAMPUS OF RELN MICE   
We have recently reported a significant aging-associated decline in Reelin expression and 
concomitant accumulation in amyloid-like plaques, which co-localize with murine proteolytic 
APP fragments (Doehner et al., 2010; Knuesel et al., 2009). We further showed that this 
pathology was accompanied by a significant reduction in cholinergic and GABAergic basal 
forebrain projection neurons, the latter known to selectively target Reelin-positive interneurons 
in the hippocampus (Madhusudan et al., 2009). Here, we tested whether the impact of reduced 
Reelin levels in heterozygous Reelin knockout mice (reln) mice correlated with putative 
accelerated neuropathological changes in the hippocampal formation. The immunohistochemical 
investigations confirmed the age-dependent reduction in Reelin expression and appearance of 
Reelin-positive plaques in CA stratum radiatum (sr), lacunosum-moleculare (slm), and dentate 
gyrus DG molecular layer (ml) in wild type (wt) mice (Fig. 1A, C).  
 
FIGURE 1: Early 
neuropathological changes in 
the hippocampus of 
heterozygous Reeler (reln) 
mice   
Immunoperoxidase labelings of 
hippocampal brain sections 
obtained from 3 mo (A-B, E-H) 
and 9 mo (C, D) old wild type 
(wt) and heterozygous Reeler 
mice (reln). A, C) Aging-related 
reduction in Reelin-IR and 
concomitant appearance of 
Reelin-positive plaques (enlarged 
view in C) in the CA1 stratum 
radiatum, lacunosum-moleculare 
(slm), and outer molecular layer 
(ml) of the DG in 9 compared to 
3 mo old wt mice. The two boxes 
in A are enlarged in E and F to 
show the dense accumulation of 
Reelin-positive cells in the 
stratum oriens and the distinct 
neuropil staining in the slm and 
ml, respectively; the latter likely 
representing the extracellular 
Reelin secreted from perforant path axonal projections. B) Reelin-positive plaques are already detectable at 3 
months of age in heterozygous Reeler mice. Note the reduction in Reelin-immunoreactive cells in stratum oriens 
(box in B is enlarged in G) and selective enrichment in plaques in the slm (arrow, box in B is enlarged in H). D) 
Prominent accumulation of Reelin in amyloid-like plaques in the subiculum, slm, and outer ml at 9 months of age. 
Scale bar: A, C = 500 μm; H = 20 μm. 
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Reelin-IR in reln mice was strongly reduced in hippocampal GABAergic interneurons and 
neuropil compared to wt littermates at all ages investigated (Fig. 1A-D). Strikingly, already at 3 
months of age, Reelin-positive amyloid-like plaques were seen in the slm of reln mice (Fig. 1B, 
arrows), while the hippocampal formation was devoid of deposits in age-matched littermates 
(Fig. 1A, E-F). In agreement with our previous findings (Knuesel et al., 2009), Reelin-plaques in 
wt mice appeared only around 9 months (Fig. 1C). Statistical evaluation of the stereological 
estimates of the Reelin plaque density confirmed the significant difference between genotypes at 
3 months (Suppl. Fig. 1A). At 9 months, however, the plaque density was comparable between 
wt and reln mice, suggesting a shift in the temporal plaque profile between genotypes and an 
acceleration of aging-related neuropathological changes in reln versus wt mice (Suppl. Fig. 1A-
B). 
 
EARLY AMYLOID-β PLAQUE DEPOSITION IN RELN/APP DOUBLE-TRANSGENIC MICE  
In order to assess whether reduced Reelin expression is also associated with altered temporal and 
spatial amyloid-β plaque pathology, we created a mutant mouse line expressing 50 % of the 
Reelin gene product in a transgenic AD background (see methods and materials), referred to as 
reln/app. Littermate controls were either wild type (wt), heterozygous for Reelin (reln), or 
transgenic AD mice (app). Immunohistochemical and biochemical experiments were performed 
across aging, ranging from 3-15 months (Table 1). Anti-Aβ immunohistochemistry revealed no 
fibrillary amyloid-β plaques at 3 months of age independent of the genotype. Likewise, brain 
sections of 6 month-old wt and reln mice were devoid of fibrillary amyloid-β plaques (data not 
shown). In line with previous reports (Knobloch et al., 2007b), we found no amyloid-β plaques 
in the hippocampal formation (Fig. 2A) and only very few in the neocortex (max. 1-2 per 
section) in app mice at 6 months. This was in contrast to reln/app littermates (Fig. 2B, arrows), 
where amyloid-β plaques of different morphologies including fibrillar and granular types (Fig. 
2C) were evident in the hippocampus and neocortex in all subjects, indicating accelerated 
amyloid-β plaque formation in Reelin-deficient AD mice. At 9 months, amyloid-β plaques were 
present in app mice throughout the cortex but largely missing in the hippocampus (Fig. 2D left, 
Suppl. Fig. 1C-D). In reln/app mice, however, the accumulation of granular and fibrillary Aβ-IR 
was strongly increased; strikingly selective in CA1 slm, DG ml, and piriform/entorhinal cortex 
layer I (Fig. 2D right, arrows, Suppl. Fig. 1C-D); notably areas with highest Reelin-IR in wt 
mice (Fig. 1A). Stereological analysis of the plaque load at 9 months revealed a significant 
increase in plaque size and a corresponding significant increase in the number of large (>75 μm 
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in diameter) granular and fibrillary plaques in hippocampus and cortical layer I of reln/app 
compared to app subjects (Table 2). In line, the cumulative size distribution revealed a 
significant shift towards larger plaques (Suppl. Fig. 1E-H, Dmax ranging from 0.18-0.37, KS-
test), despite comparable numerical densities of small (>25 μm) and medium sized plaques (25-
75 μm) between genotypes (Table 2).  
 
TABLE 2: Stereological estimates of amyloid-β plaques in 9-month-old single and double transgenic AD mice 
   app reln/app p 
Hippocampus 
 
 
granular 
 
 
small 
medium 
large 
175 ± 84 
125 ± 45 
0 ± 0 
224 ± 81 
249 ± 69 
11 ± 4** 
0.35 
0.15 
0.01 
 
fibrillar 
 
 
small 
medium 
large 
434 ± 161 
247 ± 82 
3 ± 2 
1014 ± 
313 
604 ± 175 
38 ± 17* 
0.15 
0.20 
0.04 
Cortex Layer I 
 
 
granular 
 
 
small 
medium 
large 
127 ± 57 
87 ± 31 
0 ± 0 
158 ± 49 
194 ± 53 
6 ± 3 
0.35 
0.15 
0.08 
 
fibrillar 
 
 
small 
medium 
large 
514 ± 183 
297 ± 86 
5 ± 4 
1142 ± 
316 
600 ± 136 
39 ± 17* 
0.16 
0.10 
0.04 
Cortex Layer II-VI 
 
 
granular 
 
 
small 
medium 
large 
106 ± 42 
79 ± 32 
3 ± 2 
105 ± 50 
114 ± 26 
6 ± 5 
0.82 
0.38 
0.99 
 
fibrillar 
 
 
small 
medium 
large 
382 ± 130 
243 ± 91 
21 ± 13 
960 ± 279 
543 ± 113 
42 ± 11 
0.11 
0.06 
0.12 
Values are presented as mean (± SEM) for the quantification of the estimated number of granular and fibrillary 
amyloid-β plaques, classified as either small (<25 μm), medium (25 – 75 μm), or large (>75 μm in diameter), and 
expressed as total number in the given brain area of app and reln/app (n=8) subjects. Plaque counts in the 
hippocampus were performed along its entire septo-temporal axis; numerical estimates in the cortex included the 
piriform, lateral entorhinal, as well as the neocortex. No fibrillary amyloid-β plaques were detected in wt and reln 
littermates. 
 
We also observed some strikingly large fibrillary and granular plaques in cortical layers II-VI 
(Suppl. Fig. 1C-D); however, the overall number, mean size, as well as the cumulative size 
distribution of amyloid-β plaques were not different between genotypes in these cortical layers. 
At 15 months, amyloid-β plaque density further increased and remained significantly higher in 
reln/app as compared to app mice throughout the hippocampal formation and cortex (Fig. 2E). 
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FIGURE 2: Early and accelerated amyloid-plaque deposition in reln/app double-transgenic mice  
Representative images of coronal brain sections taken from 6- (A-C), 9- (D) and 15 month-old single mutant (app) 
and double-mutant (reln/app) mice (E) processed for anti-amyloid-β immunoperoxidase stainings.  A) No amyloid-β 
plaque deposition was detected in single transgenic AD mice at 6 months. B) In contrast, numerous amyloid-β 
plaques were evident in both hippocampus and cortex of reln/app mice at this age. C) Typical dense-core fibrillar 
plaque in the CA1 stratum oriens (so). C’) Granular Aβ plaque, potentially representing precursor amyloid deposits 
in the DG molecular layer. D) Representative images of half-brain sections of a single- (left) and double-mutant 
(right) mouse processed for immunoperoxidase staining using 6E10 monoclonal anti-Aβ antibody. Note the increase 
in plaques size and the prominent layer-specific localization of amyloid-β plaques in the CA1 lacunosum-
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At this age, app mice also showed amyloid- plaques in the subiculum and CA1 slm, most 
prominently seen in the temporal pole of the hippocampus. However, in reln/app mice these 
layers were almost completely covered by amyloid--IR along the entire septal-temporal axis. 
Moreover, signs of massively enlarged ventricles and a distinct shrinkage in cortical thickness 
were evident in reln/app mice at 15 months (3/3). Quantitative volumetric analysis of the 
hippocampus (along its entire septo-temporal axis) and cortex (including piriform, entorhinal, 
motor and somatosensory areas) revealed a significant volume reduction in 15 mo old reln/app 
(hip: 10.1 ± 1.5 mm3; ctx 28.3 ± 1.5 mm3) compared to app mice (hip: 13.8 ± 1.1 mm3; p = 
0.029,  ctx 33.3 ± 1.5 mm3; p = 0.017). Volumetric reductions in the whole hippocampal 
formation of reln/app mice approached a difference of -26% compared to app; whereas 
neocortical areas were less affected (-9%). The ventricle enlargement in the posterior part was 
also significantly larger in reln/app compared to app (+11.8%, p = 0.049, Mann-Whitney U test, 
values are mean ± SD). Altogether, these results indicate that a reduction in Reelin expression 
significantly accelerates A deposition and promotes neurodegeneration in aged transgenic AD 
mice.  
 
INCREASED INFLAMMATORY RESPONSES IN DOUBLE-TRANSGENIC MICE  
Neurodegeneration is tightly linked to inflammation, a process that is characterized by the 
presence of activated microglia and reactive astrocytes around amyloid-β plaques and increased 
levels of inflammatory mediators (Wyss-Coray, 2006). To test whether the accelerated formation 
and size increase of amyloid-β plaques in double-mutant mice were accompanied by enhanced 
inflammatory changes, we used markers for activated microglia (CD68) and astrocytes (GFAP) 
combined with anti-Aβ or -Reelin immunohistochemistry (Fig. 3A-F). In line with the amyloid-
β pathology, GFAP- and CD68-IR in hippocampus and cortex at 6 months were only moderately 
higher in reln and reln/app compared to wt and app mice (Fig. 3G-H). In contrast, at 9 months of 
age, both astrocytes and microglia levels were significantly enhanced in reln/app mice compared 
to app subjects and revealed a pronounced association with amyloid-β as well as Reelin-positive 
plaques in cortex and hippocampus (Fig. 3C, F). Interestingly, despite the presence of amyloid-β  
plaques in app mice, the levels of GFAP- and CD68-IR were moderate and not different from wt 
______________________________________________________________________________ 
 
moleculare and piriform cortex layer I (arrows) of reln/app mice. E) Representative brain sections of an app (left) 
and reln/app (right) mouse at 15 months showing the further aggravated plaque load in reln/app mice as compared to 
app subjects. Note the ventricular enlargement and reduced cortical thickness in reln/app brains, indicative of 
progressive neurodegeneration. Scale bars: A, D, E = 500 μm, C = 20 μm.  
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littermates (Fig. 3G-H), suggesting that the abnormal activation of microglia and astrocytes due 
to the exacerbated amyloid-β plaque pathology in reln/app mice. 
 
 
FIGURE 3: Increased inflammatory responses in reln/app double-transgenic mice 
Low magnification images of double-immunofluorescence staining of cortical (A-C) and hippocampal (D-F) brain 
sections obtained from 9 month old single-mutant app and double-mutant reln/app mice. A-B, D-E) Pronounced 
increase in GFAP-positive astrocytes (red) selectively associated with amyloid-β plaques (anti-Aβ1-40/42 antibody, 
green) was found in reln/app compared to app subjects. C, F) A similar increase in reactive microglia was evident in 
the neocortex (C) and hippocampus (F) of 9 mo reln/app mice. Note the selective accumulation of CD68-positive 
microglia (red) with Reelin-immunoreactive plaques (green). G) Quantification of the area fraction of GFAP 
immunoreactive astrocytes revealed a main effect of Genotype (F3,20 = 4.4, p = 0.016) and significant differences 
between reln/app vs wt (p = 0.022), reln/app vs reln (p = 0.043), and reln/app vs app (p = 0.010) at 9 months of age. 
H) Similar differences emerged between reln/app vs wt (p = 0.039) and reln/app vs app (p = 0.046) subjects for the 
CD68 area fraction. Values are given as mean ± SEM. *p < 0.05 (comparison to reln/app subjects), statistical 
significance based on Fisher's LSD post hoc analysis. Scale bars: C = 50 μm, F = 10 μm. 
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AGGRAVATED AMYLOID-β PLAQUE PATHOLOGY IN RELN/APP MICE 
To investigate further the progression of reactive astrocytes, amyloid-β and Reelin-IR in reln/app 
mice, we performed high magnification confocal imaging of triple-labeled brain sections of 6, 9 
and 15 month-old mice. We found a prominent elevation in GFAP-IR surrounding granular 
amyloid-β plaques in reln/app mice across aging that was accompanied by a significant 
enlargement of individual granules and increased co-localization between amyloid-β and Reelin-
IR in granular plaques (Suppl. Fig. 2A-B). In contrast, granular plaque pathology in app subjects 
was much less pronounced, as indicated by the moderate GFAP-, Aβ- and Reelin-IR in CA1 area 
at 9 months of age (Suppl. Fig. 2C).  
Fibrillary Aβ plaques in 6 month-old reln/app mice were already densely surrounded by 
astrocytes, particularly prominent in the hippocampus, pointing again to the advanced stage in 
amyloid-β plaques formation (Suppl. Fig. 2E). A similar pattern was seen in the neocortex; 
however, astrogliosis was muss less advanced compared to the hippocampal formation (Suppl. 
Fig. 2D). Interestingly, prominent Reelin-IR was associated with fibrillary plaques, correlating 
with their size and showing partial co-localization with Aβ (Suppl. Fig. 2E, arrows), again a 
feature being much less pronounced in app as compared to the reln/app subjects. At 9 months of 
age, Reelin-IR further increased in area and intensity, most prominently in fibrillary plaques in 
the cortex and CA1 slm (Fig. 4) of reln/app mice, whereas plaque pathology in app littermates 
resembled the pattern seen in 6 mo reln/app mice (Fig. 4A, Suppl. Fig. 2D). Moreover, Reelin-
positive plaques appeared to segregate from amyloid-β plaques in hippocampus and cortex of 
reln/app but not age-matched app mice (Fig. 4H). Quantitative analysis of the area covered by 
Reelin- and Aβ plaques confirmed the increase in Reelin-IR in extracellular deposits (Suppl. 
Fig. 3) and revealed a significantly lower overlap and higher levels of segregation between 
Reelin- and Aβ-IR in extracellular plaques in reln/app as compared to app mice. These results 
point to a potential bi-directional facilitation of aggregation between Reelin and amyloid-β 
peptides. At 15 months, the further increase in plaque pathology in reln/app mice was mirrored 
by a selective reduction in neuronal density, accompanied by a massive coverage by activated 
astrocytes and microglia occupying the neuropil surrounding amyloid-β deposits (Fig. 4M-O), a 
phenomenon likely underlying the volumetric reductions of cortical areas measured in reln/app 
mice at this age (Fig. 2E). In app littermates, no evidence for a significant reduction in neuronal 
numbers in the vicinity of amyloid-β plaques was evident (Fig. 4K) and, correspondingly, glia 
activation was not as high as in double-mutants (Fig. 4J). Quantitative evaluation of the neuronal  
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FIGURE 4: Aggravation and segregation of Reelin and amyloid-β plaques pathology in the hippocampus and 
cortex of 9 and 15 mo old double-mutant reln/app mice  
A-I) Triple-immunofluorescence stainings using Cy3-GFAP (red), anti-Aβ1-40/42 (green) and anti-Reelin (blue) 
antibodies on cortical (A-F) and hippocampal (G-I) brain sections of 9 month-old app (A-C) and reln/app mice (D-
I). In the double-mutants, amyloid-β plaques were densely surrounded and tightly associated with reactive
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density around amyloid-β plaques using NeuN-immunohistochemistry supported this 
observation and revealed a significant reduction in NeuN-positive neurons in reln/app versus app 
subjects (Suppl. Fig. 4A-D), suggesting that the reduction in Reelin-mediated signaling and the 
elevation in inflammatory markers significantly contribute to progressive neurodegeneration in 
aged reln/app mice. 
 
INCREASE IN AMYLOIDOGENIC APP PROCESSING AND INSOLUBLE Aβ SPECIES IN DOUBLE-
MUTANTS  
In vitro data revealed reduced amyloidogenic APP processing in the presence of Reelin in the 
culture medium (Hoe et al., 2006). To test whether the aggravation in amyloid-β plaque 
pathology was accompanied by enhanced production and increased Aβ-peptide levels, we 
performed Western blot analysis and ELISA of SDS-soluble and insoluble; formic acid extracted 
fractions of hippocampal and cortical brain lysates of app and reln/app mice. In the soluble 
fraction, enhanced amyloidogenic APP processing in reln/app vs app was evident, as indicated 
by the presence of Aβ species and the increase in β-secretase-cleaved APP ectodomains (sAPP) 
and C-terminal fragments (β-stubs) in the hippocampus of reln/app mice as compared to app 
subjects (Fig. 5A-D). Semi-quantitative analysis of the immunoreactive bands in the soluble 
fractions revealed significantly higher levels of β-stubs and sAPP in the double-mutants as 
compared to the single transgenic AD mutants (Fig. 5B-D). Surprisingly, we also observed 
elevated levels of a N-terminal APP fragment, inversely correlating with the expression levels of 
full-length Reelin (Fig. 5C, G), further confirming that reduction in Reelin expression alters 
proteolytic processing of APP. The insoluble fractions of both hippocampal and cortical brain 
lysates of reln/app mice contained substantial amounts of Aβ species (Fig. 5E). Quantitative 
analysis using ELISA confirmed this observation and revealed significant increases in insoluble 
Aβ40 and Aβ42 peptides in both hippocampus and cortex in reln/app compared to app 
littermates (Fig. 5F). Altogether, these results suggest that reduction in Reelin increases Aβ 
levels by favoring amyloidogenic APP processing and by promoting aggregation of Aβ peptides 
in the neuropil of the hippocampus and cortex.  
 
_____________________________________________________________________________________________ 
 
astrocytes, whereas in app subjects only moderate astrogliosis was evident. Note the intense Reelin-IR associated 
with fibrillary amyloid-β plaques (B vs E, arrows) and their striking segregation from Aβ deposits (H, arrow) in the 
CA1 slm in reln/app as compared to app subjects. J-O) Aggravation of the micro- and astrogliosis in reln/app mice 
at 15 months of age was particularly prominent in the entorhinal cortex (ECtx). Note the reduction in APP-
expressing neurons in the aged double- (N) vs single-mutants (K). Scale bars: C, F, I = 10 μm; L, O = 20 μm.  
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FIGURE 5: Increase in amyloidogenic APP processing and insoluble Aβ levels in double-mutant reln/app mice  
A) Representative western blots of the SDS-soluble supernatant (SN) derived from hippocampal brain lysates of 9 
month-old mice using anti-Aβ (6E10) antibodies. B) Semi-quantitative analysis involving densitometry of the 
immunoreactive β-cleaved C-terminal APP fragments (β-stubs), run in duplicates, corrected for non-specific 
background and equal loading using β-actin as control, revealed a significant increase in reln/app as compared to 
app (p = 0.049; n = 4). Soluble Aβ-levels were very low, but clearly detectable in samples of reln/app subjects. C) 
Representative western blots using anti-Reelin (G10) antibody recognizing both full-length (FL-Reln) and the N-
terminal 180 kDa fragment (N-Reln). The N-terminal-specific APP antibody (22C11) antibody recognized besides 
full-length APP (FL-APP) and the soluble α- or β-secretase-cleaved APP ectodomain (sAPP) a short N-terminal 
fragment, presumably representing N-APP. D) Statistical analysis of the densitometrical measurements of FL-APP 
and sAPP-immunoreactive fragments revealed a significant difference between genotypes as indicated by the 
reduced FL-APP/sAPP ratio in reln/app as compared to app subjects (p = 0.033, n = 4).  In addition, a marked shift 
towards higher N-APP-immunoreactive fragments in 9 mo old reln/app mice was evident, as demonstrated by the 
significant reduction in the FL-Reelin/N-APP ratio (G, p = 0.034, n = 4). E) Representative western blots using anti-
Aβ (6E10) antibodies of SDS-insoluble fractions (pellet) of hippocampal brain lysates, which was resuspended in 
formic acid (FA). F) Quantitative analysis using ELISA with Aβ40- and Aβ42-specific antibodies revealed a 
significant increase in Aβ peptides in the insoluble fractions of reln/app compared to app littermates in the 
hippocampus (Aβ40, p = 0.021; Aβ42, p = 0.046) and neocortex (Aβ40, p = 0.016; Aβ42, p = 0.016; n = 7-8). 
Values are expressed as fraction of total protein content and given as mean ± SEM. *p < 0.05; statistical significance 
based on Mann-Whitney U test. 
 
To investigate further the accelerated aggregation state, we compared the density of fibrillary Aβ 
species between genotypes using ThioflavinS staining in combination with anti-Aβ 
immunohistochemistry (6E10). In addition, we employed an antibody against α1-syntrophin, a 
marker for astrocytic endfeet, to investigate a putative preferential association of Aβ plaques 
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with cerebral perivasculature. In agreement with our biochemical measurements, we detected a 
significant increase in the number and size of ThioflavinS-positive fibrillary aggregates in all 
brain areas investigated, including neocortical and hippocampal formation in reln/app vs app 
subjects (Fig. 6A-C).  
 
 
 
FIGURE 6: Increase in ThioflavinS-positive amyloid-β plaques in reln/app mice in neocortex and hippocampal 
formation  
Double-immunofluorescence using anti-Aβ (6E10, red) and anti-α1-syntrophin (α-Syn, blue) antibodies combined 
with ThioflavinS counterstaining (green) were performed to investigate the fibrillary amyloid-β plaque load in both 
neuropil and cerebral vasculature in 9 mo-old app (A) and reln/app mice (B). Note the increase in ThioflavinS 
signals concomitantly with the anti-Aβ-IR in the outer layers of the neocortex. C) Densitometric analysis of the 
brightness and surface area covered by ThioflavinS-positive signals in the neocortical layers I-VI (Ctx), lateral 
entorhinal cortex (EC), and dorsal and ventral hippocampus (Hip). D) Quantification of the pixel overlap between 
the green ThioflavinS-positive signals and red anti-Aβ immunoreactive staining, averaged from measurements of 8 
images (512x512 pixel in size) per animal and brain region (n = 4 per genotype) acquired in the areas indicated. 
Values are given as mean ± SEM. *p < 0.05; statistical significance based on Mann-Whitney U test. Scale bar = 50 
μm. 
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Moreover, the area covered by Aβ- and Thioflavin S-positive signals in these brain regions was 
significantly larger in reln/app as compared to app mice (Fig. 6D), supporting the view that the 
reduction in Reelin expression facilitates and accelerates the formation of fibrillary Aβ species. 
No difference with respect to neuropil vs vascular amyloidosis was found between genotypes (all 
p > 0.6), indicating that the increase in Aβ plaque deposition in reln/app mice was not associated 
with a preferential increase in β-amyloid angiopathy.  
 
ABUNDANT DYSTROPHIC NEURITES AND ELEVATION OF PHOSPHO-TAU IN AGED RELN/APP 
MICE 
Besides direct binding to APP and modulating its proteolytic processing (Hoe et al., 2006, 
2009b), Reelin-mediated signaling inhibits key mediators of Tau phosphorylation (Beffert et al., 
2002, 2004; Hiesberger et al., 1999; Ohkubo et al., 2003). We therefore reasoned that genetic 
reduction in Reelin expression – in addition to favoring amyloidogenic APP processing - might 
promote hyperphosphorylation of Tau and facilitate the formation of neurofibrillary tangles in 
aged subjects. We therefore performed biochemical and immunohistochemical analysis to assess 
the levels of phospho-Tau using an antibody raised against phosphoT205 across aging. In young 
and adult brain tissue, highest phospho-Tau levels can be detected in axonal projections 
throughout the brain, particularly prominent in mossy fibers and terminals in stratum lucidum of 
the CA3 area (data not shown). At 9 months of age, biochemical analyses revealed a significant 
elevation of phospho-Tau levels in hippocampal and cortical brain lysates of reln/app compared 
to app mice (Suppl. Fig. 4E-G), confirming that Reelin-mediated signaling in aged subjects 
remains a major modulator of Tau phosphorylation as described during neurodevelopment 
(Beffert et al., 2002; Brich et al., 2003). In line with these biochemical data, several neurons with 
distinct anti-phospho-Tau signals in the soma were detectable, sparsely distributed in plaque-
dense areas in the hippocampal formation and neocortex in 9 month old reln/app but not in app 
mice (data not shown). At 15 months of age, a striking concentric accumulation of phospho-Tau-
positive cells selectively associated with amyloid-β plaques was evident in reln/app. High-
magnification confocal microscopy revealed a distinct anti-phospho-Tau-IR enriched in neuronal 
somata and dendrites (Fig. 7B, arrow, inset). Littermate app mice at the same age showed some 
anti-phospho-Tau-IR, however, this was largely restricted to extrasomatic sites, likely 
representing axonal localization (Fig. 7A, inset).  
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FIGURE 7: Selective association of anti-phospho-Tau immunoreactivity in plaque-dense areas within CA1 slm 
A-B) Double-immunofluorescence using anti-phospho-T205 (red) and anti-Aβ (6E10, blue) antibodies combined 
with SytoxGreen™ nuclear counterstaining to investigate the relationship between amyloid-β plaque and Tau 
pathology in app (A) and reln/app (B) at 15 months of age. A) Representative amyloid-β plaque in the CA1 slm of 
app mice with a dense core and some diffuse anti-Aβ-IR surrounding it. In line with the immunoperoxidase 
stainings, anti-phospho-Tau-IR in app subjects was readily detectable in the neuropil but no evidence for any 
enrichment in cells surrounding the plaques was found (inset in A). B) Anti-amyloid-β-IR covered large areas 
within the core and surrounding areas of plaques in the CA1slm of reln/app mice. Note the selective fibrillary 
enrichment of anti-phospho-Tau signals in the cytoplasm (inset) and dendrites (arrow) of neurons selectively 
associated with amyloid plaques. The distinct spatial distribution of the amyloid-β and Tau pathology is also evident 
on the xz and yz view at the bottom and right side of the image. Scale bars in A, B = 30 μm. 
 
Typically, the area surrounding the plaques also contained pronounced anti-amyloid-β-IR in 
reln/app compared to app mice at 15 months (Fig. 8A’-B’), suggesting that 
hyperphosphorylation of Tau in soma and dendrites is selectively promoted around amyloid-β 
plaques, potentially mediated by reduced Reelin and elevated non-fibrillary Aβ levels, and/or 
glia cells and their secreted inflammatory cytokines.  
A highly similar picture emerged using immunoperoxidase labelings. Both cortical and 
hippocampal neurons associated with amyloid-β plaques in reln/app but not app mice showed 
strong somatic anti-phospho-Tau-IR (Fig. 8A-B, inset). Interestingly, some of them stood out by 
the presence of distinct phospho-Tau aggregates, suggestive of degenerating neurons (Fig. 8C, 
inset). This was also evident in the hippocampus, particularly prominent in the CA1 slm and sr 
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where we detected typical tangle-like structures (Fig. 7D, inset), indicating the presence of 
neurofibrillary depositions in aged double-mutants. To confirm the presence of this typical AD-
like neuropathological hallmark and to assess putative neurodegeneration associated with 
amyloid-β plaques, we performed also Gallyas silver staining. At 9 months of age, no indication 
of neurodegenerative processes nor tangle-like aggregates were evident in reln/app and app mice 
(data not shown). At 15 months, selectively in reln/app subjects, brightfield microscopy revealed 
the presence of distinct silver precipitates selectively associated with amyloid-β plaques, which 
likely represent dystrophic neurites (Fig. 8F-G). This feature was most prominently seen in the 
entorhinal cortex, accompanied by densely labeled cell bodies and neurites surrounding the 
plaques in the double-mutants but not app mice (Fig. 8E). In line with the anti-phospho-Tau 
immunohistochemistry, individual silver stained intracellular aggregates were detected in the 
entorhinal cortex of reln/app mice within the dystrophic compartment, suggesting the presence of 
neurofibrillary tangles selectively associated with amyloid-β plaques in aged Reelin-deficient 
AD mice.  
 
 
FIGURE 8: Concentric accumulations of phospho-Tau-positive neurons and neurofibrillary tangles around 
amyloid-β plaques in 15 mo old reln/app mice 
Representative images of brain sections obtained from app (A, E) and reln/app mice (B-D,F-G) processed for 
immunoperoxidase staining using anti-phospho-T205 antibody (A-D) or silver staining (E-G). A) In app subjects, 
uniform phospho-Tau-IR was evident in the cortical neuropil, indicative of axonal localization. No particular 
enrichment was seen in the vicinity of amyloid-β plaques, recognized by their lack of phospho-Tau-IR (asterisk). B-
C) In reln/app mice, strongly stained phospho-Tau-positive neurons were evident around amyloid-β plaques in 
neocortical areas (insets). D) In the hippocampus of reln/app mice, a similar pattern was evident in close vicinity to 
plaques; some neurons appeared dystrophic, strongly suggestive of tangle-like intraneuronal accumulations (inset in 
D). E) Silver staining revealed some dark precipitates (arrowhead) in the vicinity of large plaques (asterisk) in the 
entorhinal cortex of app mice. F) In contrast, dense silver precipitates surrounding amyloid-β plaques, indicative of  
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Altogether, the findings indicate that a genetic reduction in Reelin expression accelerates the 
production of amyloidogenic Aβ peptides which results in earlier plaque formation and an age-
related aggravation of the pathology including early signs of neurodegeneration in hippocampal 
formation and cortex of AD mice that is accompanied by elevated phospho-Tau levels and 
neurofibrillary tangle formation in aged subjects.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
dystrophic neurites, were very prominent in reln/app mice. In addition, black-labeled intraneuronal aggregates, 
likely representing neurofibrillary tangles, were seen in neurons associated with these plaques (arrows, enlarged in 
the insets). G) Representative image of a large amyloid-β plaque in the entorhinal cortex of a reln/app mouse, 
showing a concentric pattern of silver stained cells, likely representing degenerating neurons in the vicinity of 
plaques (arrowheads). Scale bars = 20 μm. 
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4.5 DISCUSSION 
 
The present study provides convergent immunohistochemical and biochemical evidence that a 
genetic reduction in Reelin expression favors amyloidogenic APP processing in vivo; resulting in 
precocious formation and age-related aggravation of amyloid-β plaque pathology, accompanied 
by concentric accumulation of phospho-Tau-positive neurons, neurofibrillary tangles, and 
neurodegeneration in the hippocampal formation. The animal model thereby unites for the first 
time amyloid-β plaque and Tau pathology in a temporal and spatial pattern that closely 
recapitulates the progression of AD neuropathology in humans (Braak and Braak, 1996), 
importantly in the absence of tau mutations. Further, it complements several previous studies 
involving genetic studies (Brich et al., 2003) in vitro experiments (Hoe et al., 2006), and in vivo 
neuronal survival assays (Beffert et al., 2006b) demonstrating that dysfunctional Reelin-mediated 
signaling through ApoER2 acts as a critical upstream modulator of amyloidogenic APP 
processing, Tau hyperphosphorylation and neuronal survival, presumed to underlie AD-
associated neuropathology. 
Our comprehensive investigations across aging revealed a significantly accelerated extracellular 
Aβ neuropathology in Reelin-deficient AD mice; indicated by the presence of amyloid-β plaques 
in hippocampus and neocortex as early as 6 months. Littermate app mice were virtually devoid 
of amyloid-β deposits at this age, in line with the original report (Knobloch et al., 2007b). At 9 
and 15 months, pathology was further aggravated in reln/app mice, resulting in a striking 
redistribution and selective accumulation of Aβ plaques in entorhinal projection areas, precisely 
corresponding to areas where Reelin-IR is enriched in extracellular plaques in reln but not app 
littermates (Fig. 1-2). Moreover, we detected numerous Aβ plaques in layer I of the entorhinal, 
piriform and neocortex, again in areas with strong Reelin expression in young and Reelin plaque 
depositions in aged subjects (Knuesel et al., 2009). Aβ plaques were also significantly larger in 
these areas in double- as compared to single-mutants, affecting both granular (presumable non-
fibrillary, soluble deposits) as well as fibrillary plaques (Table 2, Fig. 2, 6, Suppl. Fig. 1E-H). 
Biochemical investigations using SDS-soluble fractions of hippocampal and cortical lysates 
revealed significant decrease in full-length APP and concomitant increases in β-secretase-
cleaved APP ectodomains (sAPPβ), C-terminal fragments (β-stubs), and Aβ peptides (Fig. 5), 
indicating elevated amyloidogenic APP processing, in line with previous in vitro data (Hoe and 
Rebeck, 2008; Hoe et al., 2006). Western blotting and quantitative ELISA of formic acid-
extracted hippocampal and cortical brain lysates revealed also significantly higher levels of 
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insoluble Aβ40/42 peptides in reln/app compared to app littermates (Fig. 5), confirming that 
reduced Reelin levels, potentially by altering APP trafficking, membrane insertion and favoring 
β-secretase cleavage (Hoe et al., 2006), enhances Aβ production. It is further conceivable that 
reduction in Reelin-signaling promotes APP endocytosis due to reduced binding of the central 
Reelin domain to the N-terminus of APP (Hoe et al., 2009b). This scenario fits with previous 
data showing preferential APP β-secretase cleavage in endocytic vesicles (Hoe et al., 2009b; 
Rajendran et al., 2006, 2008), in line with the reported endosomal localization and pH optimum 
of β-secretase activity (Vassar et al., 1999).  
Besides the role of reduced Reelin-mediated signaling on amyloidogenic APP processing, our 
data also suggest a direct effect on Aβ aggregation. We show that a reduction in Reelin 
expression favors its own aggregation, as demonstrated by the significantly earlier but highly 
conserved Reelin plaque pathology (Knuesel et al., 2009) in reln compared to wt mice (Fig. 1). 
Thus, it is conceivable that both reduced Reelin-dependent signaling promoting Aβ production 
as well as Reelin-aggregation by providing a nucleation site for aggregation-prone peptides, 
results in aggravation of the amyloid-β plaque phenotype. Indeed, we observe an overlap 
between Reelin and amyloid-β plaques in LI of the entorhinal cortex and perforant path axonal 
projection sites where the two selectively associate and partially co-localize in granular and 
fibrillary plaques (Fig. 4, Suppl. Fig. 2). Interestingly, we also detected a segregation of Reelin-
IR from Aβ-positive fibrillary plaques in aged reln/app mice, indicating that aggregation of 
Reelin itself aggravates in the vicinity of amyloid-β plaques and reactive glia. This phenomenon 
was again more prominent in the hippocampal formation compared to neocortical regions, 
confirming the increased vulnerability of this brain area with respect to AD-like neuropathology. 
A reciprocal effect is also conceivable; with Aβ peptides promoting Reelin aggregation. Support 
for this hypothesis has been recently provided by (Botella-Lopez et al., 2010) demonstrating that 
amyloid-β peptides can alter Reelin processing and glycosylation; critical modifications 
demonstrated to be required for proper Reelin-mediated signaling (Jossin et al., 2007; Koch et 
al., 2002; Lambert de Rouvroit et al., 1999), and potentially involved in abnormal 
oligomerization and aggregation of Reelin (Kubo et al., 2002; Utsunomiya-Tate et al., 2000; 
Yasui et al., 2007).  
Difference in plaque pathology between genotypes was also associated with distinct 
inflammatory responses in reln/app versus app mice. Our investigations of reactive glia revealed 
a significant aging-related increase in GFAP- and CD68-IR, tightly intermingled with amyloid-β 
plaques in reln/app mice (Fig. 3-4, Suppl. Fig. 2). In contrast, Aβ plaques were detected without 
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or weak GFAP/CD68-IR in app littermates (Fig. 3). In line with the biochemical data, these 
findings support our interpretation of a significantly more aggravated and advanced fibrillary 
plaque pathology in aged reln/app compared to app mice. This is in agreement with 
immunohistochemical studies examining the brains of AD patients (McGeer et al., 1987), as well 
as with numerous studies using different animal models of AD (El Khoury and Luster, 2008), 
demonstrating that microglia accumulation in senile plaques is an integral part of AD 
pathogenesis. Our data also fit with recent findings showing that the phenotype of accumulating 
microglia changes as AD-like pathology progresses in tgAPP-PS1 mice (Hickman et al., 2008); 
from a protective, Aβ-clearing role during early phases to a enhanced production in 
inflammatory cytokine and loss in Aβ-clearing capabilities during later disease phases. 
Furthermore, it is conceivable that, in addition to dysfunctional Reelin signaling, pro-
inflammatory cytokines including interferon-γ, TNF-α and interleukin-1, shown to be secreted 
from glia (Hickman et al., 2008) and demonstrated to be involved in β-secretase up-regulation 
(Yamamoto et al., 2007) and γ-secretase-mediated APP cleavage APP (Liao et al., 2004b). The 
elevated release of pro-inflammatory cytokines by Aβ-activated glia is also expected to promote 
neurodegenerative processes (Blurton-Jones and Laferla, 2006; Chiarini et al., 2006). On the 
other hand, neurodegeneration in turn strongly promotes gliosis. Indeed, at 15 months, amyloid-
β plaque pathology was accompanied by striking and significant reduction in neuronal density, 
accompanied by strong astrogliosis and dystrophic neurites surrounding the plaques in reln/app, 
whereas app littermates showed only very mild signs of plaque-associated neurodegeneration 
(Fig. 8). Moreover, a significant ventricular enlargement and shrinkage of cortical areas, mostly 
affecting the hippocampal formation, was evident in double- compared to single-mutants 
(Fig. 2), indicating that reduced Reelin levels by promoting Aβ plaque deposition and 
inflammatory responses, result in neurodegeneration in aged subjects. A potential molecular 
mechanisms has been recently provided by the findings that signaling through a spliced isoform 
of the Reelin receptor ApoER2 is essential for protection against neuronal cell loss during 
normal aging (Beffert et al., 2006b), pointing to an exciting mechanistic link between Reelin 
deficiency and neurodegeneration through dysfunctional ApoER2 signaling.  On the other hand, 
we cannot rule out completely that subtle neuroanatomical changes occurring in reln mice may 
contribute to the observed neuropathology in reln/app mice. However, considering that we did 
not detect statistical differences in volume and neuronal density between genotypes up to 9 
months of age, we consider this putative confounding factor as unlikely.  
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Another striking effect accompanying these neuropathological changes was the concentric 
accumulation of phospho-Tau-positive neurons around senile plaques in reln/app mice (Fig. 7-8), 
supporting previous genetic interaction studies demonstrating a critical role of Reelin-mediated 
signaling via Dab1 phosphorylation in inhibiting Tau hyperphosphorylation (Brich et al., 2003). 
Interestingly, while neocortical neurons contained mainly cytoplasmic anti-phospho-Tau-IR, 
distinct tangle-like structures were found in the hippocampal formation (Figure 8), in line with 
the more advanced plaque pathology in this brain region in double- vs single-mutants. Silver 
staining revealed the presence of neurofibrillary tangle-like structures, selectively associated 
with dystrophic neurites surrounding the plaques in the entorhinal cortex, importantly in non-
transgenic Tau mutants. The temporal and spatial aspects of the neuropathology supports the 
critical upstream role of dysfunctional Reelin-mediated signaling that is sufficient to accelerate 
amyloid-β peptide production in the hippocampal formation, which in turn promotes Tau 
phosphorylation and tangle formation, selectively in plaque- and glia-dense areas. This is in line 
with the current hypothesis of a upstream role of Aβ species with respect to Tau pathology 
(Hardy and Selkoe, 2002; Selkoe, 2000; Walsh and Selkoe, 2004) and with the findings from 
postmortem AD tissue showing a distinct temporal and spatial progression of the neuropathology 
in humans (Braak and Braak, 1996).  
In conclusion, the data revealed for the first time in vivo that reduced expression of Reelin has a 
significant effect on amyloidogenic APP processing and amyloid-β plaque deposition as well as 
neurofibrillary tangle formation in the hippocampal formation of aged transgenic AD mice with 
a genetic reduction in the reeler gene. Considering that Reelin is also an important modulator of 
adult NMDA receptor-mediated neurotransmission and synaptic plasticity (Beffert et al., 2006a; 
Chen et al., 2005; Qiu and Weeber, 2007; Qiu et al., 2006b; Weeber et al., 2002) a stronger 
decline than normally seen during aging is expected to trigger a cascade of downstream events, 
resulting in the shift from non-amyloidogenic to amyloidogenic pathways, accompanied by 
immunological changes, Tau hyperphosphorylation and neurofibrillary tangle formation, that 
presumably underlie the progressive neurodegeneration and cognitive decline associated with 
late-onset AD. 
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IV. GENERAL DISCUSSION 
 
In this thesis we investigated the ultrastructural and proteomic properties of the aging-related 
Reelin-positive clustered structures in the hippocampal formation of wild type mice. After 
comprehensive immunohistochemical investigations, immuno-electron microscopy (IEM) was 
employed to further characterize the ultrastructural properties of the Reelin-positive deposits, 
their potential association with cellular organelles, and to confirm the preliminary findings of the 
formation of fibrillary deposits following prenatal brain infection with the viral mimic PolyI:C.  
These studies were further complemented by the determination of the biochemical compositions 
of these extracellular deposits in order to identify the proteins that are enriched in this area and 
potentially involved in the early stages of aggregation. We further aimed to decipher the putative 
association of Reelin and its functional signaling in AD-like pathology. Therefore, we 
investigated transgenic AD mice with reduced Reelin levels by biochemical and 
immunohistochemical methods. In the following section the main results of the 4 chapters 
obtained will be briefly summarized: 
 
1) A new and optimized immunohistochemical protocol was developed involving a stringent 
protease pretreatment which markedly enhanced Reelin-IR. Surprisingly, this allowed for the 
first time the specific detection of variable forms of murine APP in these particular 
structures. Ultrastructurally, the Reelin granules appeared to be of extracellular and fibrillary 
origin.  
2) Additional investigation at the subcellular level revealed striking new insights into granule 
morphology as well as its putative origin. Here, we have evidence that the granular structure 
likely originates from axonal varicosities, indicative of being an intracellular phenomenon. 
Moreover, ultrastructural investigation of prenatal immune challenged mice with the viral 
mimic PolyI:C revealed significant morphological differences in size and the elevated 
presence of organelles, namely mitochondria, in these fibrillary granular structures.  
3) We were establishing a protocol for proteomic analysis combining laser capture 
microdissection with highly sensitive mass spectrometric analysis of the Reelin-positive 
deposits. However, although further optimization with respect to sample purity, sample 
processing and reduction of sample complexity will be required, we were able to confirm for 
the first time the enrichment of full-length Reelin and the N-terminal fragment in these 
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deposits by western blotting, verifying our immunohistochemical and –electron microscopy 
findings in aged species 
4) We confirmed in vivo previous in vitro data, that a reduced Reelin expression aggravates 
amyloid pathology by altering APP processing and elevates Tau pathology in transgenic AD 
mice. We further provide biochemical evidence that alterations in Reelin expression and in 
its signaling critical modulates APP processing and Tau pathology. 
 
These data provide strong evidence and support previous investigations (Knuesel et al., 2009) 
that Reelin itself aggregates during aging, reflecting potential alterations in subcellular 
trafficking and its proteolytic processing.  
 
WHERE THE REELIN-POSITIVE AGGREGATES APPEAR – EVIDENCE OF AN INTRACELLULAR 
ORIGIN 
In the adult brain, Reelin is expressed by GABAergic interneurons that are dispersed throughout 
the forebrain, as well as by glutamatergic pyramidal neurons in layer II of the entorhinal cortex, 
olfactory mitral cells and cerebellar granule cells (Abraham and Meyer, 2003; Abraham et al., 
2004; Alcantara et al., 1998; Baloyannis, 2005; Chin et al., 2007; Knuesel et al., 2009; Lacor et 
al., 2000; Miettinen et al., 2005; Pappas et al., 2003; Pesold et al., 1998a; Ramos-Moreno et al., 
2006). These are also the layers where Reelin accumulation in the form of the granular clusters 
occurs throughout aging, accompanied by loss of Reelin expressing cells (Knuesel et al., 2009), 
going in line with the observation of high Reelin-IR after birth and in young adults, but declining 
in the course of adult life (Perez-Garcia et al., 2001). The Reelin-expressing neurons in layer II 
of the entorhinal cortex project via the perforant path to the hippocampus (Muraoka et al., 2007; 
Steward and Scoville, 1976; Witter and Groenewegen, 1984), involving axonal transport of 
Reelin to the stratum lacunosum moleculare (slm) as well as the outer molecular layer (ml) of the 
hippocampal formation. This is in agreement with the contribution of Reelin to synaptic 
plasticity (Weeber et al., 2002) as well as the detection of high levels of Reelin-IR in these 
layers. Interestingly, the described Reelin deposits mainly appear in the slm and sr region of the 
CA1 hippocampal region. Importantly, the entorhinal cortex, the basal forebrain and the 
hippocampus - core structures playing a critical role in encoding, storage and retrieval of 
episodic memory and being crucial for learning and cognitive abilities(Qiu and Weeber, 2007); 
reviewed in (Eichenbaum, 2004)) -  are primarily affected by the neuropathology of AD (Braak 
and Braak, 1991). One would suggest that the Reelin aggregates are related to axonal structures 
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terminating in these regions. This gives already rise to the assumption that Reelin aggregation 
putatively reflecting a consequence of axonal degeneration, an event playing a major role in the 
neuropathology and/or development of AD. The deposits may serve as seeding points for 
amyloid deposition. It may, however also represent a protective mechanism for keeping toxic 
substances away from neurons. This further supports the observations that there is a considerable 
variability in quantity of the Reelin deposits throughout aging.  
 
Regarding our 3D-EM studies (Study II), there is strong evidence that the granular structures are 
not simply round and ovoid individual structures, that they are interconnected representing 
dendritic and/or axonal projections; indicative of an intracellular origin. This is further supported 
by our biochemical findings reporting the presence of several proteins, especially of intracellular 
origin, within or associated with the Reelin-positive deposits ((Knuesel et al., 2009), Study III). 
Supporting, the work of Derer and Goffinet (Derer et al., 2001) and another recent paper by the 
group of Phelps (Kubasak et al., 2004) suggest that Reelin is likely to be secreted from varicose 
axons. These swelling-like structures might in turn represent a budding event of degenerative 
material formed in the axon – likely as a consequence of abnormal Reelin processing - which 
then gets removed and form the described granules. This is strongly supported by our own 
ultrastructural findings as well the positive immunostaining of Reelin and myelin basic protein 
after prenatal PolyI:C exposure (Study II). Potential disruption of the myelin sheaths on the 
axons likely due to PolyI:C-induced inflammation might trigger alterations in axonal transport in 
these subjects or further, might lead to axonal degeneration, explaining the increased density of 
clustered Reelin-positive deposits in these mice. The increased production of phosphorylated 
Tau due to PolyI:C (unpublished data) support these findings, as phosphorylation of Tau yields 
its detachment from microtubules and delocalization to somadodendritic compartments 
(Ballatore et al., 2007; Ittner et al., 2010) affecting in turn the stability and integrity of axons. 
This might be an explanation for the increased appearance of Reelin-positive granules in the 
immune challenged mice. Another paper describing axonal swellings due to disturbed autophagy 
(Lee et al., 2011) supports our hypothesis that the aggregation of Reelin into clustered granules 
might derive from inappropriate clearance of the protein. It is known that maturation of 
autophagolysosomes is inhibited in neurodegenerative diseases, resulting in swellings along 
dystrophic neurites. This is suggestive, that PolyI:C likely triggers this insufficiency of 
autophagosome formation and/or disruption of the autophagy system  in the normal wild type 
mice and therefore results in elevated Reelin plaque load. A failure in autophagy, a defending 
process for clearing altered/dead organelles and protein aggregates, would accelerate the loss of 
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cellular integrity, ultimately leading to neuronal degeneration. It can be assumed that the 
formation of these clusters is a sign of a neurodegenerative event in the aging brain, going in line 
with the finding of similar structures in the aging brain obtained by other research groups 
(Akiyama et al., 2000; Jucker and Ingram, 1994; Nakamura et al., 1995). This is further 
supported by our ultrastructural investigations as well as silver stainings that the aggregates itself 
likely represent degeneration on its own (Study II). Further support for the granules being 
degenerative came from one recent study demonstrating Periodic acid Schiff (PAS) positive 
granules in proximal axons in the spinal cord and sciatic nerves in a model of infantile 
neuroaxonal dystrophy (INAD) (Beck et al., 2011). Interestingly, they were positive for a 
mitochondrial outer membrane marker, but negative for the inner mitochondrial membrane, 
suggestive that these detected spheroids originate from degenerating mitochondria. This 
abnormal mitochondrial collapse gave rise to a focal disappearance of the axonal cytoskeleton, 
resulting in axonal swellings due to mitochondrial release of cytochrome c and reactive oxygen 
species (ROS), possibly yielding to axonal degeneration. Further, these structures are 
significantly increased in the axonal distal part in the late clinical stage. This phenomenon might 
likely be applicable to our ultrastructural as well our immunohistochemical findings, where 
Reelin-positive granules may appear from neuronal protrusions (Study II). Also findings of 
degenerating organelles in the granules investigated in our lab by EM might be potential 
degenerating mitochondria as described in (Beck et al., 2011). This data suggest that our 
investigated Reelin-positive granules originate from degeneration of presynaptic membranes at 
axonal terminals.  
However, more approaches, concerning different stainings for several markers already 
mentioned above, a complete 3D reconstruction of the granular substructure as well as a 
longitudinal study throughout aging have to be accomplished, to precisely determine the granular 
origin.   
 
CORRELATION BETWEEN REELIN AGGREGATES AND AD 
A current precise cause and cure of AD remains still elusive. Although the amyloid hypothesis 
(Hardy and Selkoe, 2002), postulating that Aβ is the pivotal cause of AD, dominated the 
research field of the disease, as highly supported by many genetic and biochemical data, there is 
growing evidence that Aβ is unlikely to be the exclusive initiating factor in the AD etiology (for 
review see Herrup, 2010; Pimplikar, 2009). Necessarily, finding other contributing factors 
and/or mechanisms contributing to the pathology of AD beside Aβ would fill gaps in our 
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knowledge of the etiology of the disease and reconcile the findings that cannot be explained 
exclusively by the amyloid cascade hypothesis. Impairment in Reelin processing and/or 
signaling as well the formation of the Reelin-positive plaques may facilitate or initiate AD 
progression. Several groups have already found a strong impact of Reelin in the pathology of AD 
by either negatively regulating Tau phosphorylation (Hiesberger et al., 1999; Ohkubo et al., 
2003; Trommsdorff et al., 1999) or by altering APP processing (Hoe et al., 2006, 2009b). These 
are just a few of several more studies conducting this potential involvement. Moreover, genetic 
evidence is given by a study (Kramer et al., 2010) revealing the RELN locus as one of the 
putative risk factors in AD. To the best of our knowledge, our data were the first describing Aβ 
aggregation in normal aging wild type mice (Study I (Doehner et al., 2010)). Findings show the 
presence of Aβ or APP fragments in the formation of the granular Reelin-positive deposits, as 
well as fibrillary Aβ deposition as seen in human in close vicinity of the granular aggregates, 
indicating that similar aging-related pathophysiological changes occur in aged rodents. With the 
collection of antibodies used, we could rule out the presence of full-length APP, however, we 
have not deciphered yet which type of APP ectodomains or which proteolytic fragments of APP 
are present in these plaques. Recent investigations by the group of Pelegri (Del Valle et al., 
2010) report also the appearance of Aβ in similar clustered granular structures in the 
hippocampal formation of SAMP8 mice, mice which are also lacking transgenic interference,  
supporting our findings in normal aged wild type mice (Study I (Doehner et al., 2010)). They 
even used specific antibodies for Aβ, binding only to cleaved ends, likely indicating, that in fact 
the Aβ peptide is present in the clustered granules. Nevertheless, based on these findings as well 
as the recent data of (Hoe et al., 2009a; Nikolaev et al., 2009), further investigations using 
specific antibodies binding to the different cleaved sites of the proteolytic APP fragments need to 
be accomplished to clearly identify the type of APP fragments as well as the interaction of 
Reelin and the N-terminal fragment of APP in young and aged wild type mice. Further, several 
other studies show that similar granular clusters are also co-localizing with Tau, MAP2 and 
syndecan-2, components which are also found in senile plaques in AD (Del Valle et al., 2010; 
Kern et al., 2011; Manich et al., 2011), supporting the hypothesis of Reelin aggregation being a 
seeding site for other aggregation prone proteins. On the other hand these findings are also 
supporting the fact that either altered Reelin signaling and/or processing and its subsequent 
aggregation correlates with axonal degeneration. Besides the studies performed here, this is 
further supported by a previous study conducted in our lab (Madhusudan et al., 2009) centering 
around the hypothesis that early accumulations of Reelin deposits in the projection areas of 
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subcortical neurons could impair the integrity of axonal terminals, potentially resulting in 
degeneration of cholinergic neurons in the basal forebrain, known to be early affected in AD. 
 
In order to identify the putative neurotoxic factors within these extracellular Reelin aggregates, 
we initiated a proteomic approach to investigate their composition as well as temporal and 
spatial progression. Using this approach we expected to confirm the presence of Reelin and 
potentially also its proteolytic fragments in these extracellular deposits and answer whether there 
is an association of proteolytic APP fragments and Reelin in wild type mice. Further, this study 
might decipher where these granules originate from. Unfortunately, the keratin contamination 
and the low amount of the sample were major limitations in the proteomic analysis of the 
microdissected Reelin granules. Although, careful and even successful efforts were made in the 
second MS experiment, we still failed to detect any Reelin peptides in these samples. However, 
this does not indicate that Reelin was not present in the sample and that the protocol is not 
working properly. It needs to be stressed that a comprehensive analysis especially of such 
complex mixtures with low abundance of the required protein are still very challenging tasks and 
should not be underestimated. Note, that for several reasons already discussed (Kuster et al., 
2005; Mallick et al., 2007), it is not the case that only the presence of a protein in a small sample 
implies the readily observation of its peptides in proteomic analysis; in the most cases only a 
single peptide might be observed for many proteins. Although, we failed to detect the target 
protein, the protocol seems already very promising, and future studies should be accomplished 
with a much higher amount of captured sample and simplifying the composition of the mixture 
by additional purification steps discussed already previously. For future proteomic studies, we 
believe that the ability to detect qualitative and quantitative differences from the plaques 
according to their appearance rate in immune challenged mice compared to the control represent 
an important asset to understand better the molecular basis of this plaque formation as well its 
association in the pathology of neurodegenerative diseases.  One further perspective, which 
should be considered in this proteomic approach, would be to study post-translational 
modifications (PTMs, like glycosylation) in the immune challenged mice compared to the NaCl 
exposed control. It is likely that Reelin glycosylation changes due to this immune challenge and 
might be a cause of the accelerated and increased plaque load in these mice. This would go in 
line with the recently addressed putative link between abnormal Reelin levels and AD 
pathogenesis (Botella-Lopez et al., 2006, 2010; Saez-Valero et al., 2003). They report altered 
glycosylation of Reelin as well as a preferential up-regulation of the N-terminal 180 kDa Reelin 
fragment in the CSF and frontal cortex of AD patients, whereas full-length and other proteolytic 
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fragments of Reelin remained unaltered in control and AD subjects (Botella-Lopez et al., 2006). 
Another recent study showed that the N-terminal fragment of Reelin can be generated within the 
endosomes after internalization of the full-length form (Hibi and Hattori, 2009), pointing to the 
possibility that in AD patients the endosomal recycling and re-secretion of this fragment into the 
extracellular space could also be significantly affected, likely indicating that the N-terminal 
fragments may preferentially oligomerize and aggregate in the extracellular matrix during aging 
after an abnormal increase. Indeed, our biochemical investigations confirmed that these Reelin 
deposits contain besides the full-length form also considerable amounts of N-terminal Reelin 
fragments (Study III). However, why Reelin starts to aggregate and which precise molecular 
mechanism potentially connects altered Reelin signaling to the pathology of AD has not been 
deciphered yet. To directly test the role of Reelin in AD pathophysiology, we crossed 
heterozygous reeler mice into a transgenic AD background (Knobloch et al., 2007b) to 
investigate the effect of reduced Reelin-mediated signaling on Aβ plaque and NFT formation, as 
well as neurodegenerative processes (Study IV (Kocherhans et al., 2010)). We could provide the 
first in vivo support that dysfunctional Reelin-mediated signaling is a critical upstream modulator 
of amyloidogenic APP processing and Tau hyperphosphorylation, both likely contributing to 
progressive neurodegeneration observed in Reelin-deficient AD mice. Altogether, these 
observations add to our understanding of the putative molecular mechanisms that underlie the 
pathogenesis of AD. Reduced Reelin-dependent signaling during aging appears as crucial 
driving force able to shift APP processing from non-amyloidogenic to amyloidogenic forms in 
vivo. Moreover, alterations in the proteolytic cleavage of Reelin might be a potential factor 
impairing Reelin signaling and causing several downstream effects being possibly involved in 
the etiology of AD. Cleavage of Reelin impairs the formation of dimers and therefore the correct 
binding to its receptors (Kohno et al., 2009; Kubo et al., 2002; Strasser et al., 2004), 
consequently impairing the signaling cascade and formation of aggregates as Reelin fragments 
are more prone to aggregation (Kubo et al., 2002). As already mentioned in the introduction we 
recently found that tPA is a potential protease cleaving Reelin at the C-terminal site (D. Krstic, 
unpublished data), which in turn is known to be susceptible to aggregate (Nakano et al., 2007).  
Importantly, tPA-mediated cleavage of Reelin potentially impairs the interaction with its 
receptors, resulting in less precise induction of its signaling cascades (Hibi and Hattori, 2009; 
Nakano et al., 2007) as well reduction in the internalization rate of ApoER2 with Reelin (D. 
Krstic, unpublished data). In line, a second protease involved in the cleavage of Reelin was 
found, namely ADAMTS-4, indicating a dominant N-terminal cleavage compared to the 
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cleavage at the C-terminal (D. Krstic, unpublished data). This would further support the 
hypothesis that the granular structures are mainly formed from N-terminal fragments of Reelin. 
Alterations in either the more likely intracellular processing or the exocytosis of the N-terminus 
(Hibi and Hattori, 2009) are a likely explanation for the intracellular aggregation of Reelin as 
shown by EM (Study II). These accumulations potentially get cleaned through axonal transport, 
supporting our findings of Reelin and/or this particular fibrillary structure in these neuritic 
processes (Study II).  
 
THE ROLE OF INFLAMMATION IN THE NEUROPATHOLOGY - PERSPECTIVES 
Studies performed by us and many other labs have provided exciting new insights into the 
function of Reelin-mediated signaling in synaptic function in the adult and aging brain. 
However, the molecular mechanisms how this developmental signaling pathway regulates 
directly or indirectly AD-associated pathophysiological processes remains to be fully elucidated. 
Moreover, many of the studies including ours have employed transgenic AD mice that model the 
genetic, early-onset form of the disease. Though, the majority of patients suffer from the age-
associated, late-onset form of AD. Furthermore, several recent studies describe an active 
involvement of the immune system in the etiology of sporadic AD (Akiyama et al., 2000; 
McGeer and McGeer, 2002; Wyss-Coray, 2006), and that peripheral infections potential drive 
the pathophysiology of this disease (Schmidt et al., 2002).  The question, therefore, is: can the 
investigations of dysfunctional Reelin-mediated signaling in normal aged wild type mice provide 
us some insights into the molecular mechanisms of late-onset AD? In other words, is an impaired 
Reelin-mediated signaling sufficient to induce AD-like neuropathological changes in aged wild 
type rodents that would allow us to study putative early disease-relevant pathophysiological 
alterations in a more physiological context?  
 
Our recent experimental approach might provide first support for this hypothesis:  (1) We have 
demonstrated that a systemic administration of the cytokine releaser and viral mimic PolyI:C in 
mice provides convincing support to the link between maternal infection during pregnancy and 
behavioral and neurochemical abnormalities in the adult offspring (Meyer et al., 2005; Shi et al., 
2003; Zuckerman et al., 2003). We have recently provided the first evidence that a prenatal 
immune challenge during late gestation results in significant acceleration of aging-associated 
neuropathological alterations in non-transgenic wild type mice. This involved reduced Reelin 
expression levels, precocious accumulation of Reelin-positive deposits, as well as long-term 
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alterations in inflammatory modulators (Knuesel et al., 2009), suggesting inflammatory 
cytokines as putative regulators of Reelin expression, proteolytic processing, and/or signaling. 
This goes in line with our ultrastructural investigations, demonstrating that immune challenged 
mice (PolyI:C) showed a trend towards larger granule size accompanied by an increased 
association with mitochondria, highly indicative of an intracellular origin, supported by 
biochemical findings. (2) The application of our adapted immunohistochemical protocol 
involving protease-pretreatment allowed for the first time the detection of murine proteolytic 
APP fragments in extracellular amyloid-like plaques (Study I (Doehner et al., 2010)), indicating 
that the experimental conditions contribute more strongly to the observed lack in amyloid 
deposition in aged rodents than anticipated. (3) In addition, we recently found that a viral like 
immune challenge at a critical time point during gestation is sufficient to cause long term 
alterations in the brain leading to the development of pathological features characteristic for AD 
as elevated processing of APP and increased Tau phosphorylation.  This was accompanied by 
Tau delocalization, and an overproduction of inflammatory cytokines (Il-1β, Il-6, Il-10; TNF-α) 
(unpublished data, (Madhusudan et al.)), the same cytokines which are increased in the brains of 
AD patients (Mrak and Griffin, 2005). Further impact of PolyI:C on Reelin processing and 
signaling was given by biochemical approaches showing altered Reelin-fragment levels 
compared to normal wild type mice (unpublished data). Interestingly, this induction triggered the 
onset of such pathology in non-transgenic animals. This data support strongly the involvement of 
neuroinflammation in the onset and progression of the late-onset form of the disease, being likely 
a causative factor. This suggests that an inflammation early in life can already sense the brain to 
develop AD, maybe due to the altered cytokine levels, which later might cause alteration in 
Reelin processing and signaling, as well as in APP processing. 
 
Our studies demonstrate that normal wild type mice are a very useful and accessible model 
system to gain insights into the development of the sporadic form of the disease. Therefore, the 
combination of these experimental paradigms presented in this thesis is expected to provide a 
potent way to address aging-associated neuropathology in non-transgenic mice or rats.  
 
CONCLUSION 
Accumulating evidence indicates that the same Reelin-mediated signaling pathway required for 
proper early neurodevelopmental processes is equally relevant for the regulation of adult 
neuronal function and plasticity. Both a decline and overproduction of Reelin in adulthood is 
Conclusion 
160 
associated with abnormal synaptic function, indicating an important homeostatic regulation of 
this extracellular glycoprotein (for review (Doehner and Knuesel, 2010)). Our investigations 
showed for the first time that aging across species is accompanied by a reduction in Reelin 
expression, accompanied by a highly selective layer-specific accumulation of Reelin-positive 
amyloid-like plaques.  
 
 
 
 
FIGURE 1: Hypothetical model representing the link between Reelin, its alterations and the influence of 
inflammation in the pathogenesis of AD. During aging, a pronounced decrease in Reelin expression accompanied 
by accumulation of Reelin deposits has been reported. There are three potential and partially interconnected 
hypotheses how altered Reelin could potentially contribute to the pathogenesis of AD: (1) Due to the aging-
associated decrease in Reelin expression and alterations in extracellular Reelin processing, Reelin starts to form 
granular deposits, which possibly serve as a seeding site for Aβ and other potential aggregation-prone proteins, 
ultimately leading to the formation of amyloid plaques. Further, alterations in Reelin processing cause changes in 
the Reelin-mediated signaling cascade which favors amyloidogenic APP processing and results in an increase in Aβ 
production, with that facilitating the accumulation of the peptides in granular deposits or in amyloid plaques. (2) 
Experimental evidence supports the hypothesis that Reelin aggregates are of intracellular origin. This might be 
caused by age-related impairments in autophagy alterations as well as in alterations in the myelin sheath structure, 
potentially related to axonal swellings accompanying improper clearance of organelles and misfolded or abnormally 
processed proteins, including Reelin. This in turn is expected to result in axonal degeneration and release of the 
accumulated proteins into the neuropil; an alternative way to provide a seeding site for amyloid plaque formation. 
(3) Elevated Tau phosphorylation due to deficiency in Reelin signaling leads to microtubule instability and therefore 
inefficient and poorly coordinated axonal transport constituting an additional detrimental factor underlying axonal 
degeneration. Alterations in all these different pathways provide a strong link between dysfunctional Reelin 
signaling and pathophysiological processes characteristic for AD (green boxes). Alterations due to early 
inflammation or genetic reduction of Reelin aggravate and accelerate these changes potentially underlying the shift 
from normal to pathological brain aging.  
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Taken together, the presented findings so far provide important information regarding putative 
temporal processes underlying the transition from normal to pathological aging, including an 
intracellular and abnormal aggregation of Reelin, possibly leading to neurodegeneration, which 
gets accelerated by a prenatal peripheral immune challenge (PolyI:C), and increased Aβ~ and 
Tau pathology due to haploinsufficiency of Reelin. Combining the results presented in this work 
with the recent findings in our lab the following model can be proposed (Fig. 1), pointing to 
Reelin as a prospective missing link in the development of neuropathological changes in the 
etiology of AD. Comprehensive ultrastructural and immunohistochemical characterizations 
indicate that Reelin, likely by self-aggregating into abnormal oligomeric or protofibrillary 
deposits during aging, is also able to induce or result from degenerative axonal varicosities that 
selectively terminate in plaque dense areas within the hippocampal formation. These findings 
give evidence that the Reelin-positive granules are of intracellular origin, and not exclusively 
extracellular as first expected. It is likely that other aggregation-prone proteins that accumulate 
and associate with these deposits further contribute to the degenerative processes investigated. 
Healthy and cognitively normal subjects are normally able to sufficiently clear and degrade these 
deposits, whereas cognitively impaired aged mice failed to do so (Knuesel et al., 2009). This 
might be indicative of alterations in the autophagy system as well as altered axonal transport 
processes. Autophagy pathway changes may also occur due to systemic inflammation, 
potentially explaining the higher plaque load in the PolyI:C exposed animals with concomitant 
appearance of mitochondria in these granular structures. Reduced Reelin, as well as 
inflammation, are likely able to trigger AD-like pathophysiological processes including 
increased APP processing and hyperphosphorylation of Tau (pTau). Increased levels of pTau in 
turn lead to the destabilization of axonal processes as well as the transport system, which 
possibly results in the appearance of Reelin aggregates in the axons. Altogether, these 
correlations potentially contribute to progressive neurodegeneration in aged individuals, as well 
providing a seeding point for aggregation prone proteins, major characteristic phenomena in the 
etiology of AD. We suggest that dysfunction in Reelin-mediated signaling and/or processing, 
either due to early inflammation events or genetic reduction of Reelin, represents an important 
driving force able to induce a shift from normal to pathological aging. 
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ABBREVIATIONS 
 
ABC  Ammonium bi-carbonate 
ACN  Acetonitrile 
AD  Alzheimer’s disease 
AICD  APP intracellular domain 
ApoE  Apolipoprotein E 
ApoER2  Apolipoprotein E Receptor 2 
APP  Amyloid precursor protein 
Aβ  Amyloid-β 
CA  Cornu ammonis 
CDK5  Cyclin-dependent kinase 5 
CID  Collision induced dissociation 
CNS  Central Nervous System 
CR  Cajal-Retzius  
Dab1  Disabled-1 
DOC  Sodium Deoxycholate 
DTT  dithiothreitol 
EM  Electron Microscopy 
EOAD  Early-onset Alzheimer’s disease 
FA  formic acid 
FDR  False discovery rate 
GABA  γ-aminobutyric acid 
GD17  gestation day 17 
GFAP  Glial fibrillary acidic protein 
GSK3β  Glycogen synthase kinase 3β 
GWAS  genome wide association studies 
HSPG  heparan sulfate proteoglycan 
HPLC High performance liquid 
chromatography 
IAA  iodoacetamide 
IEM  Immuno-electron microscopy 
IHC  Immunohistochemistry 
IR  Immunoreactivity 
kDa  Kilo Dalton 
LCM  laser capture microdissection 
LOAD  late-onset Alzheimer’s disease 
LMD  Laser microdissection 
 
LTP  long-term potentiation 
ml  molecular layer 
MS  Mass spectrometry 
NFT  Neurofibrillary tangle 
NGS  Normal goat serum 
PB  Phosphate buffer 
PBS  Phosphate buffered saline 
PG  polyglycogen 
PI3K  phosphatidylinositol 3-kinase 
PolyI:C polyriboinosinic-polyribocytidilic 
acid 
PSEN  presenilins 
pTau  hyperphosphorylated Tau  
RIPA radioimmunoprecipitation assay 
buffer 
RP  Reversed phase 
RT  room temperature 
SB  Sample buffer 
SDS-PAGE sodium dodecyl sulfate 
polyacrylamide gel electrophoresis  
SFK  Src family tyrosine kinase 
slm  stratum lacunosum moleculare 
sr  stratum radiatum 
TBS  Tris-buffered saline 
TCEP  tris-2-carboxyethyl-phosphine 
TFA  trifluoroacetic acid 
TPP  Trans Proteomic Pipeline 
WB  Western blot 
WT  wild type 
VLDLR very-low-density lipoprotein 
receptor 
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